 EX-2.1     \t \t

 \t\t

 \t\t\tExhibit 2.1 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\tAGREEMENT AND PLAN OF MERGER \t\t

 \t\t

 \t\t\tAND REORGANIZATION \t\t

 \t\t

 \t\t\tamong: \t\t

 \t\t

 \t\t\tBIOPHARMX CORPORATION, \t\t

 \t\t

 \t\t\ta Delaware corporation; \t\t

 \t\t

 \t\t\tBITI MERGER SUB, INC. \t\t

 \t\t

 \t\t\ta Delaware corporation; and \t\t

 \t\t

 \t\t\tTIMBER PHARMACEUTICALS LLC, \t\t

 \t\t

 \t\t\ta Delaware limited liability company \t\t

 \t\t

 \t\t\tDated as of January 28, 2020 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t

 \t\t

 \t\t

 \t\t

 \t\t\tTABLE OF CONTENTS \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t 

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tPage

 \t\t\t\t \t\t\t 
---|---|---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 1

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDESCRIPTION OF TRANSACTION

 \t\t\t\t \t\t\t\t|

2 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tThe Merger

 \t\t\t\t \t\t\t\t|

2 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEffects of the Merger

 \t\t\t\t \t\t\t\t|

2 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tClosing; Effective Time

 \t\t\t\t \t\t\t\t|

2 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCertificate of Formation; Directors, Managers and Officers

 \t\t\t\t \t\t\t\t|

3 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.5 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tConversion of Shares and Membership Interests

 \t\t\t\t \t\t\t\t|

3 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.6 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tClosing of the Company's Transfer Books

 \t\t\t\t \t\t\t\t|

4 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.7 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tIssuance of Certificates

 \t\t\t\t \t\t\t\t|

4 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

1.8 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tFurther Action

 \t\t\t\t \t\t\t\t|

5 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 2

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tREPRESENTATIONS AND WARRANTIES OF THE COMPANY

 \t\t\t\t \t\t\t\t|

5 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDue Organization; Subsidiaries

 \t\t\t\t \t\t\t\t|

5 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tOrganizational Documents

 \t\t\t\t \t\t\t\t|

6 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAuthority; Binding Nature of Agreement

 \t\t\t\t \t\t\t\t|

6 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tVote Required

 \t\t\t\t \t\t\t\t|

6 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.5 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNon-Contravention; Consents

 \t\t\t\t \t\t\t\t|

6 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.6 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCapitalization

 \t\t\t\t \t\t\t\t|

7 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.7 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tFinancial Statements

 \t\t\t\t \t\t\t\t|

8 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.8 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAbsence of Changes

 \t\t\t\t \t\t\t\t|

9 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.9 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAbsence of Undisclosed Liabilities

 \t\t\t\t \t\t\t\t|

9 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.10 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTitle to Assets

 \t\t\t\t \t\t\t\t|

9 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.11 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tReal Property; Leasehold

 \t\t\t\t \t\t\t\t|

9 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.12 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tIntellectual Property

 \t\t\t\t \t\t\t\t|

10 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.13 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAgreements, Contracts and Commitments

 \t\t\t\t \t\t\t\t|

13 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.14 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCompliance; Permits; Restrictions

 \t\t\t\t \t\t\t\t|

14 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.15 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tLegal Proceedings; Orders

 \t\t\t\t \t\t\t\t|

17 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.16 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTax Matters

 \t\t\t\t \t\t\t\t|

18 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.17 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEmployee and Labor Matters; Benefit Plans

 \t\t\t\t \t\t\t\t|

19 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.18 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEnvironmental Matters

 \t\t\t\t \t\t\t\t|

22 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.19 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tInsurance

 \t\t\t\t \t\t\t\t|

23 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.20 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNo Financial Advisors

 \t\t\t\t \t\t\t\t|

23 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.21 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTransactions with Affiliates

 \t\t\t\t \t\t\t\t|

23 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.22 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAnti-Bribery

 \t\t\t\t \t\t\t\t|

23 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

2.23 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDisclaimer of Other Representations or Warranties

 \t\t\t\t \t\t\t\t|

24 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 3

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tREPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

 \t\t\t\t \t\t\t\t|

24 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDue Organization; Subsidiaries

 \t\t\t\t \t\t\t\t|

24 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tOrganizational Documents

 \t\t\t\t \t\t\t\t|

25 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAuthority; Binding Nature of Agreement

 \t\t\t\t \t\t\t\t|

25 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tVote Required

 \t\t\t\t \t\t\t\t|

25 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-i-  \t\t

  

 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t

3.5 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t 

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNon-Contravention; Consents

 \t\t\t\t \t\t\t\t|

25 \t\t\t\t \t\t\t 
---|---|---|--- 
 \t\t\t \t\t\t\t

3.6 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCapitalization

 \t\t\t\t \t\t\t\t|

26 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.7 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tSEC Filings; Financial Statements

 \t\t\t\t \t\t\t\t|

27 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.8 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAbsence of Changes

 \t\t\t\t \t\t\t\t|

29 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.9 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAbsence of Undisclosed Liabilities

 \t\t\t\t \t\t\t\t|

29 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.10 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTitle to Assets

 \t\t\t\t \t\t\t\t|

29 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.11 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tReal Property; Leasehold

 \t\t\t\t \t\t\t\t|

29 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.12 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tIntellectual Property

 \t\t\t\t \t\t\t\t|

30 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.13 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAgreements, Contracts and Commitments

 \t\t\t\t \t\t\t\t|

33 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.14 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCompliance; Permits

 \t\t\t\t \t\t\t\t|

34 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.15 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tLegal Proceedings; Orders

 \t\t\t\t \t\t\t\t|

37 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.16 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTax Matters

 \t\t\t\t \t\t\t\t|

37 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.17 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEmployee and Labor Matters; Benefit Plans

 \t\t\t\t \t\t\t\t|

39 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.18 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEnvironmental Matters

 \t\t\t\t \t\t\t\t|

42 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.19 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tInsurance

 \t\t\t\t \t\t\t\t|

43 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.20 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNo Financial Advisors

 \t\t\t\t \t\t\t\t|

43 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.21 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTransactions with Affiliates

 \t\t\t\t \t\t\t\t|

43 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.22 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tValid Issuance

 \t\t\t\t \t\t\t\t|

43 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.23 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tOpinion of Financial Advisor

 \t\t\t\t \t\t\t\t|

43 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.24 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAnti-Bribery

 \t\t\t\t \t\t\t\t|

43 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

3.25 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDisclaimer of Other Representations or Warranties

 \t\t\t\t \t\t\t\t|

44 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 4

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCERTAIN COVENANTS OF THE PARTIES

 \t\t\t\t \t\t\t\t|

44 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

4.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tOperation of Parent's Business

 \t\t\t\t \t\t\t\t|

44 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

4.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tOperation of the Company's Business

 \t\t\t\t \t\t\t\t|

46 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

4.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAccess and Investigation

 \t\t\t\t \t\t\t\t|

48 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

4.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tParent Non-Solicitation

 \t\t\t\t \t\t\t\t|

49 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

4.5 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCompany Non-Solicitation

 \t\t\t\t \t\t\t\t|

50 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

4.6 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNotification of Certain Matters

 \t\t\t\t \t\t\t\t|

51 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 5

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tADDITIONAL AGREEMENTS OF THE PARTIES

 \t\t\t\t \t\t\t\t|

52 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tRegistration Statement; Proxy Statement

 \t\t\t\t \t\t\t\t|

52 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCompany Member Written Consent

 \t\t\t\t \t\t\t\t|

53 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tParent Stockholders' Meeting

 \t\t\t\t \t\t\t\t|

54 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tRegulatory Approvals

 \t\t\t\t \t\t\t\t|

56 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.5 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEmployee Benefits

 \t\t\t\t \t\t\t\t|

56 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.6 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tIndemnification of Officers and Directors

 \t\t\t\t \t\t\t\t|

56 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.7 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAdditional Agreements

 \t\t\t\t \t\t\t\t|

58 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.8 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDisclosure

 \t\t\t\t \t\t\t\t|

58 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.9 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tListing

 \t\t\t\t \t\t\t\t|

58 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.10 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTax Matters

 \t\t\t\t \t\t\t\t|

59 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.11 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDirectors and Officers

 \t\t\t\t \t\t\t\t|

59 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.12 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tSection 16 Matters

 \t\t\t\t \t\t\t\t|

59 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.13 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCooperation

 \t\t\t\t \t\t\t\t|

59 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.14 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAllocation Certificate

 \t\t\t\t \t\t\t\t|

59 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-ii-  \t\t

  

 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t

5.15 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t 

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCompany Financial Statements

 \t\t\t\t \t\t\t\t|

60 \t\t\t\t \t\t\t 
---|---|---|--- 
 \t\t\t \t\t\t\t

5.16 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTakeover Statutes

 \t\t\t\t \t\t\t\t|

60 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.17 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCalculation of Net Cash; Adjustment to Parent Allocation
Percentage

 \t\t\t\t \t\t\t\t|

60 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.18 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tParent Lease Obligations

 \t\t\t\t \t\t\t\t|

61 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

5.19 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tFunding Condition

 \t\t\t\t \t\t\t\t|

61 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 6

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY

 \t\t\t\t \t\t\t\t|

61 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

6.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEffectiveness of Registration Statement

 \t\t\t\t \t\t\t\t|

61 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

6.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNo Restraints

 \t\t\t\t \t\t\t\t|

61 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

6.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tStockholder/Member Approval

 \t\t\t\t \t\t\t\t|

61 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

6.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tListing

 \t\t\t\t \t\t\t\t|

61 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 7

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND
MERGER SUB

 \t\t\t\t \t\t\t\t|

62 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

7.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAccuracy of Representations

 \t\t\t\t \t\t\t\t|

62 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

7.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tPerformance of Covenants

 \t\t\t\t \t\t\t\t|

62 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

7.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDocuments

 \t\t\t\t \t\t\t\t|

62 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

7.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tFunding Condition

 \t\t\t\t \t\t\t\t|

62 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

7.5 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTax Certificate

 \t\t\t\t \t\t\t\t|

63 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

7.6 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNo Company Material Adverse Effect

 \t\t\t\t \t\t\t\t|

63 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 8

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY

 \t\t\t\t \t\t\t\t|

63 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

8.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAccuracy of Representations

 \t\t\t\t \t\t\t\t|

63 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

8.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tPerformance of Covenants

 \t\t\t\t \t\t\t\t|

63 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

8.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDocuments

 \t\t\t\t \t\t\t\t|

64 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

8.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNo Parent Material Adverse Effect

 \t\t\t\t \t\t\t\t|

64 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 9

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTERMINATION

 \t\t\t\t \t\t\t\t|

64 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

9.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTermination

 \t\t\t\t \t\t\t\t|

64 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

9.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEffect of Termination

 \t\t\t\t \t\t\t\t|

66 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

9.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tExpenses; Termination Fees

 \t\t\t\t \t\t\t\t|

66 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSection 10

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tMISCELLANEOUS PROVISIONS

 \t\t\t\t \t\t\t\t|

69 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.1 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNon-Survival of Representations and Warranties

 \t\t\t\t \t\t\t\t|

69 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.2 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAmendment

 \t\t\t\t \t\t\t\t|

69 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.3 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tWaiver

 \t\t\t\t \t\t\t\t|

69 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.4 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tEntire Agreement; Counterparts; Exchanges by Electronic
Transmission

 \t\t\t\t \t\t\t\t|

69 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.5 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tApplicable Law; Jurisdiction

 \t\t\t\t \t\t\t\t|

69 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.6 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAttorneys' Fees

 \t\t\t\t \t\t\t\t|

70 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.7 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tAssignability

 \t\t\t\t \t\t\t\t|

70 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.8 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNotices

 \t\t\t\t \t\t\t\t|

70 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.9 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tCooperation

 \t\t\t\t \t\t\t\t|

71 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-iii-  \t\t

  

 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t

10.10 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t 

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tSeverability

 \t\t\t\t \t\t\t\t|

71 \t\t\t\t \t\t\t 
---|---|---|--- 
 \t\t\t \t\t\t\t

10.11 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tOther Remedies; Specific Performance

 \t\t\t\t \t\t\t\t|

72 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.12 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tNo Third Party Beneficiaries

 \t\t\t\t \t\t\t\t|

72 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t

10.13 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tConstruction

 \t\t\t\t \t\t\t\t|

72 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tExhibit A Definitions

 \t\t\t\t \t\t\t 
--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tExhibit B Parent Stockholder Support Agreement

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tExhibit C Allocation of Parent Securities to be issued in
the Merger

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tExhibit D Stock Registration Form

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tExhibit E Officers and Board Designees

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-iv-  \t\t

  

 \t\t

 \t\t

 \t\t\tAGREEMENT AND PLAN OF MERGER AND REORGANIZATION \t\t

 \t\t

 \t\t\tTHIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this
"Agreement") is made and entered into as of January 28, 2020, by and among
BIOPHARMX CORPORATION, a Delaware corporation ("Parent"), BITI MERGER SUB,
INC., a Delaware corporation and wholly owned subsidiary of Parent ("Merger
Sub"), and TIMBER PHARMACEUTICALS LLC, a Delaware limited liability company
(the "Company"). Certain capitalized terms used in this Agreement are defined
in Exhibit A. \t\t

 \t\t

 \t\t\tRECITALS \t\t

 \t\t

 \t\t\tA. Parent and the Company intend to effect a merger of Merger
Sub with and into the Company (the "Merger") in accordance with this
Agreement, the DGCL, and the DLLCA. Upon consummation of the Merger, Merger
Sub will cease to exist and the Company will become a wholly-owned, limited
liability company subsidiary of Parent. \t\t

 \t\t

 \t\t\tB. The Parties intend that the Merger constitute a transaction
described in Section 351(a) of the Code. \t\t

 \t\t

 \t\t\tC. The Parent Board has (i) determined that the Contemplated
Transactions are fair to, advisable and in the best interests of Parent and
its stockholders, (ii) approved and declared advisable this Agreement and the
Contemplated Transactions, including the issuance of shares of Parent Common
Stock to the members of the Company pursuant to the terms of this Agreement
and (iii) determined to recommend, upon the terms and subject to the
conditions set forth in this Agreement, that the stockholders of Parent vote
to approve the issuance of shares of Parent Common Stock to the members of the
Company pursuant to the terms of this Agreement. \t\t

 \t\t

 \t\t\tD. The Merger Sub Board has (i) determined that the
Contemplated Transactions are fair to, advisable, and in the best interests of
Merger Sub and its sole stockholder, (ii) approved and declared advisable this
Agreement and the Contemplated Transactions and (iii) determined to recommend,
upon the terms and subject to the conditions set forth in this Agreement, that
the stockholder of Merger Sub vote to adopt this Agreement and thereby approve
the Contemplated Transactions. \t\t

 \t\t

 \t\t\tE. The Company Managers have (i) determined that the
Contemplated Transactions are fair to, advisable and in the best interests of
the Company and its members, (ii) approved and declared advisable this
Agreement and the Contemplated Transactions and (iii) determined to recommend,
upon the terms and subject to the conditions set forth in this Agreement, that
the members of the Company vote to adopt this Agreement and thereby approve
the Contemplated Transactions. \t\t

 \t\t

 \t\t\tF. Concurrently with the execution and delivery of this
Agreement and as a condition and inducement to the Company's willingness to
enter into this Agreement, all of the officers and directors of Parent (who
are listed on Section A of the Company Disclosure Schedule (solely in their
capacity as stockholders of Parent)) are executing support agreements in favor
of the Company in substantially the form attached hereto as Exhibit B (the
"Parent Stockholder Support Agreement"), pursuant to which such Persons have,
subject to the terms and conditions set forth therein and herein, agreed to
vote all shares of Parent Common Stock of which they are the beneficial owner
(as defined by Rule 13d-3 of the Exchange Act) in favor of the Parent
Stockholder Matters. \t\t

 \t\t

 \t\t\tG. It is expected that on the date that Parent holds the Parent
Stockholders' Meeting, the holders of membership interests in the Company
sufficient to adopt and approve this Agreement and the Merger as required
under the DLLCA and the Company's Organizational Documents will execute and
deliver an action by written consent adopting this Agreement in a form
reasonably acceptable to Parent, in order to obtain the Required Company
Member Vote (the "Company Member Written Consent"). \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-1-  \t\t

  

 \t\t

 \t\t

 \t\t\tAGREEMENT \t\t

 \t\t

 \t\t\tThe Parties, intending to be legally bound, agree as follows: \t\t

 \t\t

 \t\t\tSection 1 DESCRIPTION OF TRANSACTION \t\t

 \t\t

 \t\t\t1.1 The Merger. Upon the terms and subject to the conditions
set forth in this Agreement, at the Effective Time, Merger Sub shall be merged
with and into the Company, and the separate corporate existence of Merger Sub
shall cease. The Company will continue as the surviving limited liability
company in the Merger (the "Surviving Entity"). \t\t

 \t\t

 \t\t\t1.2 Effects of the Merger. The Merger shall have the effects
set forth in this Agreement, the Certificate of Merger and in the applicable
provisions of the DGCL and the DLLCA. As a result of the Merger, the Company
will become a wholly-owned, limited liability company subsidiary of
Parent. \t\t

 \t\t

 \t\t\t1.3 Closing; Effective Time. Unless this Agreement is earlier
terminated pursuant to the provisions of Section 9.1, and subject to the
satisfaction or waiver of the conditions set forth in Sections 6, 7 and 8,
the consummation of the Merger (the "Closing") shall take place remotely as
promptly as practicable (but in no event later than the second Business Day
following the satisfaction or waiver of the last to be satisfied or waived of
the conditions set forth in Sections 6, 7 and 8, other than those conditions
that by their nature are to be satisfied at the Closing, but subject to the
satisfaction or waiver of each of such conditions), or at such other time,
date and place as Parent and the Company may mutually agree. The date on which
the Closing actually takes place is referred to as the "Closing Date." At the
Closing, the Parties shall cause the Merger to be consummated by executing and
filing with the Secretary of State of the State of Delaware a certificate of
merger with respect to the Merger, satisfying the applicable requirements of
the DGCL and the DLLCA and in a form reasonably acceptable to Parent and the
Company (the "Certificate of Merger"). The Merger shall become effective at
the time of the filing of such Certificate of Merger with the Secretary of
State of the State of Delaware or at such later time as may be specified in
such Certificate of Merger with the consent of Parent and the Company (the
time as of which the Merger becomes effective being referred to as the
"Effective Time"). \t\t

 \t\t

 \t\t\t1.4 Certificate of Formation; Directors, Managers and Officers.
At the Effective Time: \t\t

 \t\t

 \t\t\t(a) the Certificate of Formation of the Company, as in effect
immediately prior to the Effective Time, shall be the Certificate of Formation
of the Surviving Entity until thereafter amended in accordance with the
provisions thereof and applicable Law. \t\t

 \t\t

 \t\t\t(b) the limited liability company agreement of the Company as
in effect immediately prior to the Effective Time shall be the limited
liability company agreement of the Surviving Entity, until thereafter amended
as provided by the DLLCA and such limited liability company agreement and as
provided herein; \t\t

 \t\t

 \t\t\t(c) the certificate of incorporation of Parent shall be
identical to the certificate of incorporation of Parent immediately prior to
the Effective Time, until thereafter amended as provided by the DGCL and such
certificate of incorporation; \t\t

 \t\t

 \t\t\t(d) the directors and officers of Parent, each to hold office
in accordance with the certificate of incorporation and bylaws of Parent,
shall be designated by the Company, and as set forth in Section 5.11;
and \t\t

 \t\t

 \t\t\t(e) the managers and officers of the Surviving Entity, each to
hold office in accordance with the limited liability company agreement of the
Surviving Entity, shall be the managers and officers of the

 \t\t

  \t\t

  \t\t\t-2-  \t\t

  

Company as set forth in Section 5.11, after giving effect to the provisions of
Section 5.11, or such other persons as shall be mutually agreed upon by Parent
and the Company. \t\t

 \t\t

 \t\t\t1.5 Conversion of Shares and Membership Interests. \t\t

 \t\t

 \t\t\t(a) At the Effective Time, by virtue of the Merger and without
any further action on the part of Parent, Merger Sub, the Company or any
member of the Company or stockholder of Parent; \t\t

 \t\t

 \t\t\t(i) The Company Preferred Equity outstanding immediately prior to
the Effective Time shall be automatically converted into the right to receive
a number of shares of a class of newly issued Parent Preferred Stock which
shall not be convertible to Parent Common Stock but which shall have economic
terms which are substantially the same as the economic terms of the Company
Preferred Equity currently outstanding. The Parties shall negotiate in good
faith prior to filing the Form S-4 with the SEC for the form of Certificate of
Designations with respect to the Parent Preferred Stock to be issued pursuant
to this paragraph. \t\t

 \t\t

 \t\t\t(ii) The Company Common Equity, together with the Company VARs
specified by the Company pursuant to Exhibit C annexed hereto, outstanding
immediately prior to the Effective Time shall be automatically converted into
the right to receive a number of shares of Parent Common Stock and/or options
or warrants to purchase Parent Common Stock equal in the aggregate to the
Timber Allocation Number (the "Merger Consideration"). \t\t

 \t\t

 \t\t\t(iii) Exhibit C annexed hereto describes how the Merger
Consideration is to be allocated among shares of stock, options and warrants
of the Parent and among the Company Equity holders including, if elected by
the Company prior to Closing, holders of the Company VARs of the Company
outstanding immediately prior to the Effective Time (with the treatment of
vesting and any such repurchase options or risks of forfeiture, also described
in Exhibit C). \t\t

 \t\t

 \t\t\t(b) No fractional shares of Parent Common Stock shall be issued
in connection with the Merger, and no certificates or scrip for any such
fractional shares shall be issued. Any holder of Company Equity who would
otherwise be entitled to receive a fraction of a share of Parent Common Stock
(after aggregating all fractional shares of Parent Common Stock issuable to
such holder) shall, in lieu of such fraction of a share and upon delivery by
such holder of a Stock Registration Form in accordance with Section 1.7(b) and
any accompanying documents as required therein, be paid in cash the dollar
amount (rounded to the nearest whole cent), without interest, determined by
multiplying such fraction by the Parent Closing Price. \t\t

 \t\t

 \t\t\t(c) All shares of common stock, $0.001 par value per share, of
Merger Sub issued and outstanding immediately prior to the Effective Time
shall be converted into and exchanged for 100% of the membership interests of
the Surviving Entity. \t\t

 \t\t

 \t\t\t(d) If, between the date of this Agreement and the Effective
Time, the outstanding Units of Company Equity or shares of Parent Common Stock
shall have been changed into, or exchanged for, a different number of shares
or a different class, by reason of any stock dividend, subdivision,
reclassification, recapitalization, split, combination or exchange of shares
or other like change, the Timber Allocation Number shall, to the extent
necessary, be equitably adjusted to reflect such change to the extent
necessary to provide the holders of Company Equity and Parent Common Stock
with the same economic effect as contemplated by this Agreement prior to such
stock dividend, subdivision, reclassification, recapitalization, split,
combination or exchange of shares or other like change; provided, however,
that nothing herein will be construed to permit the Company or Parent to take
any action with respect to Company Equity or Parent Common Stock,
respectively, that is prohibited or not expressly permitted by the terms of
this Agreement. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-3-  \t\t

  

 \t\t

 \t\t

 \t\t\t1.6 Closing of the Company's Transfer Books. At the Effective
Time: (a) all Company Equity outstanding immediately prior to the Effective
Time shall be treated in accordance with Exhibit C and all holders of Company
Equity that was outstanding immediately prior to the Effective Time shall
cease to have any rights as equity holders of the Company; and (b) the
transfer books of the Company shall be closed with respect to all Company
Equity outstanding immediately prior to the Effective Time. No further
transfer of any such Company Equity shall be made on such transfer books after
the Effective Time. If, after the Effective Time, a valid certificate (if any)
previously representing any Company Equity outstanding immediately prior to
the Effective Time is presented to the Exchange Agent or to the Surviving
Entity, such Certificate shall be canceled and shall be exchanged as provided
in Exhibit C. \t\t

 \t\t

 \t\t\t1.7 Issuance of Certificates. \t\t

 \t\t

 \t\t\t(a) On or prior to the Closing Date, the Parent shall deposit
with its transfer agent (the "Exchange Agent"): (i) certificates or evidence
of book-entry shares representing the Parent Common Stock issuable pursuant to
Section 1.5(a) and Exhibit C and (ii) cash sufficient to make payments in lieu
of fractional shares in accordance with Section 1.5(b). The Parent Common
Stock and cash amounts so deposited with the Exchange Agent, together with any
dividends or distributions received by the Exchange Agent with respect to such
shares, are referred to collectively as the "Exchange Fund." \t\t

 \t\t

 \t\t\t(b) Promptly after the Effective Time, the Parties shall cause
the holders of Company Equity listed on Exhibit C to deliver to the Exchange
Agent a completed and executed Stock Registration Form in the form of Exhibit
D. Upon delivery of each Stock Registration Form to the Exchange Agent (A)
the holder of such Company Equity shall be entitled to receive in exchange
therefor a certificate or certificates or book-entry shares representing the
Merger Consideration (in a number of whole shares of Parent Common Stock) that
such holder has the right to receive pursuant to the provisions of Section
1.5(a) and Exhibit C (and cash in lieu of any fractional share of Parent
Common Stock pursuant to the provisions of Section 1.5(b)). \t\t

 \t\t

 \t\t\t1.8 Further Action. If, at any time after the Effective Time,
any further action is determined by the Surviving Entity to be necessary or
desirable to carry out the purposes of this Agreement or to vest the Surviving
Entity with full right, title and possession of and to all rights and property
of the Company, then the officers and directors of the Surviving Entity shall
be fully authorized, and shall use their and its commercially reasonable
efforts (in the name of the Company, in the name of Merger Sub, in the name of
the Surviving Entity and otherwise) to take such action. \t\t

 \t\t

 \t\t\tSection 2 REPRESENTATIONS AND WARRANTIES OF THE COMPANY \t\t

 \t\t

 \t\t\tSubject to Section 10.13(i), except as set forth in the disclosure
schedule delivered by the Company to Parent (the "Company Disclosure
Schedule"), the Company represents and warrants to Parent and Merger Sub as
follows: \t\t

 \t\t

 \t\t\t2.1 Due Organization; Subsidiaries. \t\t

 \t\t

 \t\t\t(a) The Company is a limited liability company duly organized,
validly existing and in good standing under the Laws of the jurisdiction of
its organization and has all necessary power and authority: (i) to conduct its
business in the manner in which its business is currently being conducted;
(ii) to own or lease and use its property and assets in the manner in which
its property and assets are currently owned or leased and used; and (iii) to
perform its obligations under all Contracts by which it is bound. \t\t

 \t\t

 \t\t\t(b) The Company is duly licensed and qualified to do business,
and is in good standing (to the extent applicable in such jurisdiction), under
the Laws of all jurisdictions where the nature of its business requires

 \t\t

  \t\t

  \t\t\t-4-  \t\t

  

such licensing or qualification other than in jurisdictions where the failure
to be so qualified individually or in the aggregate would not be reasonably
expected to have a Company Material Adverse Effect. \t\t

 \t\t

 \t\t\t(c) The Company has no Subsidiaries, and does not owns any
capital stock of, or any equity, ownership or profit sharing interest of any
nature in, or controls directly or indirectly, any other Entity other than the
Entities identified in Section 2.1(c) of the Company Disclosure Schedule. Such
entity is recently formed, and representations with respect to the Company's
business shall be read to include the Company and its subsidiary as a
whole. \t\t

 \t\t

 \t\t\t2.2 Organizational Documents. The Company has delivered to
Parent accurate and complete copies of the Organizational Documents of the
Company in effect as of the date of this Agreement. The Company is not in
material breach or violation of its Organizational Documents. \t\t

 \t\t

 \t\t\t2.3 Authority; Binding Nature of Agreement. The Company has all
necessary power and authority as a limited liability company to enter into and
to perform its obligations under this Agreement and to consummate the
Contemplated Transactions. The Company Managers have (i) determined that the
Contemplated Transactions are fair to, advisable and in the best interests of
the Company and its members, (ii) approved and declared advisable this
Agreement and the Contemplated Transactions and (iii) determined to recommend,
upon the terms and subject to the conditions set forth in this Agreement, that
the members of the Company vote to adopt this Agreement and thereby approve
the Contemplated Transactions. This Agreement has been duly executed and
delivered by the Company and assuming the due authorization, execution and
delivery by Parent and Merger Sub, constitutes the legal, valid and binding
obligation of the Company, enforceable against the Company in accordance with
its terms, subject to the Enforceability Exceptions. \t\t

 \t\t

 \t\t\t2.4 Vote Required. The affirmative vote (or written consent) of
the Company Managers and holders of all of the membership interests of the
Company outstanding on the record date for the Company Member Written Consent
and entitled to vote thereon (the "Required Company Member Vote") is the only
vote (or written consent) of the holders of any class or series of Company
Equity necessary to adopt and approve this Agreement and approve the
Contemplated Transactions. \t\t

 \t\t

 \t\t\t2.5 Non-Contravention; Consents. Subject to obtaining the
Required Company Member Vote and the filing of the Certificate of Merger
required by the DGCL and the DLLCA, neither (x) the execution, delivery or
performance of this Agreement by the Company, nor (y) the consummation of the
Contemplated Transactions, will directly or indirectly (with or without notice
or lapse of time): \t\t

 \t\t

 \t\t\t(a) contravene, conflict with or result in a violation of any
of the provisions of the Company's Organizational Documents; \t\t

 \t\t

 \t\t\t(b) contravene, conflict with or result in a violation of, or
give any Governmental Body or other Person the right to challenge the
Contemplated Transactions or to exercise any remedy or obtain any relief
under, any Law or any order, writ, injunction, judgment or decree to which the
Company, or any of the assets owned or used by the Company, is subject, except
as would not reasonably be expected to be material to the Company or its
business; \t\t

 \t\t

 \t\t\t(c) contravene, conflict with or result in a violation of any
of the terms or requirements of, or give any Governmental Body the right to
revoke, withdraw, suspend, cancel, terminate or modify, any Governmental
Authorization that is held by the Company, except as would not reasonably be
expected to be material to the Company or its business; \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-5-  \t\t

  

 \t\t

 \t\t

 \t\t\t(d) contravene, conflict with or result in a violation or
breach of, or result in a default under, any provision of any Company Material
Contract, or give any Person the right to: (i) declare a default or exercise
any remedy under any Company Material Contract; (ii) any material payment,
rebate, chargeback, penalty or change in delivery schedule under any Company
Material Contract; (iii) accelerate the maturity or performance of any Company
Material Contract; or (iv) cancel, terminate or modify any term of any Company
Material Contract, except in the case of any non-material breach, default,
penalty or modification; or \t\t

 \t\t

 \t\t\t(e) result in the imposition or creation of any Encumbrance
upon or with respect to any asset owned or used by the Company (except for
Permitted Encumbrances). \t\t

 \t\t

 \t\t\tExcept for (i) any Consent set forth on Section 2.5 of the Company
Disclosure Schedule under any Company Contract, (ii) the Required Company
Member Vote, (iii) the filing of the Certificate of Merger with the Secretary
of State of the State of Delaware pursuant to the DGCL and the DLLCA, and (iv)
such consents, waivers, approvals, orders, authorizations, registrations,
declarations and filings as may be required under applicable federal and state
securities Laws, the Company is not nor will it be required to make any filing
with or give any notice to, or to obtain any Consent from, any Person in
connection with (x) the execution, delivery or performance of this Agreement,
or (y) the consummation of the Contemplated Transactions, which if
individually or in the aggregate were not given or obtained, would reasonably
be expected to prevent or materially delay the ability of the Company to
consummate the Contemplated Transactions. \t\t

 \t\t

 \t\t\t2.6 Capitalization. \t\t

 \t\t

 \t\t\t(a) Section 2.6(a) of the Company Disclosure Schedule sets
forth the outstanding Company Equity as of the date of this Agreement. \t\t

 \t\t

 \t\t\t(b) All of the outstanding membership interests of the Company
have been validly issued, and are fully paid and nonassessable. Except as
contemplated herein, there is no Company Contract relating to the voting or
registration of, or restricting any Person from purchasing, selling, pledging
or otherwise disposing of (or granting any option or similar right with
respect to), any membership interests of the Company. The Company is not under
any obligation, nor is it bound by any Contract pursuant to which it may
become obligated, to repurchase, redeem or otherwise acquire any outstanding
membership interests. \t\t

 \t\t

 \t\t\t(c) Except as set forth in Section 2.6(c) of the Company
Disclosure Schedule, the Company does not have any equity option plan or any
other plan, program, agreement or arrangement providing for any equity-based
compensation for any Person (a "Company Plan"). Section 2.6(c) of the Company
Disclosure Schedule sets a complete description of all information with
respect to the Company VARs. The Company has made available to Parent an
accurate and complete copy of the Company Plans and all agreements evidencing
outstanding Company VARs. \t\t

 \t\t

 \t\t\t(d) Except as set forth on Section 2.6(c) of the Company
Disclosure Schedule, there is no: (i) outstanding subscription, option, call,
warrant or right (whether or not currently exercisable) to acquire any
securities of the Company; (ii) outstanding security, instrument or obligation
that is or may become convertible into or exchangeable for any securities of
the Company; (iii) condition or circumstance that is reasonably likely to
give rise to or provide a basis for the assertion of a claim by any Person to
the effect that such Person is entitled to acquire or receive any securities
of the Company; or (iv) outstanding or authorized equity appreciation, phantom
equity, profit participation or other similar rights with respect to the
Company. \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-6-  \t\t

  

 \t\t

 \t\t

 \t\t\t(e) All outstanding securities of the Company have been issued
and granted in material compliance with (i) all applicable securities Laws and
other applicable Law, and (ii) all requirements set forth in applicable
Contracts. \t\t

 \t\t

 \t\t\t2.7 Financial Statements. \t\t

 \t\t

 \t\t\t(a) Concurrently with the execution hereof, the Company has
provided to Parent true and complete copies of the Company's unaudited
consolidated balance sheets at, December 31, 2019, together with related
unaudited consolidated statements of income, members' equity and cash flows,
and notes thereto, of the Company for the fiscal period then ended
(collectively, the "Company Financials", the balance sheet of December 31,
2019 being the "Company Unaudited Balance Sheet"). The Company Financials were
prepared in accordance with GAAP (except as may be indicated in the notes to
such financial statements and except that the unaudited financial statements
may not contain footnotes and are subject to normal and recurring year-end
adjustments, none of which are material) and fairly present, in all material
respects, the financial position and operating results of the Company and its
consolidated Subsidiaries as of the dates and for the periods indicated
therein. \t\t

 \t\t

 \t\t\t(b) To the Knowledge of the Company, the Company maintains
accurate books and records reflecting their assets and liabilities and
maintains a system of internal accounting controls designed to provide
reasonable assurance that: (i) transactions are executed in accordance with
management's general or specific authorizations; (ii) transactions are
recorded as necessary to permit preparation of the financial statements of the
Company and to maintain accountability of the Company's assets; (iii) access
to the Company's assets is permitted only in accordance with management's
general or specific authorization; (iv) the recorded accountability for the
Company's assets is compared with the existing assets at regular intervals and
appropriate action is taken with respect to any differences; and (v) accounts,
notes and other receivables and inventory are recorded accurately, and proper
and adequate procedures are implemented to effect the collection thereof on a
current and timely basis. The Company maintains internal control over
financial reporting that provides reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements
for external purposes. \t\t

 \t\t

 \t\t\t(c) Section 2.7(c) of the Company Disclosure Schedule lists,
and the Company has delivered to Parent accurate and complete copies of the
documentation creating or governing, all securitization transactions and "off-
balance sheet arrangements" (as defined in Item 303(c) of Regulation S-K under
the Exchange Act) effected by the Company since February 26, 2019. \t\t

 \t\t

 \t\t\t(d) Since February 26, 2019, there have been no formal internal
investigations regarding financial reporting or accounting policies and
practices discussed with, reviewed by or initiated at the direction of the
chief executive officer, chief financial officer or general counsel of the
Company, the Company Managers or any committee thereof. Since February 26,
2019, neither the Company nor its independent auditors have identified (i) any
significant deficiency or material weakness in the design or operation of the
system of internal accounting controls utilized by the Company , (ii) any
fraud, whether or not material, that involves the Company, the Company's
management or other employees who have a role in the preparation of financial
statements or the internal accounting controls utilized by the Company or
(iii) any claim or allegation regarding any of the foregoing. \t\t

 \t\t

 \t\t\t2.8 Absence of Changes. Except as set forth on Section 2.8 of
the Company Disclosure Schedule, between the date of the Company Unaudited
Balance Sheet and the date of this Agreement, the Company has conducted its
business only in the Ordinary Course of Business (except for the execution and
performance of this Agreement and the discussions, negotiations and
transactions related thereto) and there has not been any (a) Company Material
Adverse Effect or (b) action, event or occurrence that would have required the
consent of

 \t\t

  \t\t

  \t\t\t-7-  \t\t

  

Parent pursuant to Section 4.2(b) had such action, event or occurrence taken
place after the execution and delivery of this Agreement. \t\t

 \t\t

 \t\t\t2.9 Absence of Undisclosed Liabilities. The Company does not
have any liability, indebtedness, obligation or expense of any kind, whether
accrued, absolute, contingent, matured or unmatured (whether or not required
to be reflected in the financial statements in accordance with GAAP) (each a
"Liability"), individually or in the aggregate, except for: (a) Liabilities
disclosed, reflected or reserved against in the Company Unaudited Balance
Sheet; (b) normal and recurring current Liabilities that have been incurred by
the Company since the date of the Company Unaudited Balance Sheet in the
Ordinary Course of Business and which are not in excess of $10,000 in the
aggregate (c) Liabilities for performance of obligations of the Company under
Company Contracts (other than for breach thereof); (d) Liabilities incurred in
connection with the Contemplated Transactions; (e) Liabilities which would
not, individually or in the aggregate, reasonably be expected to be material
to the Company and (f) Liabilities listed in Section 2.9 of the Company
Disclosure Schedule. \t\t

 \t\t

 \t\t\t2.10 Title to Assets. The Company owns, and has good and valid
title to, or, in the case of leased properties and assets, valid leasehold
interests in, all tangible properties or tangible assets and equipment used or
held for use in its business or operations or purported to be owned by it,
including: (a) all assets reflected on the Company Unaudited Balance Sheet;
and (b) all other assets reflected in the books and records of the Company as
being owned by the Company. All of such assets are owned or, in the case of
leased assets, leased by the Company free and clear of any Encumbrances, other
than Permitted Encumbrances. \t\t

 \t\t

 \t\t\t2.11 Real Property; Leasehold. The Company does not own nor has
ever owned any real property. The Company has made available to Parent (a) an
accurate and complete list of all real properties with respect to which the
Company directly or indirectly holds a valid leasehold interest as well as any
other real estate that is in the possession of or leased by the Company, and
(b) copies of all leases under which any such real property is possessed (the
"Company Real Estate Leases"), each of which is in full force and effect, with
no existing material default thereunder. The Company's use and operation of
each such leased property conforms to all applicable Laws in all material
respects, and the Company has exclusive possession of each such leased
property and has not granted any occupancy rights to tenants or licensees with
respect to such leased property. In addition, each such leased property is
free and clear of all Encumbrances other than Permitted Encumbrances. The
Company has not received written notice from its landlords or any Governmental
Body that: (i) relates to violations of building, zoning, safety or fire
ordinances or regulations; (ii) claims any defect or deficiency with respect
to any of such properties; or (iii) requests the performance of any repairs,
alterations or other work to such properties. \t\t

 \t\t

 \t\t\t2.12 Intellectual Property. \t\t

 \t\t

 \t\t\t(a) The Company owns, or has the legal and valid right to use,
as currently being used by the Company, all Company IP Rights, and with
respect to Company IP Rights that are owned by the Company, has the right to
bring actions for the infringement of such Company IP Rights, in each case
except subject to the terms of the license agreements set forth on Section
2.12(c) of the Company Disclosure Schedule for any failure to own, have such
rights to use, or have such rights to bring actions for infringement. \t\t

 \t\t

 \t\t\t(b) Section 2.12(b) of the Company Disclosure Schedule sets
forth an accurate, true and complete listing of (i) all Company IP Rights that
are owned by the Company that are registered, filed or issued under the
authority of, with or by any Governmental Body, including all Patents,
registered Copyrights, and registered Trademarks (including domain names) and
all applications for any of the foregoing, (ii) to the Knowledge of the
Company, all Company IP Rights that are exclusively licensed to the Company
that are registered, filed or issued under the authority of, with or by any
Governmental Body, including all Patents, registered Copyrights, and
registered Trademarks (including domain names) and (iii) all applications for
any of the foregoing, and specifying as to each such item, as applicable, the
owner(s) of record (and, in the case of

 \t\t

  \t\t

  \t\t\t-8-  \t\t

  

domain names, the registrar), jurisdiction of application and/or registration,
the application and/or registration number, the date of application and/or
registration, and the status of application and/or registration. To the
Knowledge of the Company, each item of Company IP Rights that is Company
Registered IP is and at all times has been filed and maintained in compliance
with all applicable Law and all filings, payments, and other actions required
to be made or taken to maintain such item of Company Registered IP in full
force and effect have been made by the applicable deadline. \t\t

 \t\t

 \t\t\t(c) Section 2.12(c) of the Company Disclosure Schedule
accurately identifies (i) all material Company Contracts pursuant to which
Company IP Rights are licensed to the Company (other than (A) any non-
customized software that (1) is so licensed solely in executable or object
code form pursuant to a non-exclusive, internal use software license and other
Intellectual Property associated with such software and (2) is not
incorporated into, or material to the development, manufacturing, or
distribution of, any of the Company's products or services, (B) any
Intellectual Property licensed ancillary to the purchase or use of equipment,
reagents or other materials and (C) any confidential information provided
under confidentiality agreements), and (ii) whether the license or licenses
granted to the Company are exclusive or non-exclusive. For purposes of greater
certainty, the term "license" in this Section 2.12(c) and in Section 2.12(d)
includes any license, sublicense, covenant, non-assert, consent, release or
waiver. \t\t

 \t\t

 \t\t\t(d) Section 2.12(d) of the Company Disclosure Schedule
accurately identifies each material Company Contract pursuant to which the
Company has granted any license under, or any right (whether or not currently
exercisable) or interest in, any Company IP Rights to any Person (other than
any Company IP Rights non-exclusively licensed to suppliers or service
providers for the sole purpose of enabling such suppliers or service providers
to provide services for the Company's benefit). \t\t

 \t\t

 \t\t\t(e) Except as set forth in Section 2.12(e) of the Company
Disclosure Schedule, the Company is not bound by, and no Company IP Rights are
subject to, any Company Contract containing any covenant or other provision,
or any judicial, administrative or arbitral order, judgment, award, order,
decree, injunction, settlement or stipulation, that in any way limits or
restricts the ability of the Company to use, exploit, assert, enforce, sell,
transfer or dispose of any such Company IP Rights anywhere in the world, in
each case, in a manner that would materially limit the business of the Company
as currently conducted or planned to be conducted. \t\t

 \t\t

 \t\t\t(f) Except as identified in Section 2.12(f) of the Company
Disclosure Schedule, the Company is the sole and unrestricted legal and
beneficial owner of all right, title, and interest to and in Company IP Rights
(other than (i) Company IP Rights exclusively and non-exclusively licensed to
the Company or one of its Subsidiaries, as identified in Section 2.12(c) of
the Company Disclosure Schedule, (ii) any non-customized software that (A) is
licensed to the Company solely in executable or object code form pursuant to a
non-exclusive, internal use software license and other Intellectual Property
associated with such software and (B) is not incorporated into, or material to
the development, manufacturing, or distribution of, any of the Company's or
any of its Subsidiaries' products or services and (iii) any Intellectual
Property licensed ancillary to the purchase or use of equipment, reagents or
other materials), in each case, free and clear of any Encumbrances (other than
Permitted Encumbrances). Without limiting the generality of the
foregoing: \t\t

 \t\t

 \t\t\t(i) Each Person who is or was an employee or contractor of the
Company and who is or was involved in the creation or development of any
Company IP Rights has signed a valid, enforceable agreement containing an
assignment of such Intellectual Property to the Company and confidentiality
provisions protecting confidential information of the Company and the Company
has no reason to believe that any such Person is unwilling to provide the
Company with cooperation as may be reasonably required to complete or
prosecute all Company IP Rights. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-9-  \t\t

  

 \t\t

 \t\t

 \t\t\t(ii) Except as identified in Section 2.12(f)(ii) of the Company
Disclosure Schedule, no current or former member, officer, director, or
employee of the Company has any claim, right (whether or not currently
exercisable), or interest to or in any Company IP Rights purported to be owned
by the Company. To the Knowledge of the Company, no employee of the Company is
(a) bound by or otherwise subject to any Contract restricting him or her from
performing his or her duties for the Company or (b) in breach of any Contract
with any former employer or other Person concerning Company IP Rights
purported to be owned by the Company or confidentiality provisions protecting
Trade Secrets and confidential information comprising Company IP Rights
purported to be owned by the Company. \t\t

 \t\t

 \t\t\t(iii) Except as identified in Section 2.12(f)(iii) of the Company
Disclosure Schedule, no Company IP Rights were developed, in whole or in part
(A) pursuant to or in connection with the development of any professional,
technical or industry standard, (B) under contract with or using the resources
of any Governmental Body, academic institution or other entity that would
subject any Company IP Rights to the rights of any Governmental Body, academic
institution or other entity or (C) under any grants or other funding
arrangements with third parties. \t\t

 \t\t

 \t\t\t(iv) The Company has taken all commercially reasonable and
appropriate steps to protect and maintain the Company IP Rights, including to
preserve the confidentiality of all proprietary information that the Company
holds, or purports to hold, as a material Trade Secret. Any disclosure by the
Company of Trade Secrets to any third party has been pursuant to the terms of
a written agreement with such Person or is otherwise lawful. Company has
implemented and maintained a reasonable security plan consistent with industry
practices of companies offering similar products or services. The Company has
not experienced any breach of security or otherwise unauthorized access by
third parties to the confidential information in Company's possession, custody
or control. \t\t

 \t\t

 \t\t\t(v) The Company has not assigned or otherwise transferred
ownership of, or agreed to assign or otherwise transfer ownership of, any
Company IP Rights owned or purported to be owned by or exclusively licensed to
the Company to any other Person. As of the date of this Agreement, except as
set forth in Section 2.12(f)(v) of the Company Disclosure Schedule, the
Company has not sold or otherwise transferred (other than standard licenses or
rights to use granted to customers, suppliers or service providers in the
Ordinary Course of Business) any of the Company IP Rights to any third party,
and there exists no obligation by the Company to assign or otherwise transfer
any of the Company IP Rights to any third party. \t\t

 \t\t

 \t\t\t(vi) To the Knowledge of the Company, (i) the Company IP Rights are
valid and enforceable and (ii) constitute all Intellectual Property necessary
for the Company to conduct its business as currently conducted and planned to
be conducted. Company has not misrepresented, or failed to disclose, any facts
or circumstances in any application for any Company IP Rights that would
constitute fraud with respect to such application. \t\t

 \t\t

 \t\t\t(g) To the Knowledge of the Company, the manufacture,
marketing, license, sale or intended use of any product or technology
currently licensed or sold or under development by the Company does not
violate any license or agreement between the Company and any third party, and
does not infringe or misappropriate any Intellectual Property right of any
third party. Company has not been sued in any action, suit or proceeding, or
received any written communications alleging that any Company IP rights or
product or past activity has violated or would violate any Intellectual
Property Rights of any third party and to the Company's knowledge a valid
claim for such action, suit or proceeding does not exist. No Company IP Rights
are subject to any proceeding, order, judgment, settlement agreement,
stipulation or right that restricts in any manner the use, transfer, or
licensing thereof by the Company, or which may affect the validity, use or
enforceability of any Company IP Rights \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-10-  \t\t

  

 \t\t

 \t\t

 \t\t\t(h) To the Knowledge of the Company, no third party is
infringing upon any Company IP Rights or violating any license or agreement
between the Company and such third party, and the Company have not sent any
written communication to or asserted or threatened in writing any action or
claim against any Person involving or relating to any Company IP Rights. \t\t

 \t\t

 \t\t\t(i) There is no current or pending Legal Proceeding
(including, but not limited to, opposition, interference, inter partes review,
or other proceeding in any patent or other government office) contesting the
validity, ownership or right to use, sell, license or dispose of any Company
IP Rights or products or technologies, nor has the Company received any
written notice asserting or suggesting that any such Company IP Rights, or the
Company's right to use, sell, license or dispose of any such Company IP Rights
or products or technologies conflicts with or infringes or misappropriates or
will conflict with or infringe or misappropriate the rights of any other
Person. \t\t

 \t\t

 \t\t\t(j) Except as set forth in the Contracts listed on Section
2.12(j) of the Company Disclosure Schedule and except for Company Contracts
entered into in the Ordinary Course of Business, (i) the Company is not bound
by any Contract to indemnify, defend, hold harmless, or reimburse any other
Person with respect to any Intellectual Property infringement,
misappropriation, or similar claim, in each case, that would reasonably be
expected to be material to the Company or its business, and (ii) the Company
has never assumed, or agreed to discharge or otherwise take responsibility
for, any existing or potential liability of another Person for infringement,
misappropriation, or violation of any Intellectual Property right, which
assumption, agreement or responsibility is material and remains in force as of
the date of this Agreement. \t\t

 \t\t

 \t\t\t2.13 Agreements, Contracts and Commitments. \t\t

 \t\t

 \t\t\t(a) Section 2.13(a) of the Company Disclosure Schedule
identifies each Company Contract in effect as of the date of this Agreement
that involves payment or receipt by the Company of more than $10,000 in the
aggregate, or obligations after the date of this Agreement in excess of
$10,000 in the aggregate other than any Benefit Plans and includes: (each, a
"Company Material Contract" and collectively, the "Company Material
Contracts"): \t\t

 \t\t

 \t\t\t(i) each Company Contract relating to any agreement of
indemnification or guaranty not entered into in the Ordinary Course of
Business; \t\t

 \t\t

 \t\t\t(ii) each Company Contract containing (A) any covenant limiting
the freedom of the Company or the Surviving Entity to engage in any line of
business or compete with any Person, (B) any most-favored pricing arrangement,
(C) any exclusivity provision, or (D) any non-solicitation provision; \t\t

 \t\t

 \t\t\t(iii) each Company Contract relating to capital expenditures and
requiring payments after the date of this Agreement in excess of $10,000
pursuant to its express terms and not cancelable without penalty; \t\t

 \t\t

 \t\t\t(iv) each Company Contract relating to the disposition or
acquisition of material assets or any ownership interest in any Entity; \t\t

 \t\t

 \t\t\t(v) each Company Contract relating to any mortgages, indentures,
loans, notes or credit agreements, security agreements or other agreements or
instruments relating to the borrowing of money or extension of credit or
creating any material Encumbrances with respect to any assets of the Company
or any loans or debt obligations with officers or directors of the
Company; \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-11-  \t\t

  

 \t\t

 \t\t

 \t\t\t(vi) each Company Contract requiring payment by or to the Company
after the date of this Agreement in excess of $50,000 pursuant to its express
terms relating to: (A) any distribution agreement (identifying any that
contain exclusivity provisions); (B) any agreement involving provision of
services or products with respect to any pre-clinical or clinical development
activities of the Company; (C) any dealer, distributor, joint marketing,
alliance, joint venture, cooperation, development or other agreement currently
in force under which the Company has continuing obligations to develop or
market any product, technology or service, or any agreement pursuant to which
the Company has continuing obligations to develop any Intellectual Property
that will not be owned, in whole or in part, by the Company; or (D) any
Contract to license any third party to manufacture or produce any product,
service or technology of the Company or any Contract to sell, distribute or
commercialize any products or service of the Company, in each case, except for
Company Contracts entered into in the Ordinary Course of Business; \t\t

 \t\t

 \t\t\t(vii) each Company Contract with any Person, including any financial
advisor, broker, finder, investment banker or other Person, providing advisory
services to the Company in connection with the Contemplated
Transactions; \t\t

 \t\t

 \t\t\t(viii) each Company Real Estate Lease; \t\t

 \t\t

 \t\t\t(ix) each Company Contract with any Governmental Body; \t\t

 \t\t

 \t\t\t(x) each Company IP Rights Agreement required to be listed on
Section 2.12(c)or Section 2.12(d) of the Company Disclosure Schedule; \t\t

 \t\t

 \t\t\t(xi) each Company Contract containing any royalty, dividend or
similar arrangement based on the revenues or profits of the Company; or \t\t

 \t\t

 \t\t\t(xii) any other Company Contract that is not terminable at will
(with no penalty or payment) by the Company, as applicable, and (A) which
involves payment or receipt by the Company or its Subsidiaries after the date
of this Agreement under any such agreement, contract or commitment of more
than $25,000 in the aggregate, or obligations after the date of this Agreement
in excess of $10,000 in the aggregate, or (B) that is material to the business
or operations of the Company, taken as a whole. \t\t

 \t\t

 \t\t\t(b) The Company has delivered or made available to Parent
accurate and complete copies of all Company Material Contracts, including all
amendments thereto. Except as set forth in Section 2.13(b) of the Company
Disclosure Schedule, there are no Company Material Contracts that are not in
written form. The Company has not, nor to the Company's Knowledge, as of the
date of this Agreement has any other party to a Company Material Contract,
breached, violated or defaulted under, or received notice that it breached,
violated or defaulted under, any of the terms or conditions of any Company
Material Contract in such manner as would permit any other party to cancel or
terminate any such Company Material Contract, or would permit any other party
to seek damages which would reasonably be expected to be material to the
Company or its business. As to the Company, as of the date of this Agreement,
each Company Material Contract is valid, binding, enforceable and in full
force and effect, subject to the Enforceability Exceptions. No Person is
renegotiating, or has a right pursuant to the terms of any Company Material
Contract to change, any material amount paid or payable to the Company under
any Company Material Contract or any other material term or provision of any
Company Material Contract. \t\t

 \t\t

 \t\t\t2.14 Compliance; Permits; Restrictions. \t\t

 \t\t

 \t\t\t(a) The Company is, and since February 26, 2019 has been, and,
to the Company's knowledge, the entities that owned any of the Company's
material intellectual property prior to such date were, in compliance

 \t\t

  \t\t

  \t\t\t-12-  \t\t

  

in all material respects with all applicable Laws, including the Federal Food,
Drug, and Cosmetic Act ("FDCA"), the Food and Drug Administration ("FDA")
regulations adopted thereunder, the Controlled Substance Act and any other
similar Law administered or promulgated by the FDA or other comparable
Governmental Body responsible for regulation of the development, clinical
testing, manufacturing, sale, marketing, distribution and importation or
exportation of drug products (each, a "Drug Regulatory Agency"), except for
any noncompliance, either individually or in the aggregate, which would not be
material to the Company. No investigation, claim, suit, proceeding, audit or
other action by any Governmental Body is pending or, to the Knowledge of the
Company, threatened against the Company. There is no agreement, judgment,
injunction, order or decree binding upon the Company which (i) has or would
reasonably be expected to have the effect of prohibiting or materially
impairing any business practice of the Company, any acquisition of material
property by the Company or the conduct of business by the Company as currently
conducted, (ii) is reasonably likely to have an adverse effect on the
Company's ability to comply with or perform any covenant or obligation under
this Agreement, or (iii) is reasonably likely to have the effect of
preventing, delaying, making illegal or otherwise interfering with the
Contemplated Transactions. \t\t

 \t\t

 \t\t\t(b) The Company holds all required Governmental Authorizations
which are material to the operation of the business of the Company as
currently conducted (the "Company Permits"). Section 2.14(b) of the Company
Disclosure Schedule identifies each Company Permit. The Company is in material
compliance with the terms of the Company Permits. No Legal Proceeding is
pending or, to the Knowledge of the Company, threatened, which seeks to
revoke, limit, suspend, or materially modify any Company Permit. The rights
and benefits of each Company Permit will be available to the Surviving Entity
or its Subsidiaries, as applicable, immediately after the Effective Time on
terms substantially identical to those enjoyed by the Company as of the date
of this Agreement and immediately prior to the Effective Time. \t\t

 \t\t

 \t\t\t(c) There are no proceedings pending or, to the Knowledge of
the Company, threatened with respect to an alleged material violation by the
Company of the FDCA, FDA regulations adopted thereunder, the Controlled
Substance Act or any other similar Law administered or promulgated by any Drug
Regulatory Agency. \t\t

 \t\t

 \t\t\t(d) The Company holds all required Governmental Authorizations
issuable by any Drug Regulatory Agency necessary or material to the conduct of
the business of the Company or such Subsidiary as currently conducted, and, as
applicable, the development, clinical testing, manufacturing, marketing,
distribution and importation or exportation, as currently conducted, of any of
its products or product candidates (collectively, the "Company Products")
(collectively, the "Company Regulatory Permits") and no such Company
Regulatory Permit has been (i) revoked, withdrawn, suspended, cancelled or
terminated or (ii) modified in any adverse manner. The Company is in
compliance in all material respects with the Company Regulatory Permits and
have not received any written notice or other written communication, or to the
Knowledge of the Company, any other communication from any Drug Regulatory
Agency regarding (A) any material violation of or failure to comply materially
with any term or requirement of any Company Regulatory Permit or (B) any
revocation, withdrawal, suspension, cancellation, termination or material
modification of any Company Regulatory Permit. Except for the information and
files identified in Section 2.14(d) of the Company Disclosure Schedule, the
Company has made available to Parent all information requested by Parent in
the Company's or its Subsidiaries' possession or control relating to the
Company Products and the development, clinical testing, manufacturing,
importation and exportation of the Company Products, including complete copies
of the following (to the extent there are any): (x) copies of all
investigational new drug applications (INDs) submitted to the FDA, and all
supplements to and amendments of such INDs; new drug applications; adverse
event reports; clinical study reports and material study data; inspection
reports, notices of adverse findings, warning letters, filings and letters and
other material written correspondence to and from any Drug Regulatory Agency;
and meeting minutes with any Drug Regulatory Agency; and (y) similar notices,
letters, filings, correspondence and meeting minutes with any other
Governmental Body. The Company has complied in all material respects with the
ICH E9 Guidance for Industry:

 \t\t

  \t\t

  \t\t\t-13-  \t\t

  

Statistical Principles for Clinical Trials in the management of the clinical
data that have been presented to the Company. To the Knowledge of the Company,
there are no facts that would be reasonably likely to result in any warning,
untitled or notice of violation letter or Form FDA-483 from the FDA. The
Company is not aware of any studies, tests or trials the results of which the
Company believes reasonably call into question (i) the study, test or trial
results of any Company Products, (ii) the efficacy or safety of any Company
Products or (iii) any of the Company's filings with any Governmental
Body. \t\t

 \t\t

 \t\t\t(e) All clinical, pre-clinical and other studies and tests
conducted by or on behalf of, or sponsored by, the Company, or in which the
Company or its current products or product candidates, including the Company
Products, have participated, were and, if still pending, are being conducted
in all material respects in accordance with standard medical and scientific
research procedures and in compliance in all material respects with the
applicable regulations of any applicable Drug Regulatory Agency and other
applicable Law, including 21 C.F.R. Parts 50, 54, 56, 58 and 312. No
preclinical or clinical trial currently being conducted by or on behalf of the
Company has been terminated or suspended prior to completion for safety or
non-compliance reasons. Since February 26, 2019, the Company has not received
any notices, correspondence, or other communications from any Drug Regulatory
Agency requiring, or to the Knowledge of the Company threatening to initiate,
the termination or suspension of any clinical studies currently being
conducted by or on behalf of, or sponsored by, the Company or in which the
Company or its current products or product candidates, including the Company
Products, have participated. The Company has not received any notices,
correspondence, or other communications regarding any clinical studies that
have been conducted by or on behalf of, or sponsored by, the Company or in
which the Company or its products or product candidates have participated that
are anticipated to result in any material liability to Company or have a
Company Material Adverse Effect on the Company. \t\t

 \t\t

 \t\t\t(f) The Company is not the subject of any pending or, to the
Knowledge of the Company, threatened investigation in respect of its business
or products by the FDA pursuant to its "Fraud, Untrue Statements of Material
Facts, Bribery, and Illegal Gratuities" Final Policy set forth in 56 Fed. Reg.
46191 (September 10, 1991) and any amendments thereto. To the Knowledge of the
Company, the Company has not committed any acts, made any statement, or failed
to make any statement, in each case in respect of its business or products
that would violate the FDA's "Fraud, Untrue Statements of Material Facts,
Bribery, and Illegal Gratuities" Final Policy, and any amendments thereto.
None of the Company or any of its officers, employees or agents has been
convicted of any crime or engaged in any conduct that could result in a
debarment or exclusion (i) under 21 U.S.C. Section 335a or (ii) any similar
applicable Law. No debarment or exclusionary claims, actions, proceedings or
investigations in respect of their business or products are pending or, to the
Knowledge of the Company, threatened against the Company or any of its
officers, employees or agents. \t\t

 \t\t

 \t\t\t(g) The Company has complied with all Laws relating to
patient, medical or individual health information, including the Health
Insurance Portability and Accountability Act of 1996 and its implementing
regulations promulgated thereunder, all as amended from time to time
(collectively "HIPAA"), including the standards for the privacy of
Individually Identifiable Health Information at 45 C.F.R. Parts 160 and 164,
Subparts A and E, the standards for the protection of Electronic Protected
Health Information set forth at 45 C.F.R. Part 160 and 45 C.F.R. Part 164,
Subpart A and Subpart C, the standards for transactions and code sets used in
electronic transactions at 45 C.F.R. Part 160, Subpart A and Part 162, and the
standards for Breach Notification for Unsecured Protected Health Information
at 45 C.F.R. Part 164, Subpart D, all as amended from time to time. The
Company has entered into, where required, and are in compliance in all
material respects with the terms of all Business Associate (as defined in
HIPAA) agreements to which the Company or a Subsidiary is a party or otherwise
bound. The Company has created and maintained written policies and procedures
to protect the privacy of all protected health information, provide training
to all employees and agents as required under HIPAA, and have implemented
security procedures, including physical, technical and administrative
safeguards, to protect all personal information and Protected Health
Information stored or transmitted in electronic form. The Company

 \t\t

  \t\t

  \t\t\t-14-  \t\t

  

has not received written notice from the Office for Civil Rights for the U.S.
Department of Health and Human Services or any other Governmental Body of any
allegation regarding its failure to comply with HIPAA or any other state law
or regulation applicable to the protection of individually identifiable health
information or personally identifiable information. No successful Security
Incident, Breach of Unsecured Protected Health Information or breach of
personally identifiable information under applicable Laws have occurred with
respect to information maintained or transmitted to the Company, or an agent
or third party subject to a Business Associate Agreement with the Company. The
Company is currently submitting, receiving and handling or is capable of
submitting receiving and handling transactions in accordance with the Standard
Transaction Rule. All capitalized terms in this Section 2.14(g) not otherwise
defined in this Agreement shall have the meanings set forth under HIPAA. \t\t

 \t\t

 \t\t\t(h) The Company has complied in all material respects with the
ICH E9 Guidance for Industry to the extent applicable to its current
activities. \t\t

 \t\t

 \t\t\t2.15 Legal Proceedings; Orders. \t\t

 \t\t

 \t\t\t(a) As of the date of this Agreement, there is no pending Legal
Proceeding and, to the Knowledge of the Company, no Person has threatened in
writing to commence any Legal Proceeding: (i) that involves (A) the Company,
(B) any Company Associate (in his or her capacity as such) or (C) any of the
material assets owned or used by the Company; or (ii) that challenges, or that
may have the effect of preventing, delaying, making illegal or otherwise
interfering with, the Contemplated Transactions. \t\t

 \t\t

 \t\t\t(b) Except as set forth in Section 2.15(b) of the Company
Disclosure Schedule, since February 26, 2019, no Legal Proceeding has been
pending against the Company that resulted in material liability to the
Company. \t\t

 \t\t

 \t\t\t(c) There is no order, writ, injunction, judgment or decree to
which the Company, or any of the material assets owned or used by the Company,
is subject. To the Knowledge of the Company, no officer or other Key Employee
of the Company is subject to any order, writ, injunction, judgment or decree
that prohibits such officer or employee from engaging in or continuing any
conduct, activity or practice relating to the business of the Company or to
any material assets owned or used by the Company. \t\t

 \t\t

 \t\t\t2.16 Tax Matters. \t\t

 \t\t

 \t\t\t(a) The Company has timely filed all income Tax Returns and
other material Tax Returns that they were required to file under applicable
Law. All such Tax Returns are correct and complete in all material respects
and have been prepared in compliance with all applicable Law. No claim has
ever been made by any Governmental Body in any jurisdiction where the Company
does not file a particular Tax Return or pay a particular Tax that the Company
or such Subsidiary is subject to taxation by that jurisdiction. \t\t

 \t\t

 \t\t\t(b) All income and other Taxes due and owing by the Company on
or before the date hereof (whether or not shown on any Tax Return) have been
fully paid. Since the date of the Company Unaudited Balance Sheet, neither the
Company nor any of its Subsidiaries has incurred any material Liability for
Taxes outside the Ordinary Course of Business. \t\t

 \t\t

 \t\t\t(c) All Taxes that the Company is or was required by Law to
withhold or collect have been duly and timely withheld or collected in all
material respects on behalf of its employees, independent contractors,
members, or other third parties and, have been timely paid to the proper
Governmental Body or other Person or properly set aside in accounts for this
purpose. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-15-  \t\t

  

 \t\t

 \t\t

 \t\t\t(d) There are no Encumbrances for Taxes (other than Taxes not
yet due and payable) upon any of the assets of the Company. \t\t

 \t\t

 \t\t\t(e) No deficiencies for income or other Taxes with respect to
the Company has been claimed, proposed or assessed by any Governmental Body in
writing. There are no pending or ongoing, and to the Knowledge of the Company,
threatened audits, assessments or other actions for or relating to any
liability in respect of a material amount of Taxes of the Company. The Company
has not waived any statute of limitations in respect of any income or other
Taxes or agreed to any extension of time with respect to any income or other
Tax assessment or deficiency. \t\t

 \t\t

 \t\t\t(f) The Company is not a party to any Tax allocation agreement,
Tax sharing agreement, Tax indemnity agreement, or similar agreement or
arrangement, other than customary commercial contracts entered into in the
Ordinary Course of Business the principal subject matter of which is not
Taxes. \t\t

 \t\t

 \t\t\t(g) The Company will not be required to include any material
item of income in, or exclude any material item of deduction from, taxable
income for any Tax period (or portion thereof) ending after the Closing Date
as a result of any: (i) change in method of accounting for Tax purposes; (ii)
use of an improper method of accounting for a Tax period ending on or prior to
the Closing Date; (iii) "closing agreement" as described in Section 7121 of
the Code (or any similar provision of state, local or foreign Law) executed on
or prior to the Closing Date; (iv) intercompany transaction or excess loss
account described in Treasury Regulations under Section 1502 of the Code (or
any similar provision of state, local or foreign Law); (v) installment sale or
open transaction disposition made on or prior to the Closing Date; or (vi)
prepaid amount received or deferred revenue accrued on or prior to the Closing
Date. \t\t

 \t\t

 \t\t\t(h) The Company has never had a permanent establishment (within
the meaning of an applicable Tax treaty) or otherwise has an office or fixed
place of business in a jurisdiction outside of the United States. \t\t

 \t\t

 \t\t\t(i) The Company has not participated in or been a party to a
transaction that, as of the date of this Agreement, constitutes a "listed
transaction" that is required to be reported to the IRS pursuant to Section
6011 of the Code and applicable Treasury Regulations thereunder. \t\t

 \t\t

 \t\t\t(j) The Company has not taken any action or knows of any fact
that would reasonably be expected to prevent the Merger from qualifying for
the Intended Tax Treatment. \t\t

 \t\t

 \t\t\t(k) The Company has been classified as a partnership for United
States federal and applicable state income Tax purposes since its
inception. \t\t

 \t\t

 \t\t\tFor purposes of this Section 2.16, each reference to the Company shall
be deemed to include any Person that was liquidated into, merged with, or is
otherwise a predecessor to, the Company. \t\t

 \t\t

 \t\t\t2.17 Employee and Labor Matters; Benefit Plans. \t\t

 \t\t

 \t\t\t(a) Section 2.17(a) of the Company Disclosure Schedule is a
list of all material Benefit Plans, including, without limitation, each
Benefit Plan that provides for retirement, change in control, deferred
compensation, incentive compensation, severance or retiree medical or life
insurance benefits. "Benefit Plan" means each (i) "employee benefit plan" as
defined in Section 3(3) of ERISA and (ii) other pension, retirement, deferred
compensation, excess benefit, profit sharing, bonus, incentive, equity or
equity-based, phantom equity, employment, consulting, severance, change-of-
control, retention, health, life, disability, group insurance, paid-time off,
holiday, welfare and fringe benefit plan, program, contract, or arrangement
(whether written or

 \t\t

  \t\t

  \t\t\t-16-  \t\t

  

unwritten, qualified or nonqualified, funded or unfunded and including any
that have been frozen or terminated), in any case, maintained, contributed to,
or required to be contributed to, by the Company or any Company ERISA
Affiliate for the benefit of any current or former employee, director, officer
or independent contractor of the Company or under which the Company has any
actual or contingent liability (including, without limitation, as to the
result of it being treated as a single employer under Code Section 414 with
any other person). \t\t

 \t\t

 \t\t\t(b) As applicable with respect to each material Benefit Plan,
the Company has made available to Parent, true and complete copies of (i) each
material Benefit Plan, including all amendments thereto, and in the case of an
unwritten material Benefit Plan, a written description thereof, (ii) all
current trust documents, investment management contracts, custodial
agreements, administrative services agreements and insurance and annuity
contracts relating thereto, (iii) the current summary plan description and
each summary of material modifications thereto, (iv) the most recently filed
annual reports with any Governmental Body (e.g., Form 5500 and all schedules
thereto), (v) the most recent IRS determination, opinion or advisory letter,
(vi) the most recent summary annual reports, nondiscrimination testing
reports, actuarial reports, financial statements and trustee reports, (vii)
for the last year, all records, notices and filings concerning IRS or
Department of Labor or other Governmental Body audits or investigations, and
(viii) all policies and procedures established to comply with the privacy and
security rules of HIPAA. \t\t

 \t\t

 \t\t\t(c) Each Benefit Plan has been maintained, operated and
administered in compliance in all material respects with its terms and
applicable Law, including the applicable provisions of ERISA and the
Code. \t\t

 \t\t

 \t\t\t(d) Each Benefit Plan which is an "employee pension benefit
plan" within the meaning of Section 3(2) of ERISA and which is intended to
meet the qualification requirements of Section 401(a) of the Code has received
a determination letter or opinion letter from the IRS to the effect that such
plan is qualified under Section 401(a) of the Code and the related trust is
exempt from federal income Taxes under Section 501(a) of the Code,
respectively, and nothing has occurred that would reasonably be expected to
materially adversely affect the qualification of such Benefit Plan or the tax
exempt status of the related trust. \t\t

 \t\t

 \t\t\t(e) Neither the Company nor any Company ERISA Affiliate
maintains, contributes to, is required to contribute to, or has any actual or
contingent liability with respect to, (i) any "employee pension benefit plan"
(within the meaning of Section 3(2) of ERISA) that is subject to Title IV or
Section 302 of ERISA or Section 412 of the Code, (ii) any "multiemployer plan"
(within the meaning of Section 3(37) of ERISA), (iii) any "multiple employer
plan" (within the meaning of Section 413 of the Code) or (iv) any "multiple
employer welfare arrangement" (within the meaning of Section 3(40) of
ERISA). \t\t

 \t\t

 \t\t\t(f) There are no pending audits or investigations by any
Governmental Body involving any Benefit Plan, and no pending or, to the
Knowledge of the Company, threatened claims (except for individual claims for
benefits payable in the normal operation of the Benefit Plans), suits or
proceedings involving any Benefit Plan, any fiduciary thereof or service
provider thereto, in any case except as would not be reasonably expected to
result in material liability to the Company. \t\t

 \t\t

 \t\t\t(g) Neither the Company nor any Company ERISA Affiliate, nor to
the Knowledge of the Company, any fiduciary, trustee or administrator of any
Benefit Plan, has engaged in, or in connection with the transactions
contemplated by this Agreement will engage in, any transaction with respect to
any Benefit Plan which would subject any such Benefit Plan, the Company, any
of its Subsidiaries or Company ERISA Affiliates or Parent to a material Tax,
material penalty or material liability for a "prohibited transaction" under
Section 406 of ERISA or Section 4975 of the Code. \t\t

 \t\t

 \t\t\t(h) No Benefit Plan provides death, medical, dental, vision,
life insurance or other welfare benefits beyond termination of service or
retirement other than coverage mandated by Law. Section 2.17(h) of

 \t\t

  \t\t

  \t\t\t-17-  \t\t

  

the Company Disclosure Schedule sets forth all outstanding severance
obligations to existing and previously terminated employees and service
providers of the Company, listing for each individual recipient (i) name, (ii)
applicable plan or agreement, (iii) description of the severance, including
terms of payment and (iv) amount. \t\t

 \t\t

 \t\t\t(i) Neither the execution of, nor the performance of the
transactions contemplated by, this Agreement will either alone or in
connection with any other event(s) (i) result in any payment or benefit
becoming due to any current or former employee, director, officer, or
independent contractor of the Company thereof, (ii) increase any amount of
compensation or benefits otherwise payable under any Benefit Plan, (iii)
result in the acceleration of the time of payment, funding or vesting of any
benefits under any Benefit Plan, (iv) require any contribution or payment to
fund any obligation under any Benefit Plan or (v) limit the right to merge,
amend or terminate any Benefit Plan. \t\t

 \t\t

 \t\t\t(j) Neither the execution of, nor the consummation of the
transactions contemplated by this Agreement (either alone or when combined
with the occurrence of any other event, including without limitation, a
termination of employment) will result in the receipt or retention by any
person who is a "disqualified individual" (within the meaning of Code Section
280G) of any payment or benefit that is or could be characterized as an excess
"parachute payment" (within the meaning of Code Section 280G), determined
without regard to the application of Code Section 280G(b)(5). \t\t

 \t\t

 \t\t\t(k) The exercise price of each Company Option is not, never has
been and can never be less than the fair market value of the underlying
Company membership interest as of the grant date of such Company Option. Each
Benefit Plan that is a "nonqualified deferred compensation plan" (within the
meaning of Code Section 409A) complies and has at all times been in
documentary and operational compliance with Code Section 409A and IRS
regulations issued thereunder, except as would not be reasonably expected to
result in material liability to the Company. \t\t

 \t\t

 \t\t\t(l) No current or former employee, officer, director or
independent contractor of the Company has any "gross up" agreements or other
assurance of reimbursement for any Taxes imposed under Code Section 409A or
Code Section 4999. \t\t

 \t\t

 \t\t\t(m) The Company is not a party to, bound by, nor has a duty to
bargain under, any collective bargaining agreement or other Contract with a
labor union, labor organization, or similar Person representing any of its
employees, and there is no labor union, labor organization, or similar Person
representing or, to the Knowledge of the Company, purporting to represent or
seeking to represent any employees of the Company, including through the
filing of a petition for representation election. \t\t

 \t\t

 \t\t\t(n) The Company is, and since February 26, 2019 has been, in
material compliance with all applicable Laws respecting labor, employment,
employment practices, and terms and conditions of employment, including worker
classification, tax withholding, prohibited discrimination and retaliation,
equal employment opportunities, harassment, fair employment practices, meal
and rest periods, immigration, employee safety and health, wages (including
overtime wages), unemployment and workers' compensation, leaves of absence,
and hours of work. Except as would not be reasonably likely to result in a
material liability to the Company, with respect to employees of the Company ,
the Company , since February 26, 2019: (i) has withheld and reported all
amounts required by Law or by agreement to be withheld and reported with
respect to wages, salaries and other payments, benefits, or compensation to
employees, (ii) is not liable for any arrears of wages (including overtime
wages), severance pay or any Taxes or any penalty for failure to comply with
any of the foregoing, and (iii) is not liable for any payment to any trust or
other fund governed by or maintained by or on behalf of any Governmental Body,
with respect to unemployment compensation benefits, disability, social
security or other benefits or obligations for employees (other than routine
payments to be made in the Ordinary Course of Business). \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-18-  \t\t

  

 \t\t

 \t\t

 \t\t\t(o) Except as would not be reasonably likely to result in a
material liability to the Company, with respect to each individual who
currently renders services to the Company, the Company has accurately
classified each such individual as an employee, independent contractor, or
otherwise under all applicable Laws and, for each individual classified as an
employee, the Company has accurately classified him or her as overtime
eligible or overtime ineligible under all applicable Laws. The Company does
not have any material liability with respect to any misclassification of: (a)
any Person as an independent contractor rather than as an employee, (b) any
employee leased from another employer, or (c) any employee currently or
formerly classified as exempt from overtime wages. \t\t

 \t\t

 \t\t\t(p) There is not and has not been in the past three (3) years,
nor is there or has there been in the past three (3) years any threat of, any
strike, slowdown, work stoppage, lockout, union election petition, demand for
recognition, or any similar activity or dispute, or, to the Knowledge of the
Company, any union organizing activity, against the Company. No event has
occurred, and no condition or circumstance exists, that might directly or
indirectly be likely to give rise to or provide a basis for the commencement
of any such strike, slowdown, work stoppage, lockout, union election petition,
demand for recognition, any similar activity or dispute, or, to the Knowledge
of the Company, any union organizing activity. \t\t

 \t\t

 \t\t\t(q) There is no Legal Proceeding, claim, unfair labor practice
charge or complaint, labor dispute or grievance pending or, to the Knowledge
of the Company, threatened against the Company relating to labor, employment,
employment practices, or terms and conditions of employment. \t\t

 \t\t

 \t\t\t(r) As of the date hereof, no Key Employee has submitted his or
her resignation or, to the Knowledge of the Company, intends to resign. \t\t

 \t\t

 \t\t\t2.18 Environmental Matters. The Company is and since February 26,
2019 has complied with all applicable Environmental Laws, which compliance
includes the possession by the Company of all permits and other Governmental
Authorizations required under applicable Environmental Laws and compliance
with the terms and conditions thereof, except for any failure to be in such
compliance that, either individually or in the aggregate, would not reasonably
be expected to be material to the Company or its business. The Company has not
received since February 26, 2019 (or prior to that time, which is pending and
unresolved), any written notice or other communication (in writing or
otherwise), whether from a Governmental Body or other Person, that alleges
that the Company is not in compliance with or has liability pursuant to any
Environmental Law and, to the Knowledge of the Company, there are no
circumstances that would reasonably be expected to prevent or interfere with
the Company's or any of its Subsidiaries' compliance in any material respects
with any Environmental Law, except where such failure to comply would not
reasonably be expected to be material to the Company or its business. No
current or (during the time a prior property was leased or controlled by the
Company) prior property leased or controlled by the Company has had a release
of or exposure to Hazardous Materials in material violation of or as would
reasonably be expected to result in any material liability of the Company
pursuant to Environmental Law. No consent, approval or Governmental
Authorization of or registration or filing with any Governmental Body is
required by Environmental Laws in connection with the execution and delivery
of this Agreement or the Contemplated Transactions. Prior to the date hereof,
the Company has provided or otherwise made available to Parent true and
correct copies of all material environmental reports, assessments, studies and
audits in the possession or control of the Company with respect to any
property leased or controlled by the Company or any business operated by
it. \t\t

 \t\t

 \t\t\t2.19 Insurance. The Company has delivered or made available to
Parent accurate and complete copies of all material insurance policies and all
material self-insurance programs and arrangements relating to the business,
assets, liabilities and operations of the Company. Each of such insurance
policies is in full force and effect and the Company is in compliance in all
material respects with the terms thereof. Other than customary end of policy
notifications from insurance carriers, since February 26, 2019, neither the
Company nor any of its

 \t\t

  \t\t

  \t\t\t-19-  \t\t

  

Subsidiaries has received any notice or other communication regarding any
actual or possible: (i) cancellation or invalidation of any insurance policy;
or (ii) refusal or denial of any coverage, reservation of rights or rejection
of any material claim under any insurance policy. The Company has provided
timely written notice to the appropriate insurance carrier(s) of each Legal
Proceeding that is currently pending against the Company for which the Company
has insurance coverage, and no such carrier has issued a denial of coverage or
a reservation of rights with respect to any such Legal Proceeding, or informed
the Company of its intent to do so. \t\t

 \t\t

 \t\t\t2.20 No Financial Advisors. Except as set forth on Section 2.20
of the Company Disclosure Schedule, no broker, finder or investment banker is
entitled to any brokerage fee, finder's fee, opinion fee, success fee,
transaction fee or other fee or commission in connection with the Contemplated
Transactions based upon arrangements made by or on behalf of the
Company. \t\t

 \t\t

 \t\t\t2.21 Transactions with Affiliates. \t\t

 \t\t

 \t\t\t(a) Section 2.21(a) of the Company Disclosure Schedule
describes any material transactions or relationships, since February 26, 2019,
between, on one hand, the Company and, on the other hand, any (i) executive
officer or director of the Company or any of such executive officer's or
manager's immediate family members, (ii) owner of more than five percent (5%)
of the voting power of the outstanding Company Equity or (iii) to the
Knowledge of the Company, any "related person" (within the meaning of Item 404
of Regulation S-K under the Securities Act) of any such officer, director or
owner (other than the Company) in the case of each of (i), (ii) or (iii) that
is of the type that would be required to be disclosed under Item 404 of
Regulation S-K under the Securities Act. \t\t

 \t\t

 \t\t\t(b) Section 2.21(b) of the Company Disclosure Schedule lists
each member agreement, voting agreement, registration rights agreement, co-
sale agreement or other similar Contract between the Company and any holders
of Company Equity, including any such Contract granting any Person investor
rights, rights of first refusal, rights of first offer, registration rights,
director designation rights or similar rights. \t\t

 \t\t

 \t\t\t2.22 Anti-Bribery. None of the Company or any of their respective
managers, officers, employees or agents or any other Person acting on their
behalf has directly or indirectly made any bribes, rebates, payoffs, influence
payments, kickbacks, illegal payments, illegal political contributions, or
other payments, in the form of cash, gifts, or otherwise, or taken any other
action, in violation of the Foreign Corrupt Practices Act of 1977, the UK
Bribery Act of 2010 or any other anti-bribery or anti-corruption Law
(collectively, the "Anti-Bribery Laws"). The Company is not or has been the
subject of any investigation or inquiry by any Governmental Body with respect
to potential violations of Anti-Bribery Laws. \t\t

 \t\t

 \t\t\t2.23 Disclaimer of Other Representations or Warranties. Except as
previously set forth in this Section 2 or in any certificate delivered by the
Company to Parent and/or Merger Sub pursuant to this Agreement, the Company
makes no representation or warranty, express or implied, at law or in equity,
with respect to it or any of its assets, liabilities or operations, and any
such other representations or warranties are hereby expressly
disclaimed. \t\t

 \t\t

 \t\t\tSection 3 REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER
SUB \t\t

 \t\t

 \t\t\tSubject to Section 10.13(i), except (i) as set forth in the disclosure
schedule delivered by Parent to the Company (the "Parent Disclosure Schedule")
or (ii) as disclosed in the Parent SEC Documents filed with the SEC on or
after March 1, 2019 and prior to the date hereof and publicly available on the
SEC's Electronic Data Gathering Analysis and Retrieval, system (but (A)
without giving effect to information in any exhibits to Parent SEC Documents,
even if publicly available on the SEC's Electronic Data Gathering Analysis and
Retrieval system or incorporated by reference and (B) excluding any
disclosures contained under the heading "Risk Factors" and

 \t\t

  \t\t

  \t\t\t-20-  \t\t

  

any disclosure of risks included in any "forward-looking statements"
disclaimer or in any other section to the extent they are forward-looking
statements or cautionary, predictive or forward-looking in nature), Parent and
Merger Sub represent and warrant to the Company as follows: \t\t

 \t\t

 \t\t\t3.1 Due Organization; Subsidiaries. \t\t

 \t\t

 \t\t\t(a) Each of Parent and Merger Sub is a corporation duly
incorporated, validly existing and in good standing under the Laws of the
State of Delaware and has all necessary corporate power and authority to
conduct its business in the manner in which its business is currently being
conducted and to own or lease and use its property and assets in the manner in
which its property and assets are currently owned or leased and used. Since
the date of its incorporation, Merger Sub has not engaged in any activities
other than activities incident to its formation or in connection with or as
contemplated by this Agreement. \t\t

 \t\t

 \t\t\t(b) Parent is duly licensed and qualified to do business, and
is in good standing (to the extent applicable in such jurisdiction), under the
Laws of all jurisdictions where the nature of its business requires such
licensing or qualification other than in jurisdictions where the failure to be
so qualified individually or in the aggregate would not be reasonably expected
to have a Parent Material Adverse Effect. \t\t

 \t\t

 \t\t\t(c) Each of Parent's Subsidiaries is a corporation or other
legal entity duly organized, validly existing and, if applicable, in good
standing under the Laws of the jurisdiction of its organization and has all
necessary corporate or other power and authority to conduct its business in
the manner in which its business is currently being conducted and to own or
lease and use its property and assets in the manner in which its property and
assets are currently owned or leased and used, except where the failure to
have such power or authority would not be reasonably expected to have a Parent
Material Adverse Effect. \t\t

 \t\t

 \t\t\t3.2 Organizational Documents. Parent has made available to the
Company accurate and complete copies of Parent's and Merger Sub's
Organizational Documents in effect as of the date of this Agreement. Neither
Parent nor Merger Sub is in material breach or violation of its respective
Organizational Documents. \t\t

 \t\t

 \t\t\t3.3 Authority; Binding Nature of Agreement. Each of Parent and
Merger Sub has all necessary corporate power and authority to enter into and
to perform its obligations under this Agreement and to consummate the
Contemplated Transactions. The Parent Board (at meetings duly called and held)
has: (a) determined that the Contemplated Transactions are fair to, advisable
and in the best interests of Parent and its stockholders; (b) approved and
declared advisable this Agreement and the Contemplated Transactions, including
the issuance of shares of Parent Common Stock to the members of the Company
pursuant to the terms of this Agreement; and (c) determined to recommend, upon
the terms and subject to the conditions set forth in this Agreement, that the
stockholders of Parent vote to approve this Agreement and the Contemplated
Transactions, including the issuance of shares of Parent Common Stock to the
members of the Company pursuant to the terms of this Agreement. The Merger Sub
Board (by unanimous written consent) has: (x) determined that the Contemplated
Transactions are fair to, advisable, and in the best interests of Merger Sub
and its sole stockholder; (y) deemed advisable and approved this Agreement and
the Contemplated Transactions; and (z) determined to recommend, upon the terms
and subject to the conditions set forth in this Agreement, that the
stockholder of Merger Sub vote to adopt this Agreement and thereby approve the
Contemplated Transactions. This Agreement has been duly executed and delivered
by Parent and Merger Sub and, assuming the due authorization, execution and
delivery by the Company, constitutes the legal, valid and binding obligation
of Parent and Merger Sub, enforceable against each of Parent and Merger Sub in
accordance with its terms, subject to the Enforceability Exceptions. \t\t

 \t\t

 \t\t\t3.4 Vote Required. The affirmative vote of a majority of the
shares of Parent Common Stock that are outstanding and eligible to vote at the
Parent Stockholders' Meeting is the only vote of the holders of any

 \t\t

  \t\t

  \t\t\t-21-  \t\t

  

class or series of Parent's capital stock necessary to approve the Share
Issuance Proposal, the Reverse Stock Split Proposal and such other proposals
as may be required to approve the transactions contemplated by this Agreement
(collectively, the "Required Parent Stockholder Matters", and such votes, the
"Required Parent Stockholder Vote"). \t\t

 \t\t

 \t\t\t3.5 Non-Contravention; Consents. Subject to obtaining the
Required Parent Stockholder Vote and the filing of the Certificate of Merger
required by the DGCL and the DLLCA, neither (x) the execution, delivery or
performance of this Agreement by Parent or Merger Sub, nor (y) the
consummation of the Contemplated Transactions, will directly or indirectly
(with or without notice or lapse of time): \t\t

 \t\t

 \t\t\t(a) contravene, conflict with or result in a violation of any
of the provisions of the Organizational Documents of Parent or Merger
Sub; \t\t

 \t\t

 \t\t\t(b) contravene, conflict with or result in a violation of, or
give any Governmental Body or other Person the right to challenge the
Contemplated Transactions or to exercise any remedy or obtain any relief
under, any Law or any order, writ, injunction, judgment or decree to which
Parent or Merger Sub, or any of the assets owned or used by Parent or Merger
Sub, is subject, except as would not reasonably be expected to be material to
Parent or its business; \t\t

 \t\t

 \t\t\t(c) contravene, conflict with or result in a violation of any
of the terms or requirements of, or give any Governmental Body the right to
revoke, withdraw, suspend, cancel, terminate or modify, any Governmental
Authorization that is held by Parent, except as would not reasonably be
expected to be material to Parent or its business; \t\t

 \t\t

 \t\t\t(d) contravene, conflict with or result in a violation or
breach of, or result in a default under, any provision of any Parent Material
Contract, or give any Person the right to: (i) declare a default or exercise
any remedy under any Parent Material Contract; (ii) any material payment,
rebate, chargeback, penalty or change in delivery schedule under any Parent
Material Contract; (iii) accelerate the maturity or performance of any Parent
Material Contract; or (iv) cancel, terminate or modify any term of any Parent
Material Contract, except in the case of any non-material breach, default,
penalty or modification; or \t\t

 \t\t

 \t\t\t(e) result in the imposition or creation of any Encumbrance
upon or with respect to any asset owned or used by Parent (except for
Permitted Encumbrances). \t\t

 \t\t

 \t\t\tExcept for (i) any Consent set forth on Section 3.5 of the Parent
Disclosure Schedule under any Parent Contract, (ii) the Required Parent
Stockholder Vote, (iii) the filing of the Certificate of Merger with the
Secretary of State of the State of Delaware pursuant to the DGCL and the
DLLCA, and (iv) such consents, waivers, approvals, orders, authorizations,
registrations, declarations and filings as may be required under applicable
federal and state securities Laws, Parent is not and will not be required to
make any filing with or give any notice to, or to obtain any Consent from, any
Person in connection with (x) the execution, delivery or performance of this
Agreement, or (y) the consummation of the Contemplated Transactions, which if
individually or in the aggregate were not given or obtained, would reasonably
be expected to prevent or materially delay the ability of Parent and Merger
Sub to consummate the Contemplated Transactions. The Parent Board and the
Merger Sub Board have taken and will take all actions necessary to ensure that
the restrictions applicable to business combinations contained in Section 203
of the DGCL are, and will be, inapplicable to the execution, delivery and
performance of this Agreement and to the consummation of the Contemplated
Transactions. No other state Takeover Statute or similar Law applies or
purports to apply to the Merger, this Agreement or any of the other
Contemplated Transactions. \t\t

 \t\t

 \t\t\t3.6 Capitalization. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-22-  \t\t

  

 \t\t

 \t\t

 \t\t\t(a) The authorized capital stock of Parent consists of
450,000,000 shares of Parent Common Stock, par value $0.001 per share, of
which 15,227,891 shares have been issued and are outstanding as of December
31, 2019 (the "Capitalization Date") and 10,000,000 shares of preferred stock,
par value $0.001 per share, none of which are outstanding at the
Capitalization Date. Parent does not hold any shares of its capital stock in
its treasury. \t\t

 \t\t

 \t\t\t(b) All of the outstanding shares of Parent Common Stock have
been duly authorized and validly issued, and are fully paid and nonassessable.
None of the outstanding shares of Parent Common Stock is entitled or subject
to any preemptive right, right of participation, right of maintenance or any
similar right and none of the outstanding shares of Parent Common Stock is
subject to any right of first refusal in favor of Parent. Except as
contemplated herein, there is no Parent Contract relating to the voting or
registration of, or restricting any Person from purchasing, selling, pledging
or otherwise disposing of (or granting any option or similar right with
respect to), any shares of Parent Common Stock. Parent is not under any
obligation, nor is it bound by any Contract pursuant to which it may become
obligated, to repurchase, redeem or otherwise acquire any outstanding shares
of Parent Common Stock or other securities. \t\t

 \t\t

 \t\t\t(c) Except for the 2016 Equity Incentive Plan, as amended in
March 2017 and August 2018, and the 2014 Equity Incentive Plan (under which
awards may no longer be granted, collectively the "Parent Stock Plan"), and
except for 6,667 inducement options further described in Section 3.6(c) of the
Parent Disclosure Schedule, Parent does not have any stock option plan or any
other plan, program, agreement or arrangement providing for any equity-based
compensation for any Person. As of the date of this Agreement, 1,247,536
shares have been reserved for issuance upon exercise of Parent Options granted
under the Parent Stock Plan that are outstanding as of the date of this
Agreement, no shares that have been reserved for issuance with respect to the
inducement options and 1,729,742 shares remain available for future issuance
pursuant to the Parent Stock Plan. \t\t

 \t\t

 \t\t\t(d) Except for the Parent Stock Plan, the inducement options
described above, warrants to purchase securities of Parent, the Bridge
Warrants and the Exchange Agreement, and as otherwise set forth on Section
3.6(d) of the Parent Disclosure Schedule, there is no: (i) outstanding
subscription, option, call, warrant or right (whether or not currently
exercisable) to acquire any shares of the capital stock or other securities of
Parent or any of its Subsidiaries; (ii) outstanding security, instrument or
obligation that is or may become convertible into or exchangeable for any
shares of the capital stock or other securities of Parent or any of its
Subsidiaries; or (iii) condition or circumstance that is reasonably likely to
give rise to or provide a basis for the assertion of a claim by any Person to
the effect that such Person is entitled to acquire or receive any shares of
capital stock or other securities of Parent or any of its Subsidiaries. There
are no outstanding or authorized stock appreciation, phantom stock, profit
participation or other similar rights with respect to Parent or any of its
Subsidiaries. \t\t

 \t\t

 \t\t\t(e) All outstanding shares of Parent Common Stock, Parent
Options, and other securities of Parent have been issued and granted in
material compliance with (i) all applicable securities Laws and other
applicable Law, and (ii) all requirements set forth in applicable
Contracts. \t\t

 \t\t

 \t\t\t3.7 SEC Filings; Financial Statements. \t\t

 \t\t

 \t\t\t(a) Parent has delivered or made available to the Company
accurate and complete copies of all registration statements, proxy statements,
Certifications (as defined below) and other statements, reports, schedules,
forms and other documents filed by Parent with the SEC since January 31, 2016
(the "Parent SEC Documents"), other than such documents that can be obtained
on the SEC's website at www.sec.gov. All material statements, reports,
schedules, forms and other documents required to have been filed by Parent or
its officers with the SEC have been so filed on a timely basis. As of the time
it was filed with the SEC (or, if amended or superseded by a filing prior to
the date of this Agreement, then on the date of such filing), each of the
Parent SEC Documents complied in all material respects with the applicable
requirements of the Securities Act or the

 \t\t

  \t\t

  \t\t\t-23-  \t\t

  

Exchange Act (as the case may be) and, as of the time they were filed, none of
the Parent SEC Documents contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under
which they were made, not misleading. The certifications and statements
required by (i) Rule 13a-14 under the Exchange Act and (ii) 18 U.S.C. 1350
(Section 906 of the Sarbanes-Oxley Act) relating to the Parent SEC Documents
(collectively, the "Certifications") are accurate and complete and comply as
to form and content with all applicable Laws. As used in this Section 3.7, the
term "file" and variations thereof shall be broadly construed to include any
manner in which a document or information is furnished, supplied or otherwise
made available to the SEC. Except as set forth in Section 3.7 of the Parent
Disclosure Schedule, the Parent has never been and is not currently an issuer
as such term is described in Rule 144(i) of the Securities Act. \t\t

 \t\t

 \t\t\t(b) The financial statements (including any related notes)
contained or incorporated by reference in the Parent SEC Documents: (i)
complied as to form in all material respects with the published rules and
regulations of the SEC applicable thereto; (ii) were prepared in accordance
with GAAP (except as may be indicated in the notes to such financial
statements or, in the case of unaudited financial statements, except as
permitted by Form 10-Q of the SEC, and except that the unaudited financial
statements may not contain footnotes and are subject to normal and recurring
year-end adjustments none of which are material) applied on a consistent basis
unless otherwise noted therein throughout the periods indicated; and (iii)
fairly present, in all material respects, the financial position of Parent and
its Subsidiaries as of the respective dates thereof and the results of
operations and cash flows of Parent for the periods covered thereby. Other
than as expressly disclosed in the Parent SEC Documents filed prior to the
date hereof, there has been no material change in Parent's or its
Subsidiaries' accounting methods or principles that would be required to be
disclosed in Parent's financial statements in accordance with GAAP. The books
of account and other financial records of Parent and each of its Subsidiaries
are true and complete in all material respects. \t\t

 \t\t

 \t\t\t(c) Parent is in compliance in all material respects with the
applicable current listing and governance rules and regulations of the NYSE
American Exchange and has not received any written notice that it is not in
compliance with all current listing and governance rules and regulations of
NYSE American Exchange, except as disclosed in the Parent SEC Documents. \t\t

 \t\t

 \t\t\t(d) Parent maintains a system of internal control over
financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the
Exchange Act) that is designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with GAAP and to provide reasonable
assurance (i) that transactions are recorded as necessary to permit
preparation of financial statements in accordance with GAAP, (ii) that
receipts and expenditures are made only in accordance with authorizations of
management and the Parent Board and (iii) regarding prevention or timely
detection of the unauthorized acquisition, use or disposition of Parent's
assets that could have a material effect on Parent's financial statements.
Parent has evaluated the effectiveness of Parent's internal control over
financial reporting as of January 31, 2019, and, to the extent required by
applicable Law, presented in any applicable Parent SEC Document that is a
report on Form 10-K or Form 10-Q (or any amendment thereto) its conclusions
about the effectiveness of the internal control over financial reporting as of
the end of the period covered by such report or amendment based on such
evaluation. Parent has disclosed, based on its most recent evaluation of
internal control over financial reporting, to Parent's auditors and audit
committee (and made available to the Company a summary of the significant
aspects of such disclosure) (A) all significant deficiencies and material
weaknesses, if any, in the design or operation of internal control over
financial reporting that are reasonably likely to adversely affect Parent's
ability to record, process, summarize and report financial information and (B)
any known fraud that involves management or other employees who have a
significant role in Parent's internal control over financial reporting. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-24-  \t\t

  

 \t\t

 \t\t

 \t\t\t(e) Parent maintains "disclosure controls and procedures" (as
defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) that are
reasonably designed to ensure that information required to be disclosed by
Parent in the periodic reports that it files or submits under the Exchange Act
is recorded, processed, summarized and reported within the required time
periods, and that all such information is accumulated and communicated to
Parent's management as appropriate to allow timely decisions regarding
required disclosure and to make the Certifications. \t\t

 \t\t

 \t\t\t3.8 Absence of Changes. Except as set forth on Section 3.8 of
the Parent Disclosure Schedule, between the date of the Parent Balance Sheet
and the date of this Agreement, the Parent has conducted its business only in
the Ordinary Course of Business (except for the execution and performance of
this Agreement and the discussions, negotiations and transactions related
thereto) and there has not been any (a) Parent Material Adverse Effect or (b)
action, event or occurrence that would have required the consent of Parent
pursuant to Section 4.2(b) had such action, event or occurrence taken place
after the execution and delivery of this Agreement. \t\t

 \t\t

 \t\t\t3.9 Absence of Undisclosed Liabilities. As of the date hereof,
Parent does not have any Liability, individually or in the aggregate, of a
type required to be recorded or reflected on a balance sheet or disclosed in
the footnotes thereto under GAAP except for: (a) Liabilities disclosed,
reflected or reserved against in the Parent Balance Sheet; (b) Liabilities
that have been incurred by Parent since the date of the Parent Balance Sheet
in the Ordinary Course of Business and which are not in excess of $10,000; (c)
Liabilities for performance of obligations of Parent under Parent Contracts;
(d) Liabilities incurred in connection with the Contemplated Transactions; (e)
Liabilities which would not, individually or in the aggregate, reasonably be
expected to be material to Parent; and (f) Liabilities described in Section
3.9 of the Parent Disclosure Schedule. \t\t

 \t\t

 \t\t\t3.10 Title to Assets. The Parent owns, and has good and valid
title to, or, in the case of leased properties and assets, valid leasehold
interests in, all tangible properties or tangible assets and equipment used or
held for use in its business or operations or purported to be owned by it,
including: (a) all assets reflected on the Parent Balance Sheet; and (b) all
other assets reflected in the books and records of the Parent as being owned
by the Parent. All of such assets are owned or, in the case of leased assets,
leased by the Parent free and clear of any Encumbrances, other than Permitted
Encumbrances. \t\t

 \t\t

 \t\t\t3.11 Real Property; Leasehold. Parent does not own any real
property. Parent has made available to the Company (a) an accurate and
complete list of all real properties with respect to which Parent directly or
indirectly holds a valid leasehold interest as well as any other real estate
that is in the possession of or leased by Parent, and (b) copies of all leases
under which any such real property is possessed (the "Parent Real Estate
Leases"), each of which is in full force and effect, with no existing material
default thereunder. Parent's use and operation of each such leased property
conforms to all applicable Laws in all material respects, and Parent has
exclusive possession of each such leased property and has not granted any
occupancy rights to tenants or licensees with respect to such leased property.
In addition, each such leased property is free and clear of all Encumbrances
other than Permitted Encumbrances. Parent has not received written notice from
its landlords or any Governmental Body that: (i) relates to violations of
building, zoning, safety or fire ordinances or regulations; (ii) claims any
defect or deficiency with respect to any of such properties; or (iii) requests
the performance of any repairs, alterations or other work to such
properties. \t\t

 \t\t

 \t\t\t3.12 Intellectual Property. \t\t

 \t\t

 \t\t\t(a) The Parent owns, or has the legal and valid right to use,
as currently being used by the Parent, all Parent IP Rights, and with respect
to Parent IP Rights that are owned by the Parent, has the right to bring
actions for the infringement of such Parent IP Rights, in each case except
subject to the terms of the license agreements set forth on Section 3.12(c) of
the Parent Disclosure Schedule for any failure to own, have such rights to
use, or have such rights to bring actions for infringement. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-25-  \t\t

  

 \t\t

 \t\t

 \t\t\t(b) Section 3.12(b) of the Parent Disclosure Schedule sets
forth an accurate, true and complete listing of (i) all Parent IP Rights that
are owned by the Parent that are registered, filed or issued under the
authority of, with or by any Governmental Body, including all Patents,
registered Copyrights, and registered Trademarks (including domain names) and
all applications for any of the foregoing, (ii) to the Knowledge of the
Parent, all Parent IP Rights that are exclusively licensed to the Parent that
are registered, filed or issued under the authority of, with or by any
Governmental Body, including all Patents, registered Copyrights, and
registered Trademarks (including domain names) and (iii) all applications for
any of the foregoing, and specifying as to each such item, as applicable, the
owner(s) of record (and, in the case of domain names, the registrar),
jurisdiction of application and/or registration, the application and/or
registration number, the date of application and/or registration, and the
status of application and/or registration. To the Knowledge of the Parent,
each item of Parent IP Rights that is Parent Registered IP is and at all times
has been filed and maintained in compliance with all applicable Law and all
filings, payments, and other actions required to be made or taken to maintain
such item of Parent Registered IP in full force and effect have been made by
the applicable deadline. \t\t

 \t\t

 \t\t\t(c) Section 3.12(c) of the Parent Disclosure Schedule
accurately identifies (i) all material Parent Contracts pursuant to which
Parent IP Rights are licensed to the Parent (other than (A) any non-customized
software that (1) is so licensed solely in executable or object code form
pursuant to a non-exclusive, internal use software license and other
Intellectual Property associated with such software and (2) is not
incorporated into, or material to the development, manufacturing, or
distribution of, any of the Parent's products or services, (B) any
Intellectual Property licensed ancillary to the purchase or use of equipment,
reagents or other materials and (C) any confidential information provided
under confidentiality agreements), and (ii) whether the license or licenses
granted to the Parent are exclusive or non-exclusive. For purposes of greater
certainty, the term "license" in this Section 3.12(c) and in Section 3.12(d)
includes any license, sublicense, covenant, non-assert, consent, release or
waiver. \t\t

 \t\t

 \t\t\t(d) Section 3.12(d) of the Parent Disclosure Schedule
accurately identifies each material Parent Contract pursuant to which the
Parent has granted any license under, or any right (whether or not currently
exercisable) or interest in, any Parent IP Rights to any Person (other than
any Parent IP Rights non-exclusively licensed to suppliers or service
providers for the sole purpose of enabling such suppliers or service providers
to provide services for the Parent's benefit). \t\t

 \t\t

 \t\t\t(e) Except as set forth in Section 3.12(e) of the Parent
Disclosure Schedule, the Parent is not bound by, and no Parent IP Rights are
subject to, any Parent Contract containing any covenant or other provision, or
any judicial, administrative or arbitral order, judgment, award, order,
decree, injunction, settlement or stipulation, that in any way limits or
restricts the ability of the Parent to use, exploit, assert, enforce, sell,
transfer or dispose of any such Parent IP Rights anywhere in the world, in
each case, in a manner that would materially limit the business of the Parent
as currently conducted or planned to be conducted. \t\t

 \t\t

 \t\t\t(f) Except as identified in Section 3.12(f) of the Parent
Disclosure Schedule, the Parent is the sole and unrestricted legal and
beneficial owner of all right, title, and interest to and in Parent IP Rights
(other than (i) Parent IP Rights exclusively and non-exclusively licensed to
the Parent or one of its Subsidiaries, as identified in Section 3.12(c) of the
Parent Disclosure Schedule, (ii) any non-customized software that (A) is
licensed to the Parent solely in executable or object code form pursuant to a
non-exclusive, internal use software license and other Intellectual Property
associated with such software and (B) is not incorporated into, or material to
the development, manufacturing, or distribution of, any of the Parent's or any
of its Subsidiaries' products or services and (iii) any Intellectual Property
licensed ancillary to the purchase or use of equipment, reagents or other
materials), in each case, free and clear of any Encumbrances (other than
Permitted Encumbrances). Without limiting the generality of the
foregoing: \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-26-  \t\t

  

 \t\t

 \t\t

 \t\t\t(i) Each Person who is or was an employee or contractor of the
Parent and who is or was involved in the creation or development of any Parent
IP Rights has signed a valid, enforceable agreement containing an assignment
of such Intellectual Property to the Parent and confidentiality provisions
protecting confidential information of the Parent and Parent has no reason to
believe that any such Person is unwilling to provide Parent with cooperation
as may reasonably be required to complete or prosecute all Parent IP
Rights. \t\t

 \t\t

 \t\t\t(ii) No current nor, to the Knowledge of Parent, former member,
officer, director, or employee of the Parent has any claim, right (whether or
not currently exercisable), or interest to or in any Parent IP Rights
purported to be owned by the Parent. To the Knowledge of the Parent, no
employee of the Parent is (a) bound by or otherwise subject to any Contract
restricting him or her from performing his or her duties for the Parent or (b)
in breach of any Contract with any former employer or other Person concerning
Parent IP Rights purported to be owned by the Parent or confidentiality
provisions protecting Trade Secrets and confidential information comprising
Parent IP Rights purported to be owned by the Parent. \t\t

 \t\t

 \t\t\t(iii) Except as identified in Section 3.12(f)(iii) of the Parent
Disclosure Schedule, no Parent IP Rights were developed, in whole or in part
(A) pursuant to or in connection with the development of any professional,
technical or industry standard, (B) under contract with or using the resources
of any Governmental Body, academic institution or other entity that would
subject any Parent IP Rights to the rights of any Governmental Body, academic
institution or other entity or (C) under any grants or other funding
arrangements with third parties. \t\t

 \t\t

 \t\t\t(iv) The Parent has taken all commercially reasonable and
appropriate steps to protect and maintain the Parent IP Rights, including to
preserve the confidentiality of all proprietary information that the Parent
holds, or purports to hold, as a material Trade Secret. Any disclosure by the
Parent of Trade Secrets to any third party has been pursuant to the terms of a
written agreement with such Person or is otherwise lawful. Parent has
implemented and maintained a reasonable security plan consistent with industry
practices of companies offering similar products or services. Parent has not
experienced any breach of security or otherwise unauthorized access by third
parties to the confidential information in Parent's possession, custody or
control \t\t

 \t\t

 \t\t\t(v) The Parent has not assigned or otherwise transferred ownership
of, or agreed to assign or otherwise transfer ownership of, any Parent IP
Rights owned or purported to be owned by or exclusively licensed to the Parent
to any other Person. As of the date of this Agreement, except as set forth in
Section 3.12(f)(v) of the Parent Disclosure Schedule, the Parent has not sold
or otherwise transferred (other than standard licenses or rights to use
granted to customers, suppliers or service providers in the Ordinary Course of
Business) any of the Parent IP Rights to any third party, and there exists no
obligation by the Parent to assign or otherwise transfer any of the Parent IP
Rights to any third party. \t\t

 \t\t

 \t\t\t(vi) To the Knowledge of the Parent, (i) the Parent IP Rights are
valid and enforceable and (ii) constitute all Intellectual Property necessary
for the Parent to conduct its business as currently conducted and planned to
be conducted. Parent has not misrepresented, or failed to disclose, any facts
or circumstances in any application for any Parent IP Rights that would
constitute fraud with respect to such application. \t\t

 \t\t

 \t\t\t(g) To the Knowledge of the Parent, the manufacture, marketing,
license, sale or intended use of any product or technology currently licensed
or sold or under development by the Parent does not violate any license or
agreement between the Parent or its Subsidiaries and any third party, and does
not infringe or misappropriate any Intellectual Property right of any third
party. Parent has not been sued in any action, suit or proceeding, or received
any written communications alleging that any Parent IP Rights or product or
past activity has violated or would violate any Intellectual Property rights
of any third party and to the Parent's knowledge a valid claim for such
action, suit or proceeding does not exist. No Parent IP Rights are subject to
any proceeding,

 \t\t

  \t\t

  \t\t\t-27-  \t\t

  

order, judgment, settlement agreement, stipulation or right that restricts in
any manner the use, transfer, or licensing thereof by Parent, or which may
affect the validity, use or enforceability of any such Parent IP Rights. \t\t

 \t\t

 \t\t\t(h) To the Knowledge of the Parent, no third party is
infringing upon any Parent IP Rights or violating any license or agreement
between the Parent and such third party, and the Parent have not sent any
written communication to or asserted or threatened in writing any action or
claim against any Person involving or relating to any Parent IP Rights \t\t

 \t\t

 \t\t\t(i) There is no current or pending Legal Proceeding
(including, but not limited to, opposition, interference, inter partes review,
or other proceeding in any patent or other government office) contesting the
validity, ownership or right to use, sell, license or dispose of any Parent IP
Rights or products or technologies, nor has the Parent received any written
notice asserting or suggesting that any such Parent IP Rights, or the Parent's
right to use, sell, license or dispose of any such Parent IP Rights or
products or technologies conflicts with or infringes or misappropriates or
will conflict with or infringe or misappropriate the rights of any other
Person. \t\t

 \t\t

 \t\t\t(j) Except as set forth in the Contracts listed on Section
3.12(j) of the Parent Disclosure Schedule and except for Parent Contracts
entered into in the Ordinary Course of Business, (i) the Parent is not bound
by any Contract to indemnify, defend, hold harmless, or reimburse any other
Person with respect to any Intellectual Property infringement,
misappropriation, or similar claim, in each case, that would reasonably be
expected to be material to the Parent or its business, and (ii) the Parent has
never assumed, or agreed to discharge or otherwise take responsibility for,
any existing or potential liability of another Person for infringement,
misappropriation, or violation of any Intellectual Property right, which
assumption, agreement or responsibility is material and remains in force as of
the date of this Agreement. \t\t

 \t\t

 \t\t\t3.13 Agreements, Contracts and Commitments. \t\t

 \t\t

 \t\t\t(a) Section 3.13 of the Parent Disclosure Schedule identifies
each Parent Contract in effect as of the date of this Agreement that involves
payment or receipt by the Company of more than $10,000 in the aggregate, or
obligations after the date of this Agreement in excess of $10,000 in the
aggregate other than any Benefit Plans and includes: \t\t

 \t\t

 \t\t\t(i) a material contract as defined in Item 601(b)(10) of
Regulation S-K as promulgated under the Securities Act; \t\t

 \t\t

 \t\t\t(ii) each Contract relating to any agreement of indemnification or
guaranty not entered into in the Ordinary Course of Business; \t\t

 \t\t

 \t\t\t(iii) each Contract containing (A) any covenant limiting the
freedom of Parent to engage in any line of business or compete with any
Person, (B) any most-favored pricing arrangement, (C) any exclusivity
provision, or (D) any non-solicitation provision; \t\t

 \t\t

 \t\t\t(iv) each Contract relating to capital expenditures and requiring
payments after the date of this Agreement in excess of $10,000 pursuant to its
express terms and not cancelable without penalty; \t\t

 \t\t

 \t\t\t(v) each Contract relating to the disposition or acquisition of
material assets or any ownership interest in any Entity; \t\t

 \t\t

 \t\t\t(vi) each Contract relating to any mortgages, indentures, loans,
notes or credit agreements, security agreements or other agreements or
instruments relating to the borrowing of money or

 \t\t

  \t\t

  \t\t\t-28-  \t\t

  

extension of credit or creating any material Encumbrances with respect to any
assets of Parent or any loans or debt obligations with officers or directors
of Parent; \t\t

 \t\t

 \t\t\t(vii) each Contract requiring payment by or to Parent after the date
of this Agreement in excess of $50,000 pursuant to its express terms relating
to: (A) any distribution agreement (identifying any that contain exclusivity
provisions); (B) any agreement involving provision of services or products
with respect to any pre-clinical or clinical development activities of Parent;
(C) any dealer, distributor, joint marketing, alliance, joint venture,
cooperation, development or other agreement currently in force under which
Parent has continuing obligations to develop or market any product, technology
or service, or any agreement pursuant to which Parent has continuing
obligations to develop any Intellectual Property that will not be owned, in
whole or in part, by Parent; or (D) any Contract to license any third party to
manufacture or produce any product, service or technology of Parent or any
Contract to sell, distribute or commercialize any products or service of
Parent, in each case, except for Contracts entered into in the Ordinary Course
of Business; \t\t

 \t\t

 \t\t\t(viii) each Contract with any Person, including any financial
advisor, broker, finder, investment banker or other Person, providing advisory
services to Parent in connection with the Contemplated Transactions; \t\t

 \t\t

 \t\t\t(ix) each Parent Real Estate Lease; \t\t

 \t\t

 \t\t\t(x) each Contract with any Governmental Body; \t\t

 \t\t

 \t\t\t(xi) each Parent IP Agreement; \t\t

 \t\t

 \t\t\t(xii) each Contract containing any royalty, dividend or similar
arrangement based on the revenues or profits of Parent; or \t\t

 \t\t

 \t\t\t(xiii) any other Contract that is not terminable at will (with no
penalty or payment) by Parent and (A) which involves payment or receipt by
Parent after the date of this Agreement under any such agreement, contract or
commitment of more than $25,000 in the aggregate, or obligations after the
date of this Agreement in excess of $10,000 in the aggregate, or (B) that is
material to the business or operations of Parent. \t\t

 \t\t

 \t\t\t(b) Parent has delivered or made available to the Company
accurate and complete copies of all Contracts to which Parent is a party or by
which it is bound of the type described in the foregoing clauses (i)-(xiii)
(any such Contract, a "Parent Material Contract"). There are no Parent
Material Contracts that are not in written form. Parent has not nor, to
Parent's Knowledge, as of the date of this Agreement, has any other party to a
Parent Material Contract, breached, violated or defaulted under, or received
notice that it breached, violated or defaulted under, any of the terms or
conditions of any Parent Material Contract in such manner as would permit any
other party to cancel or terminate any such Parent Material Contract, or would
permit any other party to seek damages which would reasonably be expected to
be material to Parent or its business. As to Parent, as of the date of this
Agreement, each Parent Material Contract is valid, binding, enforceable and in
full force and effect, subject to the Enforceability Exceptions. No Person is
renegotiating, or has a right pursuant to the terms of any Parent Material
Contract to change, any material amount paid or payable to Parent under any
Parent Material Contract or any other material term or provision of any Parent
Material Contract. \t\t

 \t\t

 \t\t\t3.14 Compliance; Permits. \t\t

 \t\t

 \t\t\t(a) Parent is, and since February 1, 2016 has been, in
compliance in all material respects with all applicable Laws, including the
FDCA, the FDA regulations adopted thereunder, the Controlled Substance Act and
any other similar Law administered or promulgated by the FDA or other Drug
Regulatory Agency, except

 \t\t

  \t\t

  \t\t\t-29-  \t\t

  

for any noncompliance, either individually or in the aggregate, which would
not be material to Parent. No investigation, claim, suit, proceeding, audit or
other action by any Governmental Body is pending or, to the Knowledge of
Parent, threatened against Parent. There is no agreement, judgment,
injunction, order or decree binding upon Parent which (i) has or would
reasonably be expected to have the effect of prohibiting or materially
impairing any business practice of Parent or any of its Subsidiaries, any
acquisition of material property by Parent or any of its Subsidiaries or the
conduct of business by Parent or any of its Subsidiaries as currently
conducted (ii) is reasonably likely to have an adverse effect on Parent's
ability to comply with or perform any covenant or obligation under this
Agreement, or (iii) is reasonably likely to have the effect of preventing,
delaying, making illegal or otherwise interfering with the Contemplated
Transactions. \t\t

 \t\t

 \t\t\t(b) Parent holds all required Governmental Authorizations which
are material to the operation of the business of Parent as currently conducted
(the "Parent Permits"). Parent is in material compliance with the terms of the
Parent Permits. No Legal Proceeding is pending or, to the Knowledge of Parent,
threatened, which seeks to revoke, limit, suspend, or materially modify any
Parent Permit. \t\t

 \t\t

 \t\t\t(c) There are no proceedings pending or, to the Knowledge of
Parent, threatened with respect to an alleged material violation by Parent of
the FDCA, FDA regulations adopted thereunder, the Controlled Substance Act or
any other similar Law administered or promulgated by any Drug Regulatory
Agency. \t\t

 \t\t

 \t\t\t(d) Parent and each Subsidiary holds all required Governmental
Authorizations issuable by any Drug Regulatory Agency necessary or material to
the conduct of the business of the Company or such Subsidiary as currently
conducted, and, as applicable, the development, clinical testing,
manufacturing, marketing, distribution and importation or exportation, as
currently conducted, of any of its products or product candidates
(collectively, the "Parent Products") (collectively, the "Parent Regulatory
Permits") and no such Parent Regulatory Permit has been (i) revoked,
withdrawn, suspended, cancelled or terminated or (ii) modified in any adverse
manner. Parent and each Subsidiary is in compliance in all material respects
with the Parent Regulatory Permits and has not received any written notice or
other written communication, or to the Knowledge of Parent and each
Subsidiary, any other communication from any Drug Regulatory Agency regarding
(A) any material violation of or failure to comply materially with any term or
requirement of any Parent Regulatory Permit or (B) any revocation, withdrawal,
suspension, cancellation, termination or material modification of any Parent
Regulatory Permit. Parent has made available to Company all information
relating to the Parent Products and the development, clinical testing,
manufacturing, importation and exportation of the Parent Products, including
complete copies of the following (to the extent there are any): (x) copies of
all investigational new drug applications (INDs) submitted to the FDA, and all
supplements to and amendments of such INDs; new drug applications; adverse
event reports; clinical study reports and material study data; inspection
reports, notices of adverse findings, warning letters, filings and letters and
other material written correspondence to and from any Drug Regulatory Agency;
and meeting minutes with any Drug Regulatory Agency; and (y) similar notices,
letters, filings, correspondence and meeting minutes with any other
Governmental Body. Parent and each Subsidiary has complied in all material
respects with the ICH E9 Guidance for Industry: Statistical Principles for
Clinical Trials in the management of the clinical data that have been
presented to the Parent. To the Knowledge of Parent and each Subsidiary, there
are no facts that would be reasonably likely to result in any warning,
untitled or notice of violation letter or Form FDA-483 from the FDA. Neither
Parent nor any Subsidiary is aware of any studies, tests or trials the results
of which Parent or any Subsidiary believes reasonably call into question (i)
the study, test or trial results of any Parent Products, (ii) the efficacy or
safety of any Parent Products or (iii) any of the Parent or its Subsidiaries
filings with any Governmental Body. \t\t

 \t\t

 \t\t\t(e) All clinical, pre-clinical and other studies and tests
conducted by or on behalf of, or sponsored by, Parent or its Subsidiaries, or
in which Parent or its Subsidiaries or their respective products or product
candidates have participated, were and, if still pending, are being conducted
in all material respects in

 \t\t

  \t\t

  \t\t\t-30-  \t\t

  

accordance with standard medical and scientific research procedures and in
compliance in all material respects with the applicable regulations of any
applicable Drug Regulatory Agency and other applicable Law, including 21
C.F.R. Parts 50, 54, 56, 58 and 312. No preclinical or clinical trial
currently being conducted by or on behalf of Parent or any of its Subsidiaries
has been terminated or suspended prior to completion for safety or non-
compliance reasons. Since February 1, 2016, neither Parent nor any of its
Subsidiaries has received any notices, correspondence, or other communications
from any Drug Regulatory Agency requiring, or to the Knowledge of Parent
threatening to initiate, the termination or suspension of any clinical studies
currently being conducted by or on behalf of, or sponsored by, Parent or any
of its Subsidiaries or in which Parent or any of its Subsidiaries or their
respective current products or product candidates, currently participate.
Neither Parent nor any of its Subsidiaries has received any notices,
correspondence, or other communications regarding any clinical studies that
have been conducted by or on behalf of, or sponsored by, Parent or any of its
Subsidiaries or in which Parent or any of its Subsidiaries or their respective
products or product candidates have participated that are anticipated to
result in any material liability to Parent or its Subsidiaries or have a
Parent Material Adverse Effect. \t\t

 \t\t

 \t\t\t(f) Neither Parent nor any of its Subsidiaries is the subject
of any pending or, to the Knowledge of Parent, threatened investigation in
respect of its business or products by the FDA pursuant to its "Fraud, Untrue
Statements of Material Facts, Bribery, and Illegal Gratuities" Final Policy
set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments
thereto. To the Knowledge of Parent, neither Parent nor any of its
Subsidiaries has committed any acts, made any statement, or failed to make any
statement, in each case in respect of its business or products that would
violate the FDA's "Fraud, Untrue Statements of Material Facts, Bribery, and
Illegal Gratuities" Final Policy, and any amendments thereto. None of Parent,
any of its Subsidiaries or any of their respective officers, employees or
agents has been convicted of any crime or engaged in any conduct that could
result in a debarment or exclusion (i) under 21 U.S.C. Section 335a or (ii)
any similar applicable Law. No debarment or exclusionary claims, actions,
proceedings or investigations in respect of their business or products are
pending or, to the Knowledge of Parent, threatened against Parent, any of its
Subsidiaries or any of their respective officers, employees or agents. \t\t

 \t\t

 \t\t\t(g) Parent and its Subsidiaries are in compliance with all Laws
relating to patient, medical or individual health information, including
HIPAA, including the standards for the privacy of Individually Identifiable
Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the
standards for the protection of Electronic Protected Health Information set
forth at 45 C.F.R. Part 160 and 45 C.F.R. Part 164, Subpart A and Subpart C,
the standards for transactions and code sets used in electronic transactions
at 45 C.F.R. Part 160, Subpart A and Part 162, and the standards for Breach
Notification for Unsecured Protected Health Information at 45 C.F.R. Part 164,
Subpart D, all as amended from time to time. Parent and its Subsidiaries have
entered into, where required, and are in compliance in all material respects
with the terms of all Business Associate (as defined in HIPAA) agreements to
which Parent or a Subsidiary is a party or otherwise bound. Parent and its
Subsidiaries have created and maintained written policies and procedures to
protect the privacy of all protected health information, provide training to
all employees and agents as required under HIPAA, and have implemented
security procedures, including physical, technical and administrative
safeguards, to protect all personal information and Protected Health
Information stored or transmitted in electronic form. Neither Parent nor its
Subsidiaries have received written notice from the Office for Civil Rights for
the U.S. Department of Health and Human Services or any other Governmental
Body of any allegation regarding its failure to comply with HIPAA or any other
state law or regulation applicable to the protection of individually
identifiable health information or personally identifiable information. No
successful Security Incident, Breach of Unsecured Protected Health Information
or breach of personally identifiable information under applicable state or
federal laws have occurred with respect to information maintained or
transmitted to Parent, any of its Subsidiaries, or an agent or third party
subject to a Business Associate Agreement with Parent or a Subsidiary of
Parent. Parent and each of its subsidiaries is currently submitting, receiving
and handling or is capable of submitting receiving and handling

 \t\t

  \t\t

  \t\t\t-31-  \t\t

  

transactions in accordance with the Standard Transaction Rule. All capitalized
terms in this Section 3.14(g) not otherwise defined in this Agreement shall
have the meanings set forth under HIPAA. \t\t

 \t\t

 \t\t\t(h) Parent and each of its Subsidiaries have complied in all
material respects with the ICH E9 Guidance for Industry to the extent
applicable to their current activities. \t\t

 \t\t

 \t\t\t3.15 Legal Proceedings; Orders. \t\t

 \t\t

 \t\t\t(a) As of the date of this Agreement, there is no material
pending Legal Proceeding and, to the Knowledge of Parent, no Person has
threatened in writing to commence any Legal Proceeding: (i) that involves (A)
Parent, (B) any Parent Associate (in his or her capacity as such) or (C) any
of the material assets owned or used by Parent; or (ii) that challenges, or
that may have the effect of preventing, delaying, making illegal or otherwise
interfering with, the Contemplated Transactions. \t\t

 \t\t

 \t\t\t(b) Except as set forth in Section 3.15(b) of the Parent
Disclosure Schedule, since February 1, 2016, no Legal Proceeding has been
pending against Parent that resulted in material liability to Parent. \t\t

 \t\t

 \t\t\t(c) There is no order, writ, injunction, judgment or decree to
which Parent, or any of the material assets owned or used by Parent, is
subject. To the Knowledge of Parent, no officer or other Key Employee of
Parent is subject to any order, writ, injunction, judgment or decree that
prohibits such officer or employee from engaging in or continuing any conduct,
activity or practice relating to the business of Parent or to any material
assets owned or used by Parent. \t\t

 \t\t

 \t\t\t3.16 Tax Matters. \t\t

 \t\t

 \t\t\t(a) Parent has timely filed all income Tax Returns and other
material Tax Returns that they were required to file under applicable Law. All
such Tax Returns are correct and complete in all material respects and have
been prepared in compliance with all applicable Law. No claim has ever been
made by any Governmental Body in any jurisdiction where Parent does not file a
particular Tax Return or pay a particular Tax that Parent is subject to
taxation by that jurisdiction. \t\t

 \t\t

 \t\t\t(b) All income and other Taxes due and owing by Parent on or
before the date hereof (whether or not shown on any Tax Return) have been
fully paid. Since the Parent Balance Sheet Date, Parent has not incurred any
material Liability for Taxes outside the Ordinary Course of Business. \t\t

 \t\t

 \t\t\t(c) All Taxes that Parent is or was required by Law to withhold
or collect have been duly and timely withheld or collected in all material
respects on behalf of its respective employees, independent contractors,
stockholders, or other third parties and, have been timely paid to the proper
Governmental Body or other Person or properly set aside in accounts for this
purpose. \t\t

 \t\t

 \t\t\t(d) There are no Encumbrances for Taxes (other than Taxes not
yet due and payable) upon any of the assets of Parent. \t\t

 \t\t

 \t\t\t(e) No deficiencies for income or other Taxes with respect to
Parent have been claimed, proposed or assessed by any Governmental Body in
writing. There are no pending or ongoing, and to the Knowledge of Parent,
threatened audits, assessments or other actions for or relating to any
liability in respect of a material amount of Taxes of Parent. Neither Parent
nor any of its predecessors has waived any statute of limitations in respect
of any income or other Taxes or agreed to any extension of time with respect
to any income or other Tax assessment or deficiency. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-32-  \t\t

  

 \t\t

 \t\t

 \t\t\t(f) Parent is not a party to any Tax allocation agreement, Tax
sharing agreement, Tax indemnity agreement, or similar agreement or
arrangement, other than customary commercial contracts entered into in the
Ordinary Course of Business the principal subject matter of which is not
Taxes. \t\t

 \t\t

 \t\t\t(g) Parent will not be required to include any material item of
income in, or exclude any material item of deduction from, taxable income for
any Tax period (or portion thereof) ending after the Closing Date as a result
of any: (i) change in method of accounting for Tax purposes; (ii) use of an
improper method of accounting for a Tax period ending on or prior to the
Closing Date; (iii) "closing agreement" as described in Section 7121 of the
Code (or any similar provision of state, local or foreign Law) executed on or
prior to the Closing Date; (iv) intercompany transaction or excess loss
account described in Treasury Regulations under Section 1502 of the Code (or
any similar provision of state, local or foreign Law); (v) installment sale or
open transaction disposition made on or prior to the Closing Date; or (vi)
prepaid amount received or deferred revenue accrued on or prior to the Closing
Date. \t\t

 \t\t

 \t\t\t(h) Parent has never been a member of a consolidated, combined
or unitary Tax group (other than such a group the common parent of which is
Parent). Parent has no Liability for any Taxes of any Person (other than
Parent and any of its Subsidiaries) under Treasury Regulations Section
1.1502-6 (or any similar provision of state, local, or foreign Law), or as a
transferee or successor. \t\t

 \t\t

 \t\t\t(i) Parent has not distributed stock of another Person, or had
its stock distributed by another Person, in a transaction that was purported
or intended to be governed in whole or in part by Section 355 of the Code or
Section 361 of the Code (or any similar provisions of state, local or foreign
Law). \t\t

 \t\t

 \t\t\t(j) Parent has never had a permanent establishment (within the
meaning of an applicable Tax treaty) or otherwise has an office or fixed place
of business in a jurisdiction outside of the United States. \t\t

 \t\t

 \t\t\t(k) Parent has not participated in or been a party to a
transaction that, as of the date of this Agreement, constitutes a "listed
transaction" that is required to be reported to the IRS pursuant to Section
6011 of the Code and applicable Treasury Regulations thereunder. \t\t

 \t\t

 \t\t\t(l) Neither Parent nor any of its Subsidiaries has taken any
action or knows of any fact that would reasonably be expected to prevent the
Merger from qualifying for the Intended Tax Treatment. \t\t

 \t\t

 \t\t\tFor purposes of this Section 3.16, each reference to Parent shall be
deemed to include any Person that was liquidated into, merged with, or is
otherwise a predecessor to, Parent. \t\t

 \t\t

 \t\t\t3.17 Employee and Labor Matters; Benefit Plans. \t\t

 \t\t

 \t\t\t(a) Section 3.17(a) of the Parent Disclosure Schedule is a list
of all material Parent Benefit Plans, including, without limitation, each
Parent Benefit Plan that provides for retirement, change in control, deferred
compensation, incentive compensation, severance or retiree medical or life
insurance benefits. "Parent Benefit Plan" means each (i) "employee benefit
plan" as defined in Section 3(3) of ERISA and (ii) other pension, retirement,
deferred compensation, excess benefit, profit sharing, bonus, incentive,
equity or equity-based, phantom equity, employment, consulting, severance,
change-of-control, retention, health, life, disability, group insurance, paid-
time off, holiday, welfare and fringe benefit plan, program, contract, or
arrangement (whether written or unwritten, qualified or nonqualified, funded
or unfunded and including any that have been frozen or terminated), in any
case, maintained, contributed to, or required to be contributed to, by Parent
or any Parent ERISA Affiliate for the benefit of any current or former
employee, director, officer or independent contractor of Parent or any of its
Subsidiaries or under which Parent has any actual or contingent liability
(including, without limitation, as to the result of it being treated as a
single employer under Code Section 414 with any other person). \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-33-  \t\t

  

 \t\t

 \t\t

 \t\t\t(b) As applicable with respect to each material Parent Benefit
Plan, Parent has made available to the Company, true and complete copies of
(i) each material Parent Benefit Plan, including all amendments thereto, and
in the case of an unwritten material Parent Benefit Plan, a written
description thereof, (ii) all current trust documents, investment management
contracts, custodial agreements, administrative services agreements and
insurance and annuity contracts relating thereto, (iii) the current summary
plan description and each summary of material modifications thereto, (iv) the
most recently filed annual reports with any Governmental Body (e.g., Form 5500
and all schedules thereto), (v) the most recent IRS determination, opinion or
advisory letter, (vi) the most recent summary annual reports,
nondiscrimination testing reports, actuarial reports, financial statements and
trustee reports, (vii) for the last three years, all records, notices and
filings concerning IRS or Department of Labor or other Governmental Body
audits or investigations, and (viii) all policies and procedures established
to comply with the privacy and security rules of HIPAA. \t\t

 \t\t

 \t\t\t(c) Each Parent Benefit Plan has been maintained, operated and
administered in compliance in all material respects with its terms and
applicable Law, including the applicable provisions of ERISA and the
Code. \t\t

 \t\t

 \t\t\t(d) Each Parent Benefit Plan which is an "employee pension
benefit plans" within the meaning of Section 3(2) of ERISA and which is
intended to meet the qualification requirements of Section 401(a) of the Code
has received a determination letter or opinion letter from the IRS to the
effect that such plan is qualified under Section 401(a) of the Code and the
related trust is exempt from federal income Taxes under Section 501(a) of the
Code, respectively, and nothing has occurred that would reasonably be expected
to materially adversely affect the qualification of such Parent Benefit Plan
or the tax exempt status of the related trust. \t\t

 \t\t

 \t\t\t(e) Neither Parent or any Parent ERISA Affiliate maintains,
contributes to, is required to contribute to, or has any actual or contingent
liability with respect to, (i) any "employee pension benefit plan" (within the
meaning of Section 3(2) of ERISA) that is subject to Title IV or Section 302
of ERISA or Section 412 of the Code, (ii) any "multiemployer plan" (within the
meaning of Section 3(37) of ERISA), (iii) any "multiple employer plan" (within
the meaning of Section 413 of the Code) or (iv) any "multiple employer welfare
arrangement" (within the meaning of Section 3(40) of ERISA). \t\t

 \t\t

 \t\t\t(f) There are no pending audits or investigations by any
Governmental Body involving any Parent Benefit Plan, and no pending or, to the
Knowledge of Parent, threatened claims (except for individual claims for
benefits payable in the normal operation of the Parent Benefit Plans), suits
or proceedings involving any Parent Benefit Plan, any fiduciary thereof or
service provider thereto, in any case except as would not be reasonably
expected to result in material liability to Parent. \t\t

 \t\t

 \t\t\t(g) Neither Parent or any Parent ERISA Affiliate, nor to the
Knowledge of Parent, any fiduciary, trustee or administrator of any Parent
Benefit Plan, has engaged in, or in connection with the transactions
contemplated by this Agreement will engage in, any transaction with respect to
any Parent Benefit Plan which would subject any such Parent Benefit Plan,
Parent or any of its Subsidiaries or Parent ERISA Affiliates to a material
Tax, material penalty or material liability for a "prohibited transaction"
under Section 406 of ERISA or Section 4975 of the Code. \t\t

 \t\t

 \t\t\t(h) No Parent Benefit Plan provides death, medical, dental,
vision, life insurance or other welfare benefits beyond termination of service
or retirement other than coverage mandated by Law and neither Parent nor any
Parent ERISA Affiliate has made a written or oral representation promising the
same. Section 3.17(h) of the Parent Disclosure Schedule sets forth all
outstanding severance obligations to existing and previously terminated
employees and service providers of Parent and its Subsidiaries, listing for
each individual recipient (i) name, (ii) applicable plan or agreement, (iii)
description of the severance, including terms of payment and (iv) amount. All
such severance obligations are included within the Budget. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-34-  \t\t

  

 \t\t

 \t\t

 \t\t\t(i) Neither the execution of, nor the performance of the
transactions contemplated by, this Agreement will either alone or in
connection with any other event(s) (i) result in any payment or benefit
becoming due to any current or former employee, director, officer, or
independent contractor of Parent, (ii) increase any amount of compensation or
benefits otherwise payable under any Parent Benefit Plan, (iii) result in the
acceleration of the time of payment, funding or vesting of any benefits under
any Parent Benefit Plan, (iv) require any contribution or payment to fund any
obligation under any Parent Benefit Plan or (v) limit the right to merge,
amend or terminate any Parent Benefit Plan. \t\t

 \t\t

 \t\t\t(j) Neither the execution of, nor the consummation of the
transactions contemplated by this Agreement (either alone or when combined
with the occurrence of any other event, including without limitation, a
termination of employment) will result in the receipt or retention by any
person who is a "disqualified individual" (within the meaning of Code Section
280G) of any payment or benefit that is or could be characterized as an
"excess parachute payment" (within the meaning of Code Section 280G),
determined without regard to the application of Code Section 280G(b)(5). \t\t

 \t\t

 \t\t\t(k) The exercise price of each Parent Option is not, never has
been and can never be less than the fair market value of one share of Parent
Common Stock as of the grant date of such Parent Option. Each Parent Benefit
Plan that is a "nonqualified deferred compensation plan" (within the meaning
of Code Section 409A) complies and has at all times been in documentary and
operational compliance with Code Section 409A and IRS regulations issued
thereunder, except as would not be reasonably expected to result in material
liability to Parent. \t\t

 \t\t

 \t\t\t(l) No current or former employee, officer, director or
independent contractor of Parent has any "gross up" agreements or other
assurance of reimbursement for any Taxes imposed under Code Section 409A or
Code Section 4999. \t\t

 \t\t

 \t\t\t(m) Parent is not a party to, bound by, nor has a duty to
bargain under, any collective bargaining agreement or other Contract with a
labor union, labor organization, or similar Person representing any of its
employees, and there is no labor union, labor organization, or similar Person
representing or, to the Knowledge of Parent, purporting to represent or
seeking to represent any employees of Parent, including through the filing of
a petition for representation election. \t\t

 \t\t

 \t\t\t(n) Parent is, and since February 1, 2016 has been, in material
compliance with all applicable Laws respecting labor, employment, employment
practices, and terms and conditions of employment, including worker
classification, tax withholding, prohibited discrimination and retaliation,
equal employment opportunities, harassment, fair employment practices, meal
and rest periods, immigration, employee safety and health, wages (including
overtime wages), unemployment and workers' compensation, leaves of absence,
and hours of work. Except as would not be reasonably likely to result in a
material liability to Parent, with respect to employees of Parent, Parent,
since February 1, 2016: (i) has withheld and reported all amounts required by
Law or by agreement to be withheld and reported with respect to wages,
salaries and other payments, benefits, or compensation to employees, (ii) is
not liable for any arrears of wages (including overtime wages), severance pay
or any Taxes or any penalty for failure to comply with any of the foregoing,
and (iii) is not liable for any payment to any trust or other fund governed by
or maintained by or on behalf of any Governmental Body, with respect to
unemployment compensation benefits, disability, social security or other
benefits or obligations for employees (other than routine payments to be made
in the Ordinary Course of Business). \t\t

 \t\t

 \t\t\t(o) Except as would not be reasonably likely to result in a
material liability to Parent, with respect to each individual who currently
renders services to Parent, Parent has accurately classified each such
individual as an employee, independent contractor, or otherwise under all
applicable Laws and, for each individual classified as an employee, Parent has
accurately classified him or her as overtime eligible or overtime ineligible

 \t\t

  \t\t

  \t\t\t-35-  \t\t

  

under all applicable Laws. Parent has no material liability with respect to
any misclassification of: (a) any Person as an independent contractor rather
than as an employee, (b) any employee leased from another employer, or (c) any
employee currently or formerly classified as exempt from overtime wages. \t\t

 \t\t

 \t\t\t(p) There is not and has not been in the past three (3) years,
nor is there or has there been in the past three (3) years any threat of, any
strike, slowdown, work stoppage, lockout, union election petition, demand for
recognition, or any similar activity or dispute, or, to the Knowledge of
Parent, any union organizing activity, against Parent. No event has occurred,
and no condition or circumstance exists, that might directly or indirectly be
likely to give rise to or provide a basis for the commencement of any such
strike, slowdown, work stoppage, lockout, union election petition, demand for
recognition, any similar activity or dispute, or, to the Knowledge of Parent,
any union organizing activity. \t\t

 \t\t

 \t\t\t(q) There is no Legal Proceeding, claim, unfair labor practice
charge or complaint, labor dispute or grievance pending or, to the Knowledge
of Parent, threatened against Parent relating to labor, employment, employment
practices, or terms and conditions of employment. \t\t

 \t\t

 \t\t\t(r) As of the date hereof, no Key Employee has submitted his or
her resignation or, except as disclosed in Section 3.17(r) of the Parent
Disclosure Schedules, to the Knowledge of Parent, intends to resign. \t\t

 \t\t

 \t\t\t3.18 Environmental Matters. Parent is and since February 1, 2016
has complied with all applicable Environmental Laws, which compliance includes
the possession by Parent of all permits and other Governmental Authorizations
required under applicable Environmental Laws and compliance with the terms and
conditions thereof, except for any failure to be in such compliance that,
either individually or in the aggregate, would not reasonably be expected to
be material to Parent or its business. Parent has not received since February
1, 2016 (or prior to that time, which is pending and unresolved), any written
notice or other communication (in writing or otherwise), whether from a
Governmental Body or other Person, that alleges that Parent is not in
compliance with or has liability pursuant to any Environmental Law and, to the
Knowledge of Parent, there are no circumstances that would reasonably be
expected to prevent or interfere with Parent's compliance in any material
respects with any Environmental Law, except where such failure to comply would
not reasonably be expected to be material to Parent or its business. No
current or (during the time a prior property was leased or controlled by
Parent) prior property leased or controlled by Parent has had a release of or
exposure to Hazardous Materials in material violation of or as would
reasonably be expected to result in any material liability of Parent pursuant
to Environmental Law. No consent, approval or Governmental Authorization of or
registration or filing with any Governmental Body is required by Environmental
Laws in connection with the execution and delivery of this Agreement or the
consummation of Contemplated Transactions. Prior to the date hereof, Parent
has provided or otherwise made available to the Company true and correct
copies of all material environmental reports, assessments, studies and audits
in the possession or control of Parent with respect to any property leased or
controlled by Parent or any business operated by it. \t\t

 \t\t

 \t\t\t3.19 Insurance. Parent has delivered or made available to the
Company accurate and complete copies of all material insurance policies and
all material self-insurance programs and arrangements relating to the
business, assets, liabilities and operations of Parent and each of its
Subsidiaries. Each of such insurance policies is in full force and effect and
Parent and each of its Subsidiaries are in compliance in all material respects
with the terms thereof. Other than customary end of policy notifications from
insurance carriers, since February 1, 2017, neither Parent nor any of its
Subsidiaries has received any notice or other communication regarding any
actual or possible: (i) cancellation or invalidation of any insurance policy;
or (ii) refusal or denial of any coverage, reservation of rights or rejection
of any material claim under any insurance policy. Parent and each of its
Subsidiaries have provided timely written notice to the appropriate insurance
carrier(s) of each Legal Proceeding that is currently pending against Parent
or any of its Subsidiaries for which Parent or such Subsidiary has insurance

 \t\t

  \t\t

  \t\t\t-36-  \t\t

  

coverage, and no such carrier issued a denial of coverage or a reservation of
rights with respect to any such Legal Proceeding, or informed Parent or any of
its Subsidiaries of its intent to do so. \t\t

 \t\t

 \t\t\t3.20 No Financial Advisors. Except as set forth on Section 3.20
of the Parent Disclosure Schedule, no broker, finder or investment banker is
entitled to any brokerage fee, finder's fee, opinion fee, success fee,
transaction fee or other fee or commission in connection with the Contemplated
Transactions based upon arrangements made by or on behalf of Parent. All such
fees, as well as fees to the Parent Financial Advisor, are included within the
Budget. \t\t

 \t\t

 \t\t\t3.21 Transactions with Affiliates. Except as set forth in the
Parent SEC Documents, since the date of Parent's last proxy statement filed in
2019 with the SEC, no event has occurred that would be required to be reported
by Parent pursuant to Item 404 of Regulation S-K. \t\t

 \t\t

 \t\t\t3.22 Valid Issuance. The Parent Common Stock to be issued in the
Merger will, when issued in accordance with the provisions of this Agreement,
be validly issued, fully paid and nonassessable. \t\t

 \t\t

 \t\t\t3.23 Opinion of Financial Advisor. The Parent Board has received
an opinion of Cassel Salpeter and Co., LLC ("Parent Financial Advisor") to the
effect that, as of the date of such opinion, and based upon and subject to the
assumptions, qualifications, limitations and other matters considered in
connection with the preparation of such opinion, the Merger Consideration to
be issued by Parent in the Merger pursuant to this Agreement is fair, from a
financial point of view, to Parent. It is agreed and understood that such
opinion is for the benefit of the Parent Board and may not be relied upon by
the Company. \t\t

 \t\t

 \t\t\t3.24 Anti-Bribery. None of Parent or any of its Subsidiaries or
any of their respective directors, officers, employees or agents or any other
Person acting on their behalf has directly or indirectly made any bribes,
rebates, payoffs, influence payments, kickbacks, illegal payments, illegal
political contributions, or other payments, in the form of cash, gifts, or
otherwise, or taken any other action, in violation of the Anti-Bribery Laws.
Neither Parent nor any of its Subsidiaries is or has been the subject of any
investigation or inquiry by any Governmental Body with respect to potential
violations of Anti-Bribery Laws. \t\t

 \t\t

 \t\t\t3.25 Disclaimer of Other Representations or Warranties. Except as
previously set forth in this Section 3 or in any certificate delivered by
Parent or Merger Sub to the Company pursuant to this Agreement, neither Parent
nor Merger Sub makes any representation or warranty, express or implied, at
law or in equity, with respect to it or any of its assets, liabilities or
operations, and any such other representations or warranties are hereby
expressly disclaimed. \t\t

 \t\t

 \t\t\tSection 4 CERTAIN COVENANTS OF THE PARTIES \t\t

 \t\t

 \t\t\t4.1 Operation of Parent's Business. \t\t

 \t\t

 \t\t\t(a) Except as set forth on Section 4.1(a) of the Parent
Disclosure Schedule, as expressly permitted by this Agreement, as required by
applicable Law or unless the Company shall otherwise consent in writing (which
consent shall not be unreasonably withheld, delayed or conditioned), during
the period commencing on the date of this Agreement and continuing until the
earlier to occur of the termination of this Agreement pursuant to Section 9
and the Effective Time (the "Pre-Closing Period"): Parent shall conduct its
business and operations in the Ordinary Course of Business as it has been
conducted in the past month and in accordance, in all material respects, with
the Budget set forth in Section 4.1(a) of the Parent Disclosure Schedule, and
(c) in compliance with all applicable Laws and the requirements of all
Contracts that constitute Parent Material Contracts. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-37-  \t\t

  

 \t\t

 \t\t

 \t\t\t(b) Except (i) as expressly permitted by this Agreement, (ii)
as set forth in Section 4.1(b) of the Parent Disclosure Schedule, (iii) as
required by applicable Law or (iv) with the prior written consent of the
Company (which consent shall not be unreasonably withheld, delayed or
conditioned), at all times during the Pre-Closing Period, Parent shall
not: \t\t

 \t\t

 \t\t\t(i) declare, accrue, set aside or pay any dividend or make any
other distribution in respect of any shares of its capital stock or
repurchase, redeem or otherwise reacquire any shares of its capital stock or
other securities (except in connection with the payment of the exercise price
and/or withholding Taxes incurred upon the exercise, settlement or vesting of
any award granted under the Parent Stock Plan); \t\t

 \t\t

 \t\t\t(ii) sell, issue, grant, pledge or otherwise dispose of or
encumber or authorize any of the foregoing with respect to: (A) any capital
stock or other security of Parent (except for Parent Common Stock issued upon
the valid exercise of outstanding Parent Options or outstanding warrants of
Parent); (B) any option, warrant or right to acquire any capital stock or any
other security; or (C) any instrument convertible into or exchangeable for any
capital stock or other security of Parent; \t\t

 \t\t

 \t\t\t(iii) except as required to give effect to anything in
contemplation of the Closing, amend any of its Organizational Documents, or
effect or be a party to any merger, consolidation, share exchange, business
combination, recapitalization, reclassification of shares, stock split,
reverse stock split or similar transaction except, for the avoidance of doubt,
the Contemplated Transactions; \t\t

 \t\t

 \t\t\t(iv) form any Subsidiary or acquire any equity interest or other
interest in any other Entity or enter into a joint venture with any other
Entity; \t\t

 \t\t

 \t\t\t(v) (A) lend money to any Person, (B) incur or guarantee any
indebtedness for borrowed money, (C) incur or guarantee any debt securities of
others, or (D) make any capital expenditure or commitment in excess of the
budgeted capital expenditure and commitment amounts set forth in the
Budget; \t\t

 \t\t

 \t\t\t(vi) other than as required by applicable Law or the terms of any
Parent Benefit Plan as in effect on the date of this Agreement (including any
retention arrangement entered into prior to the date of this Agreement and
disclosed in Section 3.17(a)of the Parent Disclosure Schedule): (A) adopt,
terminate, establish or enter into any Parent Benefit Plan; (B) cause or
permit any Parent Benefit Plan to be amended in any material respect; (C) pay
any bonus or make any profit-sharing or similar payment to, or increase the
amount of the wages, salary, commissions, benefits or other compensation or
remuneration payable to, any of its directors, officers or employees, other
than increases in base salary and annual cash bonus opportunities and payments
made in the Ordinary Course of Business consistent with past practice; (D)
increase the severance or change of control benefits offered to any current or
new employees, directors or consultants or (E) hire any officer or
employee. \t\t

 \t\t

 \t\t\t(vii) recognize any labor union, labor organization, or similar
Person; \t\t

 \t\t

 \t\t\t(viii) enter into any material transaction other than in the Ordinary
Course of Business and as contemplated by the Budget; \t\t

 \t\t

 \t\t\t(ix) acquire any material asset or sell, lease or otherwise
irrevocably dispose of any of its assets or properties, or grant any
Encumbrance with respect to such assets or properties, except in the Ordinary
Course of Business and consistent with the Budget; \t\t

 \t\t

 \t\t\t(x) sell, assign, transfer, license, sublicense, or otherwise
dispose of any material Parent IP Rights (other than pursuant to non-exclusive
licenses in the Ordinary Course of Business); \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-38-  \t\t

  

 \t\t

 \t\t

 \t\t\t(xi) make, change or revoke any Tax election, fail to pay any
income or other material Tax as such Tax becomes due and payable, file any
amendment making any material change to any Tax Return, settle or compromise
any income or other material Tax liability, enter into any Tax allocation,
sharing, indemnification or other similar agreement or arrangement, request or
consent to any extension or waiver of any limitation period with respect to
any claim or assessment for any income or other material Taxes (other than in
connection with any extension of time to file any Tax Return), or adopt or
change any accounting method in respect of Taxes; \t\t

 \t\t

 \t\t\t(xii) enter into, materially amend or terminate any Parent Material
Contract; \t\t

 \t\t

 \t\t\t(xiii) make any expenditures, incur any Liabilities or discharge or
satisfy any Liabilities, in each case, in amounts that exceed the amounts
contemplated in the Budget; \t\t

 \t\t

 \t\t\t(xiv) other than as required by Law or GAAP, take any action to
change accounting policies or procedures; or \t\t

 \t\t

 \t\t\t(xv) agree, resolve or commit to do any of the foregoing. \t\t

 \t\t

 \t\t\tNothing contained in this Agreement shall give the Company, directly
or indirectly, the right to control or direct the operations of Parent prior
to the Effective Time. Prior to the Effective Time, Parent shall exercise,
consistent with the terms and conditions of this Agreement, complete
unilateral control and supervision over its business operations. \t\t

 \t\t

 \t\t\t4.2 Operation of the Company's Business. \t\t

 \t\t

 \t\t\t(a) Except as set forth on Section 4.2(a) of the Company
Disclosure Schedule, as expressly permitted by this Agreement, as required by
applicable Law or unless Parent shall otherwise consent in writing (which
consent shall not be unreasonably withheld, delayed or conditioned), during
the Pre-Closing Period: the Company shall conduct its business and operations
in the Ordinary Course of Business and in compliance with all applicable Laws
and the requirements of all Contracts that constitute Company Material
Contracts. \t\t

 \t\t

 \t\t\t(b) Except (i) as expressly permitted by this Agreement, (ii)
as set forth in Section 4.2(b) of the Company Disclosure Schedule, (iii) as
required by applicable Law or (iv) with the prior written consent of Parent
(which consent shall not be unreasonably withheld, delayed or conditioned), at
all times during the Pre-Closing Period, the Company shall not, nor shall it
cause or permit any of its Subsidiaries to, do any of the following: \t\t

 \t\t

 \t\t\t(i) declare, accrue, set aside or pay any dividend or make any
other distribution in respect of any membership interests; or repurchase,
redeem or otherwise reacquire any of its securities (except for membership
interests from terminated employees, managers or consultants of the
Company); \t\t

 \t\t

 \t\t\t(ii) sell, issue, grant, pledge or otherwise dispose of or
encumber or authorize any of the foregoing with respect to: (A) any security
of the Company (except for membership interests issued upon the valid exercise
of Company VARs); (B) any option, warrant or right to acquire any security,
other than option grants to employees and service providers in the Ordinary
Course of Business; or (C) any instrument convertible into or exchangeable for
any security of the Company; \t\t

 \t\t

 \t\t\t(iii) except as required to give effect to anything in
contemplation of the Closing, amend any of its Organizational Documents, or
effect or be a party to any merger, consolidation, share

 \t\t

  \t\t

  \t\t\t-39-  \t\t

  

exchange, business combination, recapitalization, reclassification of shares,
stock split, reverse stock split or similar transaction except, for the
avoidance of doubt, the Contemplated Transactions; \t\t

 \t\t

 \t\t\t(iv) form any Subsidiary or acquire any equity interest or other
interest in any other Entity or enter into a joint venture with any other
Entity; \t\t

 \t\t

 \t\t\t(v) (A) lend money to any Person, (B) incur or guarantee any
indebtedness for borrowed money, or (C) guarantee any debt securities of
others; \t\t

 \t\t

 \t\t\t(vi) other than as required by applicable Law or the terms of any
Benefit Plan, including any retention arrangement entered into prior to the
date of this Agreement and disclosed in Section 2.17(a) of the Company
Disclosure Schedule, as in effect on the date of this Agreement: (A) adopt,
terminate, establish or enter into any Benefit Plan; (B) cause or permit any
Benefit Plan to be amended in any material respect; (C) pay any bonus or make
any profit-sharing or similar payment to, or increase the amount of the wages,
salary, commissions, benefits or other compensation or remuneration payable
to, any of its managers, officers or employees, other than increases in base
salary and annual cash bonus opportunities and payments made in the Ordinary
Course of Business consistent with past practice; (D) increase the severance
or change of control benefits offered to any current or new employees,
managers or consultants or (E) hire any officer or employee. \t\t

 \t\t

 \t\t\t(vii) recognize any labor union, labor organization, or similar
Person; \t\t

 \t\t

 \t\t\t(viii) enter into any material transaction other than in the Ordinary
Course of Business; \t\t

 \t\t

 \t\t\t(ix) acquire any material asset or sell, lease or otherwise
irrevocably dispose of any of its assets or properties, or grant any
Encumbrance with respect to such assets or properties, except in the Ordinary
Course of Business; \t\t

 \t\t

 \t\t\t(x) sell, assign, transfer, license, sublicense or otherwise
dispose of any material Company IP Rights (other than pursuant to non-
exclusive licenses in the Ordinary Course of Business); \t\t

 \t\t

 \t\t\t(xi) make, change or revoke any Tax election, fail to pay any
income or other material Tax as such Tax becomes due and payable, file any
amendment making any material change to any Tax Return, settle or compromise
any income or other material Tax liability, enter into any Tax allocation,
sharing, indemnification or other similar agreement or arrangement, request or
consent to any extension or waiver of any limitation period with respect to
any claim or assessment for any income or other material Taxes (other than in
connection with any extension of time to file any Tax Return), or adopt or
change any accounting method in respect of Taxes; \t\t

 \t\t

 \t\t\t(xii) (A) terminate any Company Material Contract or (B) subject to
Section 4.2(d) below, enter into or materially amend any Company Material
Agreement if such proposed Company Material Agreement or amendment to a
Company Material Agreement (x) is not in the Ordinary Course of Business and
payments by the Company thereunder are expected to exceed $100,000, or (y) is
in the Ordinary Course of Business but payments thereunder are expected to
exceed $300,000; \t\t

 \t\t

 \t\t\t(xiii) other than as required by Law or GAAP, take any action to
change accounting policies or procedures; or \t\t

 \t\t

 \t\t\t(xiv) agree, resolve or commit to do any of the foregoing. \t\t

 \t\t

 \t\t\t(c) Nothing contained in this Agreement shall give either
Party, directly or indirectly, the right to control or direct the operations
of the other Party prior to the Effective Time. Prior to the Effective Time,
the

 \t\t

  \t\t

  \t\t\t-40-  \t\t

  

Company shall exercise, consistent with the terms and conditions of this
Agreement, complete unilateral control and supervision over its business
operations. \t\t

 \t\t

 \t\t\t(d) Notwithstanding anything in Section 4.2(b) to the contrary,
in the event that the Company wishes to obtain Parent's written consent to
enter into or materially amend any Company Material Agreement as contemplated
by Section 4.2(b)(xii) above, the Company shall provide notice thereof to
Parent in accordance with Section 10.8 and include with such notice a copy of
the proposed Company Material Agreement or the proposed amendment to a Company
Material Agreement, as applicable. Parent shall have three (3) Business Days
to review such notice and may request additional information or documents as
Parent may require in its reasonable discretion in connection with such
review. Parent's consent to any proposed Company Material Agreement or
proposed amendment to a Company Material Agreement shall not be unreasonably
withheld. Parent shall be deemed to have consented to any such proposed
Company Material Agreement or proposed amendment to a Company Material
Agreement if Parent does not respond to the Company by the end of such three
(3) Business Day period. \t\t

 \t\t

 \t\t\t4.3 Access and Investigation. Subject to the terms of the
Confidentiality Agreement, which the Parties agree will continue in full force
following the date of this Agreement, during the Pre-Closing Period, upon
reasonable notice, Parent, on the one hand, and the Company, on the other
hand, shall and shall use commercially reasonable efforts to cause such
Party's Representatives to: (a) provide the other Party and such other Party's
Representatives with reasonable access during normal business hours to such
Party's Representatives, personnel, property and assets and to all existing
books, records, Tax Returns, work papers and other documents and information
relating to such Party; (b) provide the other Party and such other Party's
Representatives with such copies of the existing books, records, Tax Returns,
work papers, product data, and other documents and information relating to
such Party, and with such additional financial, operating and other data and
information regarding such Party as the other Party may reasonably request;
(c) permit the other Party's officers and other employees to meet, upon
reasonable notice and during normal business hours, with the chief financial
officer and other officers and managers of such Party responsible for such
Party's financial statements and the internal controls of such Party to
discuss such matters as the other Party may deem necessary or appropriate and;
(d) make available to the other Party copies of unaudited financial
statements, material operating and financial reports prepared for senior
management or the board of directors or managers of such Party, and any
material notice, report or other document filed with or sent to or received
from any Governmental Body in connection with the Contemplated Transactions.
Any investigation conducted by either Parent or the Company pursuant to this
Section 4.3 shall be conducted in such manner as not to interfere unreasonably
with the conduct of the business of the other Party. \t\t

 \t\t

 \t\t\tNotwithstanding the foregoing, any Party may restrict the foregoing
access to the extent that any Law applicable to such Party requires such Party
to restrict or prohibit access to any such properties or information or as may
be necessary to preserve the attorney-client privilege under any circumstances
in which such privilege may be jeopardized by such disclosure or access. \t\t

 \t\t

 \t\t\t4.4 Parent Non-Solicitation. \t\t

 \t\t

 \t\t\t(a) Parent agrees that, during the Pre-Closing Period, neither
it nor any of its Subsidiaries shall, nor shall it or any of its Subsidiaries
authorize any of its Representatives to, directly or indirectly: (i) solicit,
initiate or knowingly encourage, induce, discuss, negotiate or facilitate the
communication, making, submission or announcement of any Acquisition Proposal
or Acquisition Inquiry or take any action that could reasonably be expected to
lead to an Acquisition Proposal or Acquisition Inquiry; (ii) furnish any non-
public information regarding Parent or any of its Subsidiaries to any Person
in connection with or in response to an Acquisition Proposal or Acquisition
Inquiry; (iii) engage in discussions or negotiations with any Person with
respect to any Acquisition Proposal or Acquisition Inquiry; (iv) approve,
endorse or recommend any Acquisition Proposal

 \t\t

  \t\t

  \t\t\t-41-  \t\t

  

(subject to Section 5.3); (v) execute or enter into any letter of intent or
any Contract contemplating or otherwise relating to any Acquisition
Transaction; or (vi) publicly propose to do any of the foregoing; provided,
however, that, notwithstanding anything contained in this Section 4.4 and
subject to compliance with this Section 4.4, prior to obtaining the Required
Parent Stockholder Vote, Parent may furnish non-public information regarding
Parent and its Subsidiaries to, and enter into discussions or negotiations
with, any Person in response to a bona fide written Acquisition Proposal by
such Person which the Parent Board determines in good faith, after
consultation with Parent's outside financial advisors and outside legal
counsel, constitutes, or is reasonably likely to result in, a Superior Offer
(and is not withdrawn) if: (A) neither Parent nor any of its Representatives
shall have breached this Section 4.4 in any material respect, (B) the Parent
Board concludes in good faith based on the advice of outside legal counsel,
that the failure to take such action is reasonably likely to be inconsistent
with the fiduciary duties of the Parent Board under applicable Law; (C) Parent
receives from such Person an executed confidentiality agreement containing
provisions (including nondisclosure provisions, use restrictions, non-
solicitation provisions and no hire provisions) at least as favorable to
Parent as those contained in the Confidentiality Agreement; and (D)
substantially contemporaneously with furnishing any such nonpublic information
to such Person, Parent furnishes such nonpublic information to the Company (to
the extent such information has not been previously furnished by Parent to the
Company). Without limiting the generality of the foregoing, Parent
acknowledges and agrees that, in the event any Representative of Parent
(whether or not such Representative is purporting to act on behalf of Parent)
takes any action that, if taken by Parent, would constitute a breach of this
Section 4.4, the taking of such action by such Representative shall be deemed
to constitute a breach of this Section 4.4 by Parent for purposes of this
Agreement. Notwithstanding the foregoing, Parent may, as set forth in Section
5.3 of the Parent Disclosure Schedule, continue to solicit potential bidders
who might have an interest in acquiring its \'01 and its \'04 programs
provided that Parent receives from any potential bidder a confidentiality
agreement in form reasonably satisfactory to the Company and Parent keeps the
Company fully informed of the status of all such negotiations, including but
not limited to advising the Company orally (and promptly thereafter in
writing) of any proposal for the purchase of any such interest in its '01
and/or '04 programs (including the identity of any person making or
submitting a proposal for the acquisition of any such interest and the terms
of such a proposal, as well as any material modifications of any such
proposal), and no contract for the sale of the assets related to the '01
and/or '04 programs may be entered into nor consummated without the written
consent of the Company, which consent shall not be unreasonably
withheld. \t\t

 \t\t

 \t\t\t(b) If Parent or any Representative of Parent receives an
Acquisition Proposal or Acquisition Inquiry at any time during the Pre-Closing
Period, then Parent shall promptly (and in no event later than two Business
Day after Parent becomes aware of such Acquisition Proposal or Acquisition
Inquiry) advise the Company orally (and promptly thereafter in writing) of
such Acquisition Proposal or Acquisition Inquiry (including the identity of
the Person making or submitting such Acquisition Proposal or Acquisition
Inquiry, and the material terms thereof). Parent shall keep the Company
reasonably informed with respect to the status and material terms of any such
Acquisition Proposal or Acquisition Inquiry and any material modification or
proposed material modification thereto. \t\t

 \t\t

 \t\t\t(c) Parent shall immediately cease and cause to be terminated
any existing discussions, negotiations and communications with any Person that
relate to any Acquisition Proposal or Acquisition Inquiry as of the date of
this Agreement and request the destruction or return of any nonpublic
information of Parent or any of its Subsidiaries provided to such
Person. \t\t

 \t\t

 \t\t\t4.5 Company Non-Solicitation. \t\t

 \t\t

 \t\t\t(a) The Company agrees that, during the Pre-Closing Period,
neither it nor any of its Subsidiaries shall, nor shall it or any of its
Subsidiaries authorize any of its Representatives to, directly or indirectly:
(i) solicit, initiate or knowingly encourage, induce, discuss, negotiate or
facilitate the communication,

 \t\t

  \t\t

  \t\t\t-42-  \t\t

  

making, submission or announcement of any Acquisition Proposal or Acquisition
Inquiry or take any action that could reasonably be expected to lead to an
Acquisition Proposal or Acquisition Inquiry; (ii) furnish any non-public
information regarding the Company to any Person in connection with or in
response to an Acquisition Proposal or Acquisition Inquiry; (iii) engage in
discussions or negotiations with any Person with respect to any Acquisition
Proposal or Acquisition Inquiry; (iv) approve, endorse or recommend any
Acquisition Proposal (subject to Section 5.2); (v) execute or enter into any
letter of intent or any Contract contemplating or otherwise relating to any
Acquisition Transaction; or (vi) publicly propose to do any of the foregoing;
provided, however, that, notwithstanding anything contained in this Section
4.5 and subject to compliance with this Section 4.5, prior to obtaining the
Required Company Member Vote, the Company may furnish non-public information
regarding the Company to, and enter into discussions or negotiations with, any
Person in response to a bona fide written Acquisition Proposal by such Person
which the Company Managers determines in good faith, after consultation with
the Company's outside financial advisors and outside legal counsel,
constitutes, or is reasonably likely to result in, a Superior Offer (and is
not withdrawn) if: (A) neither the Company nor any of its Representatives
shall have breached this Section 4.5 in any material respect, (B) the Company
Managers conclude in good faith based on the advice of outside legal counsel,
that the failure to take such action is reasonably likely to be inconsistent
with the fiduciary duties of the Company Managers under applicable Law; (C)
the Company receives from such Person an executed confidentiality agreement
containing provisions (including nondisclosure provisions, use restrictions,
non-solicitation provisions and no hire provisions) at least as favorable to
the Company as those contained in the Confidentiality Agreement; and (D)
substantially contemporaneously with furnishing any such nonpublic information
to such Person, the Company furnishes such nonpublic information to Parent (to
the extent such information has not been previously furnished by the Company
to Parent). Without limiting the generality of the foregoing, the Company
acknowledges and agrees that, in the event any Representative of the Company
(whether or not such Representative is purporting to act on behalf of the
Company) takes any action that, if taken by the Company, would constitute a
breach of this Section 4.5, the taking of such action by such Representative
shall be deemed to constitute a breach of this Section 4.5 by the Company for
purposes of this Agreement. \t\t

 \t\t

 \t\t\t(b) If the Company or any Representative of the Company
receives an Acquisition Proposal or Acquisition Inquiry at any time during the
Pre-Closing Period, then the Company shall promptly (and in no event later
than one Business Day after the Company becomes aware of such Acquisition
Proposal or Acquisition Inquiry) advise Parent orally and in writing of such
Acquisition Proposal or Acquisition Inquiry (including the identity of the
Person making or submitting such Acquisition Proposal or Acquisition Inquiry,
and the material terms thereof). The Company shall keep Parent reasonably
informed with respect to the status and material terms of any such Acquisition
Proposal or Acquisition Inquiry and any material modification or proposed
material modification thereto. \t\t

 \t\t

 \t\t\t(c) The Company shall immediately cease and cause to be
terminated any existing discussions, negotiations and communications with any
Person that relate to any Acquisition Proposal or Acquisition Inquiry as of
the date of this Agreement and request the destruction or return of any
nonpublic information of the Company provided to such Person. \t\t

 \t\t

 \t\t\t4.6 Notification of Certain Matters. (a) During the Pre-Closing
Period, the Company shall promptly notify Parent (and, if in writing, furnish
copies of) if any of the following occurs: (i) any notice or other
communication is received from any Person alleging that the Consent of such
Person is or may be required in connection with any of the Contemplated
Transactions; (ii) any Legal Proceeding against or involving or otherwise
affecting the Company is commenced, or, to the Knowledge of the Company,
threatened against the Company or, to the Knowledge of the Company, any
manager, officer or Key Employee of the Company; (iii) the Company becomes
aware of any inaccuracy in any representation or warranty made by it in this
Agreement; or (iv) the failure of the Company to comply with any covenant or
obligation of the Company; in each case that could reasonably be expected to
make the timely satisfaction of any of the conditions set forth in Sections 6,
7

 \t\t

  \t\t

  \t\t\t-43-  \t\t

  

and 8, as applicable, impossible or materially less likely. No notification
given to Parent pursuant to this Section 4.6 shall change, limit or otherwise
affect any of the representations, warranties, covenants or obligations of the
Company contained in this Agreement or the Company Disclosure Schedule for
purposes of Sections 6, 7 and 8, as applicable. \t\t

 \t\t

 \t\t\t(b) During the Pre-Closing Period, Parent shall promptly notify
the Company (and, if in writing, furnish copies of) if any of the following
occurs: (i) any notice or other communication is received from any Person
alleging that the Consent of such Person is or may be required in connection
with any of the Contemplated Transactions; (ii) any Legal Proceeding against
or involving or otherwise affecting Parent or its Subsidiaries is commenced,
or, to the Knowledge of Parent, threatened against Parent or its Subsidiaries
or, to the Knowledge of Parent, any director, officer or Key Employee of
Parent or its Subsidiaries; (iii) Parent becomes aware of any inaccuracy in
any representation or warranty made by it in this Agreement; or (iv) the
failure of Parent to comply with any covenant or obligation of Parent; in each
case that could reasonably be expected to make the timely satisfaction of any
of the conditions set forth in Sections 6, 7 and 8, as applicable, impossible
or materially less likely. No notification given to Company pursuant to this
Section 4.6 shall change, limit or otherwise affect any of the
representations, warranties, covenants or obligations of Parent or any of its
Subsidiaries contained in this Agreement or the Parent Disclosure Schedule for
purposes of Sections 6, 7 and 8, as applicable. \t\t

 \t\t

 \t\t\tSection 5 ADDITIONAL AGREEMENTS OF THE PARTIES \t\t

 \t\t

 \t\t\t5.1 Registration Statement; Proxy Statement. \t\t

 \t\t

 \t\t\t(a) As promptly as practicable after the date of this
Agreement, the Parties shall prepare, and Parent shall cause to be filed with
the SEC, the Registration Statement, in which the Proxy Statement will be
included as a prospectus. Parent represents, covenants and agrees that the
Proxy Statement, including any pro forma financial statements included therein
(and the letter to stockholders, notice of meeting and form of proxy included
therewith) will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order to
make the statements made therein, in light of the circumstances under which
they were made, not misleading. The Company represents, covenants and agrees
that the information provided by the Company to Parent for inclusion in the
Proxy Statement (including the Company Financials) will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make such information not misleading.
Notwithstanding the foregoing, Parent makes no covenant, representation or
warranty with respect to statements made in the Proxy Statement (and the
letter to stockholders, notice of meeting and form of proxy included
therewith), if any, based on information provided by the Company or any of its
Representatives specifically for inclusion therein. The Company and its legal
counsel shall be given reasonable opportunity to review and comment on the
Proxy Statement, including all amendments and supplements thereto, prior to
the filing thereof with the SEC (at least three (3) business days prior to the
filing thereof), and on the response to any comments of the SEC on the Proxy
Statement, prior to the filing thereof with the SEC. Parent shall use
commercially reasonable efforts to cause the Registration Statement and the
Proxy Statement to comply with the applicable rules and regulations
promulgated by the SEC, to respond promptly to any comments of the SEC or its
staff and to have the Registration Statement declared effective under the
Securities Act as promptly as practicable after it is filed with the SEC. Each
of the Parties shall use commercially reasonable efforts to cause the Proxy
Statement to be mailed to Parent's stockholders as promptly as practicable
after the Registration Statement is declared effective under the Securities
Act. Each Party shall promptly furnish to the other Party all information
concerning such Party and such Party's Affiliates and such Party's
stockholders that may be required or reasonably requested in connection with
any action contemplated by this Section 5.1. If Parent, Merger Sub or the
Company become aware of any event or information that, pursuant to the
Securities Act or the Exchange Act, should be disclosed in an amendment or
supplement to the Registration Statement or Proxy Statement, as the case may
be, then such Party, as the case

 \t\t

  \t\t

  \t\t\t-44-  \t\t

  

may be, shall promptly inform the other Parties thereof and shall cooperate
with such other Parties in filing such amendment or supplement with the SEC
and, if appropriate, in mailing such amendment or supplement to the Parent
stockholders. \t\t

 \t\t

 \t\t\t(b) The Company shall reasonably cooperate with Parent and
provide, and require its Representatives to provide, Parent and its
Representatives, with all true, correct and complete information regarding the
Company that is required by Law to be included in the Registration Statement
or reasonably requested by Parent to be included in the Registration
Statement. Without limiting the foregoing, the Company will use commercially
reasonable efforts to cause to be delivered to Parent a consent letter of the
Company's independent accounting firm that is customary in scope and substance
for consent letters delivered by independent public accountants in connection
with registration statements similar to the Registration Statement. \t\t

 \t\t

 \t\t\t5.2 Company Member Written Consent. \t\t

 \t\t

 \t\t\t(a) On or prior to the date of the Parent Stockholders'
Meeting, the Company shall obtain the approval by written consent from Company
members sufficient for the Required Company Member Vote in lieu of a meeting
pursuant to Section 12-302 of the DLLCA, for purposes of adopting and
approving this Agreement and the Contemplated Transactions. Under no
circumstances shall the Company assert that any other approval or consent is
necessary by its members to approve this Agreement and the Contemplated
Transactions. \t\t

 \t\t

 \t\t\t(b) The Company agrees that: (i) the Company Managers shall
recommend that the Company's members vote to adopt and approve this Agreement
and the Contemplated Transactions and shall use reasonable best efforts to
solicit such approval within the time set forth in Section 5.2(a) (the
recommendation of the Company Managers that the Company's members vote to
adopt and approve this Agreement being referred to as the "Company Managers
Recommendation"); and (ii) the Company Managers Recommendation shall not be
withdrawn or modified (and the Company Managers shall not publicly propose to
withdraw or modify the Company Managers Recommendation) in a manner adverse to
Parent, and no resolution by the Company Managers or any committee thereof to
withdraw or modify the Company Managers Recommendation in a manner adverse to
Parent or to adopt, approve or recommend (or publicly propose to adopt,
approve or recommend) any Acquisition Proposal shall be adopted or proposed
(the actions set forth in the foregoing clause (ii), collectively, a "Company
Managers Adverse Recommendation Change"). \t\t

 \t\t

 \t\t\t(c) Notwithstanding anything to the contrary contained in
Section 5.2(b), and subject to compliance with Section 4.5 and Section 5.2, if
at any time prior to the approval of the Required Parent Stockholder Matters
by the Required Parent Stockholder Vote, the Company receives a bona fide
written Superior Offer, the Company Managers may make a Company Managers
Adverse Recommendation Change if, but only if, following the receipt of and on
account of such Superior Offer, (i) the Company Managers determine in good
faith, based on the advice of its outside legal counsel, that the failure to
make a Company Managers Adverse Recommendation Change would be reasonably
likely to be inconsistent with its fiduciary duties under applicable Law, (ii)
the Company has, and has caused its financial advisors and outside legal
counsel to, during the Company Notice Period (as defined below), negotiate
with Parent in good faith (if Parent so desires) to make such adjustments to
the terms and conditions of this Agreement so that such Acquisition Proposal
ceases to constitute a Superior Offer, and (iii) if after Parent shall have
delivered to the Company a written offer to alter the terms or conditions of
this Agreement during the Company Notice Period, the Company Managers shall
have determined in good faith, based on the advice of its outside legal
counsel, that the failure to withhold, amend, withdraw or modify the Company
Managers Recommendation would be reasonably likely to be inconsistent with its
fiduciary duties under applicable Law (after taking into account such
alterations of the terms and conditions of this Agreement); provided that
Parent receives written notice from the Company confirming that the Company
Managers have determined to change their recommendation at least four Business
Days in advance of such Company Managers Adverse Recommendation Change, (the
"Company Notice Period"), which notice shall

 \t\t

  \t\t

  \t\t\t-45-  \t\t

  

include written copies of any relevant proposed transaction agreements with
any party making a potential Superior Offer. In the event of any material
amendment to any Superior Offer, the Company shall be required to provide
Parent with notice of such material amendment and the Company Notice Period
shall be extended, if applicable, to ensure that at least two Business Days
remain in the Company Notice Period following such notification during which
the Parties shall comply again with the requirements of this Section 5.3(c)
and the Company Managers shall not make a Company Managers Adverse
Recommendation Change prior to the end of such Company Notice Period as so
extended. \t\t

 \t\t

 \t\t\t5.3 Parent Stockholders' Meeting. \t\t

 \t\t

 \t\t\t(a) Parent shall take all action necessary under applicable Law
to call, give notice of and hold a meeting of the holders of Parent Common
Stock to consider and vote to (i) approve the issuance of the shares of Parent
Common Stock to the members of the Company pursuant to the terms of this
Agreement (the "Share Issuance Proposal"), (ii) approve the change of the
corporate name of Parent (the "Name Change Proposal"), (iii) approve the
reverse stock split of the Company (the "Reverse Stock Split Proposal"), (iv)
approve, if required, (a) the terms of the Parent Preferred Stock to be issued
to the current holders of the preferred membership interests of the Company
and (b) the issuance of Parent Common Stock underlying the warrants, if any,
being issued to any financing sources related to the transactions contemplated
by this Agreement, and (v) approve such other matters as are determined to be
required to complete the Closing (collectively, the "Parent Stockholder
Matters" and such meeting, the "Parent Stockholders' Meeting"). The Parent
Stockholders' Meeting shall be held as promptly as practicable after the
Registration Statement is declared effective under the Securities Act. Parent
shall take reasonable measures to ensure that all proxies solicited in
connection with the Parent Stockholders' Meeting are solicited in compliance
with all applicable Law. Notwithstanding anything to the contrary contained
herein, if on the date of the Parent Stockholders' Meeting, or a date
preceding the date on which the Parent Stockholders' Meeting is scheduled,
Parent reasonably believes that (i) it will not receive proxies sufficient to
obtain the Required Parent Stockholder Vote, whether or not a quorum would be
present or (ii) it will not have sufficient shares of Parent Common Stock
represented (whether in person or by proxy) to constitute a quorum necessary
to conduct the business of the Parent Stockholders' Meeting, Parent shall
postpone or adjourn, or make one or more successive postponements or
adjournments of, the Parent Stockholders' Meeting as long as the date of the
Parent Stockholders' Meeting is not postponed or adjourned more than an
aggregate of 60 calendar days in connection with any postponements or
adjournments. Parent agrees that in connection with the reverse stock split,
it will obtain the consent of the Company prior to (a) fixing any range for
the reverse split to be approved by Parent's shareholders and (b) setting a
final reverse stock split ratio to be effected by the Parent. Parent shall
retain, and be responsible for the fees and expenses of, a nationally-
recognized proxy solicitor, to be retained for the purpose of the solicitation
of votes at the Parent Stockholders' Meeting and any postponements or
adjournments thereof. \t\t

 \t\t

 \t\t\t(b) Parent agrees that, subject to Section 5(c): (i) the Parent
Board shall recommend that the holders of Parent Common Stock vote to approve
the Parent Stockholder Matters, (ii) the Proxy Statement shall include a
statement to the effect that the Parent Board recommends that Parent's
stockholders vote to approve the Parent Stockholder Matters (the
recommendation of the Parent Board being referred to as the "Parent Board
Recommendation"); and (iii) the Parent Board Recommendation shall not be
withheld, amended, withdrawn or modified (and the Parent Board shall not
publicly propose to withhold, amend, withdraw or modify the Parent Board
Recommendation) in a manner adverse to the Company (the actions set forth in
the foregoing clause (iii), collectively, a "Parent Board Adverse
Recommendation Change"). \t\t

 \t\t

 \t\t\t(c) Notwithstanding anything to the contrary contained in
Section 5.3(b), and subject to compliance with Section 4.4 and Section 5.3, if
at any time prior to the approval of the Required Parent Stockholder Matters
by the Required Parent Stockholder Vote, Parent receives a bona fide written
Superior Offer,

 \t\t

  \t\t

  \t\t\t-46-  \t\t

  

the Parent Board may make a Parent Board Adverse Recommendation Change if, but
only if, following the receipt of and on account of such Superior Offer, (i)
the Parent Board determines in good faith, based on the advice of its outside
legal counsel, that the failure to make a Parent Board Adverse Recommendation
Change would be reasonably likely to be inconsistent with its fiduciary duties
under applicable Law, (ii) Parent has, and has caused its financial advisors
and outside legal counsel to, during the Parent Notice Period (as defined
below), negotiate with the Company in good faith (if the Company so desires)
to make such adjustments to the terms and conditions of this Agreement so that
such Acquisition Proposal ceases to constitute a Superior Offer, and (iii) if
after the Company shall have delivered to Parent a written offer to alter the
terms or conditions of this Agreement during the Parent Notice Period, the
Parent Board shall have determined in good faith, based on the advice of its
outside legal counsel, that the failure to withhold, amend, withdraw or modify
the Parent Board Recommendation would be reasonably likely to be inconsistent
with its fiduciary duties under applicable Law (after taking into account such
alterations of the terms and conditions of this Agreement); provided that the
Company receives written notice from Parent confirming that the Parent Board
has determined to change its recommendation at least four Business Days in
advance of such Parent Board Adverse Recommendation Change, (the "Parent
Notice Period"), which notice shall include written copies of any relevant
proposed transaction agreements with any party making a potential Superior
Offer. In the event of any material amendment to any Superior Offer, Parent
shall be required to provide the Company with notice of such material
amendment and the Parent Notice Period shall be extended, if applicable, to
ensure that at least two Business Days remain in the Parent Notice Period
following such notification during which the Parties shall comply again with
the requirements of this Section 5.3(c) and the Parent Board shall not make a
Parent Board Adverse Recommendation Change prior to the end of such Parent
Notice Period as so extended. \t\t

 \t\t

 \t\t\t(d) Nothing contained in this Agreement shall prohibit Parent
or the Parent Board from (i) complying with Rules 14d-9 and 14e-2(a)
promulgated under the Exchange Act, (ii) issuing a "stop, look and listen"
communication or similar communication of the type contemplated by Section
14d-9(f) under the Exchange Act or (iii) otherwise making any disclosure to
the Parent stockholders; provided however, that in the case of the foregoing
clause (iii) the Parent Board determines in good faith, after consultation
with its outside legal counsel, that failure to make such disclosure would be
reasonably likely to be inconsistent with applicable Law, including its
fiduciary duties under applicable Law; provided, further, that any such
disclosures (other than a "stop, look and listen" communication or similar
communication of the type contemplated by Section 14d-9(f) under the Exchange
Act) shall be deemed to be a change of the Parent Board Recommendation unless
the Parent Board expressly publicly reaffirms the Parent Board Recommendation
(i) in such communication or (ii) within three Business Days after being
requested in writing to do so by the Company. \t\t

 \t\t

 \t\t\t5.4 Regulatory Approvals. Each Party shall use reasonable best
efforts to file or otherwise submit, as soon as practicable after the date of
this Agreement, all applications, notices, reports and other documents
reasonably required to be filed by such Party with or otherwise submitted by
such Party to any Governmental Body with respect to the Contemplated
Transactions, and to submit promptly any additional information requested by
any such Governmental Body. \t\t

 \t\t

 \t\t\t5.5 Employee Benefits. For purposes of vesting, eligibility to
participate, and level of benefits under the benefit plans, programs,
contracts or arrangements of Parent or any of its Subsidiaries (including,
following the Closing, the Surviving Entity) providing benefits to any
Continuing Employee after the Closing (the "Post-Closing Plans"), each
employee who continues to be employed by the Surviving Entity or any of their
respective Subsidiaries immediately following the Closing ("Continuing
Employees") shall be credited with his or her years of service with Parent,
the Company or any of their respective Subsidiaries and their respective
predecessors; provided that the foregoing shall not apply to the extent that
its application would result in a duplication of benefits. In addition, and
without limiting the generality of the foregoing, for purposes of each Post-
Closing Plan providing medical, dental, pharmaceutical and/or vision benefits
to a Continuing Employee, Parent shall cause

 \t\t

  \t\t

  \t\t\t-47-  \t\t

  

all pre-existing condition exclusions and actively-at-work requirements of
such Post-Closing Plan to be waived for such Continuing Employee and his or
her covered dependents except to the extent such conditions would not have
been waived or satisfied under the employee benefit plan whose coverage is
being replaced under the Post-Closing Plan, and Parent shall use commercially
reasonable efforts to cause any eligible expenses incurred by a Continuing
Employee and his or her covered dependents during the portion of such plan
year in which coverage is replaced with coverage under a Post-Closing Plan to
be taken into account under such Post-Closing Plan with respect to the plan
year in which participation in such Post-Closing Plan begins for purposes of
satisfying all deductible, coinsurance and maximum out-of-pocket requirements
applicable to such Continuing Employee and his or her covered dependents for
such plan year as if such amounts had been paid in accordance with such Post-
Closing Plan. \t\t

 \t\t

 \t\t\t5.6 Indemnification of Officers and Directors. \t\t

 \t\t

 \t\t\t(a) From the Effective Time through the sixth anniversary of
the date on which the Effective Time occurs, each of Parent and the Surviving
Entity shall indemnify and hold harmless each person who is now, or has been
at any time prior to the date hereof, or who becomes prior to the Effective
Time, a director, manager, officer, fiduciary or agent of Parent or the
Company, respectively (the "DandO Indemnified Parties"), against all claims,
losses, liabilities, damages, judgments, fines and reasonable fees, costs and
expenses, including attorneys' fees and disbursements (collectively, "Costs"),
incurred in connection with any claim, action, suit, proceeding or
investigation, whether civil, criminal, administrative or investigative,
arising out of or pertaining to the fact that the DandO Indemnified Party is or
was a director, manager, officer, fiduciary or agent of Parent or of the
Company, whether asserted or claimed prior to, at or after the Effective Time,
in each case, to the fullest extent permitted under applicable Law. Each DandO
Indemnified Party will be entitled to advancement of expenses incurred in the
defense of any such claim, action, suit, proceeding or investigation from each
of Parent and the Surviving Entity, jointly and severally, upon receipt by
Parent or the Surviving Entity from the DandO Indemnified Party of a request
therefor; provided that any such person to whom expenses are advanced provides
an undertaking to Parent, to the extent then required by the DGCL, to repay
such advances if it is ultimately determined that such person is not entitled
to indemnification. \t\t

 \t\t

 \t\t\t(b) The provisions of the certificate of incorporation and
bylaws of Parent with respect to indemnification, advancement of expenses and
exculpation of present and former directors and officers of Parent that are
presently set forth in the certificate of incorporation and bylaws of Parent
shall not be amended, modified or repealed for a period of six years from the
Effective Time in a manner that would adversely affect the rights thereunder
of individuals who, at or prior to the Effective Time, were officers or
directors of Parent. The certificate of incorporation and bylaws of the
Surviving Entity shall contain, and Parent shall cause the certificate of
incorporation and bylaws of the Surviving Entity to so contain, provisions no
less favorable with respect to indemnification, advancement of expenses and
exculpation of present and former directors and officers as those presently
set forth in the certificate of incorporation and bylaws of Parent. \t\t

 \t\t

 \t\t\t(c) From and after the Effective Time, (i) the Surviving Entity
shall fulfill and honor in all respects the obligations of the Company to its
DandO Indemnified Parties as of immediately prior to the Closing pursuant to any
indemnification provisions under the Company's Organizational Documents and
pursuant to any indemnification agreements between the Company and such DandO
Indemnified Parties, with respect to claims arising out of matters occurring
at or prior to the Effective Time and (ii) Parent shall fulfill and honor in
all respects the obligations of Parent to its DandO Indemnified Parties as of
immediately prior to the Closing pursuant to any indemnification provisions
under Parent's Organizational Documents and pursuant to any indemnification
agreements between Parent and such DandO Indemnified Parties, with respect to
claims arising out of matters occurring at or prior to the Effective
Time. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-48-  \t\t

  

 \t\t

 \t\t

 \t\t\t(d) From and after the Effective Time, Parent shall maintain
directors' and officers' liability insurance policies, with an effective date
as of the Closing Date, on commercially available terms and conditions and
with coverage limits customary for U.S. public companies similarly situated to
Parent. \t\t

 \t\t

 \t\t\t(e) From and after the Effective Time, Surviving Entity shall
pay all expenses, including reasonable attorneys' fees, that are incurred by
the persons referred to in this Section 5.6 in connection with their
successful enforcement of the rights provided to such persons in this Section
5.6. \t\t

 \t\t

 \t\t\t(f) The provisions of this Section 5.6 are intended to be in
addition to the rights otherwise available to the current and former officers
and directors of Parent and the Company by Law, charter, statute, bylaw or
agreement, and shall operate for the benefit of, and shall be enforceable by,
each of the DandO Indemnified Parties, their heirs and their
representatives. \t\t

 \t\t

 \t\t\t(g) In the event Parent or the Surviving Entity or any of their
respective successors or assigns (i) consolidates with or merges into any
other Person and shall not be the continuing or surviving entity or entity of
such consolidation or merger, or (ii) transfers all or substantially all of
its properties and assets to any Person, then, and in each such case, proper
provision shall be made so that the successors and assigns of Parent or the
Surviving Entity, as the case may be, shall succeed to the obligations set
forth in this Section 5.6. Parent shall cause the Surviving Entity to perform
all of the obligations of the Surviving Entity under this Section 5.6. \t\t

 \t\t

 \t\t\t5.7 Additional Agreements. The Parties shall use commercially
reasonable efforts to cause to be taken all actions necessary to consummate
the Contemplated Transactions. Without limiting the generality of the
foregoing, each Party to this Agreement: (a) shall make all filings and other
submissions (if any) and give all notices (if any) required to be made and
given by such Party in connection with the Contemplated Transactions; (b)
shall use reasonable best efforts to obtain each Consent (if any) reasonably
required to be obtained (pursuant to any applicable Law or Contract, or
otherwise) by such Party in connection with the Contemplated Transactions or
for such Contract to remain in full force and effect; (c) shall use
commercially reasonable efforts to lift any injunction prohibiting, or any
other legal bar to, the Contemplated Transactions; and (d) shall use
commercially reasonable efforts to satisfy the conditions precedent to the
consummation of this Agreement. \t\t

 \t\t

 \t\t\t5.8 Disclosure. Without limiting any Party's obligations under
the Confidentiality Agreement, no Party shall, and no Party shall permit any
of its Subsidiaries or any Representative of such Party to, issue any press
release or make any disclosure (to any customers or employees of such Party,
to the public or otherwise) regarding the Contemplated Transactions unless:
(a) the other Party shall have approved such press release or disclosure in
writing, such approval not to be unreasonably conditioned, withheld or
delayed; or (b) such disclosure is requested by a Governmental Body or such
Party shall have determined in good faith that such disclosure is required by
applicable Law or by obligations pursuant to any listing agreement with or
rules of any national securities exchange or interdealer quotation service
and, to the extent practicable, before such press release or disclosure is
issued or made, such Party shall have used commercially reasonable efforts to
advise the other Party of, and consult with the other Party regarding, the
text of such press release or disclosure; provided, however, that Parent may
make any public statement in response to specific questions by the press,
analysts, investors or those attending industry conferences or financial
analyst conference calls, so long as any such statements are consistent with
previous press releases, public disclosures or public statements made by the
Company or Parent in compliance with this Section 5.8. \t\t

 \t\t

 \t\t\t5.9 Listing. At all times prior to Closing, Parent shall
maintain its listing on the NYSE American Market. Parent shall use its
commercially reasonable efforts, (a) to the extent required by the rules and
regulations of the NYSE American Market, to prepare and submit to the NYSE
American Market a notification form for the listing of the shares of Parent
Common Stock to be issued in connection with the Contemplated Transactions,
and to cause such shares to be approved for listing (subject to official
notice of issuance); and (b) to the extent required

 \t\t

  \t\t

  \t\t\t-49-  \t\t

  

by the NYSE American Market Rule 101, to file an initial listing application
for the Parent Common Stock on the NYSE American Market (the "NYSE Listing
Application") and to cause such the NYSE Listing Application to be
conditionally approved prior to the Effective Time. The Parties will use
commercially reasonable efforts to coordinate with respect to compliance with
the NYSE rules and regulations. Parent agrees to pay all the NYSE fees
associated with the NYSE Listing Application. The Company will cooperate with
Parent as reasonably requested by Parent with respect to the NYSE Listing
Application and promptly furnish to Parent all information concerning the
Company and its members that may be required or reasonably requested in
connection with any action contemplated by this Section 5.9. \t\t

 \t\t

 \t\t\t5.10 Tax Matters. \t\t

 \t\t

 \t\t\t(a) For United States federal income Tax purposes, the Parties
intend that the Merger constitute a transaction described in Section 351(a) of
the Code (the "Intended Tax Treatment"). \t\t

 \t\t

 \t\t\t(b) The Parties shall use their respective reasonable best
efforts to cause the Merger to qualify, and will not take any action or cause
any action to be taken which action would reasonably be expected to prevent
the Merger from qualifying, for the Intended Tax Treatment. \t\t

 \t\t

 \t\t\t5.11 Directors and Officers. The Parties shall use reasonable
best efforts and take all necessary action so that immediately after the
Effective Time, (a) the Parent Board is comprised of up to seven (7) members
designated by the Company and (b) the Persons listed in Exhibit E under the
heading "Officers" are elected or appointed, as applicable, to the positions
of officers of Parent and the Surviving Entity, as set forth therein, to serve
in such positions effective as of the Effective Time until successors are duly
appointed and qualified in accordance with applicable Law. If any Person
listed in Exhibit E is unable or unwilling to serve as an officer of Parent or
the Surviving Entity, as set forth therein, as of the Effective Time, the
Parties shall mutually agree upon a successor. The Persons listed in Exhibit E
under the heading "Board Designees" shall be the Company's designees pursuant
to clause (a) of this Section 5.11 (which list may be changed by the Company
at any time prior to the Closing by written notice to Parent). \t\t

 \t\t

 \t\t\t5.12 Section 16 Matters. Prior to the Effective Time, Parent and
the Company shall take all such steps as may be required (to the extent
permitted under applicable Laws) to cause any acquisitions of Parent Common
Stock and any options to purchase Parent Common Stock in connection with the
Contemplated Transactions, by each individual who is reasonably expected to
become subject to the reporting requirements of Section 16(a) of the Exchange
Act with respect to Parent, to be exempt under Rule 16b-3 promulgated under
the Exchange Act. At least thirty (30) days prior to the Anticipated Closing
Date, the Company shall furnish the following information to Parent for each
individual who, immediately after the Effective Time, will become subject to
the reporting requirements of Section 16(a) of the Exchange Act with respect
to Parent: (a) the number of shares of Company Equity owned by such individual
and expected to be exchanged for shares of Parent Common Stock pursuant to the
Merger, and (b) the number of other derivative securities (if any) with
respect to Company Equity owned by such individual and expected to be
converted into shares of Parent Common Stock or derivative securities with
respect to Parent Common Stock in connection with the Merger. \t\t

 \t\t

 \t\t\t5.13 Cooperation. Each Party shall cooperate reasonably with the
other Party and shall provide the other Party with such assistance as may be
reasonably requested for the purpose of facilitating the performance by each
Party of its respective obligations under this Agreement and to enable the
combined entity to continue to meet its obligations following the Effective
Time. \t\t

 \t\t

 \t\t\t5.14 Allocation Certificate. The Company will prepare and deliver
to Parent at least ten days prior to the Anticipated Closing Date a
certificate signed by the Chief Executive Officer of the Company in a form
reasonably acceptable to Parent to update Exhibit C so as to set forth (as of
immediately prior to the Effective

 \t\t

  \t\t

  \t\t\t-50-  \t\t

  

Time) (a) each holder of Company membership interests, (b) such holder's name
and address; (c) the number and type of Company Equity held; and (d) the
number of shares of Parent Common Stock to be issued to such holder pursuant
to this Agreement in respect of the Company Equity held by such holder as of
immediately prior to the Effective Time (the "Allocation Certificate"). \t\t

 \t\t

 \t\t\t5.15 Company Financial Statements. As promptly as reasonably
practicable following the date of this Agreement, the Company will furnish to
Parent audited financial statements for the fiscal year ended December 31,
2019, for inclusion in the Proxy Statement and the Registration Statement (the
"Company Audited Financial Statements"), and for each interim period completed
prior to Closing that would be required to be included in the Registration
Statement or any periodic report due prior to the Closing if the Company were
subject to the periodic reporting requirements under the Securities Act or the
Exchange Act (the "Company Interim Financial Statements"). Each of the Company
Audited Financial Statements and the Company Interim Financial Statements will
be suitable for inclusion in the Proxy Statement and the Registration
Statement and prepared in accordance with GAAP as applied on a consistent
basis during the periods involved (except in each case as described in the
notes thereto) and on that basis will present fairly, in all material
respects, the financial position and the results of operations, changes in
members' equity, and cash flows of the Company as of the dates of and for the
periods referred to in the Company Audited Financial Statements or the Company
Interim Financial Statements, as the case may be. \t\t

 \t\t

 \t\t\t5.16 Takeover Statutes. If any Takeover Statute is or may become
applicable to the Contemplated Transactions, each of the Company, the Company
Managers, Parent and the Parent Board, as applicable, shall grant such
approvals and take such actions as are necessary so that the Contemplated
Transactions may be consummated as promptly as practicable on the terms
contemplated by this Agreement and otherwise act to eliminate or minimize the
effects of such statute or regulation on the Contemplated Transactions. \t\t

 \t\t

 \t\t\t5.17 Calculation of Parent Net Cash. At least ten (10) days prior
to the Anticipated Closing Date, Parent shall deliver the Parent Net Cash
Schedule to the Company. Upon the reasonable request of the Company, Parent
shall make the work papers and back-up materials used or useful in preparing
the Parent Net Cash Schedule available to the Company. Within three (3)
Business Days after Parent delivers the Parent Net Cash Schedule to the
Company (the "Parent Net Cash Response Date"), subject to the terms and
definitions of this Agreement, the Company will have the right to dispute any
part of such Parent Net Cash Schedule by delivering a written notice to that
effect to Parent (a "Company Dispute Notice"). Any Company Dispute Notice
shall identify in reasonable detail the nature of any proposed revisions to
the calculation of Parent Net Cash set forth in the Parent Net Cash Schedule.
If on or prior to the Parent Net Cash Response Date, (i) the Company notifies
Parent in writing that it has no objections to the Parent Net Cash Schedule or
(ii) the Company fails to deliver a Company Dispute Notice, then Parent Net
Cash as set forth in the Parent Net Cash Schedule shall be deemed to have been
finally determined for purposes of this Agreement and to represent the Parent
Net Cash at the Anticipated Closing Date for purposes of this Agreement. If
the Company delivers a Company Dispute Notice on or prior to the Parent Net
Cash Response Date, then members of senior management of Parent and the
Company shall promptly meet in person or telephonically at mutually agreed
upon times and attempt in good faith to resolve the disputed item(s) and
negotiate an agreed-upon determination of Parent Net Cash, which agreed upon
Parent Net Cash amount shall be deemed to have been finally determined for
purposes of this Agreement and to represent the Parent Net Cash at the
Anticipated Closing Date for purposes of this Agreement. \t\t

 \t\t

 \t\t\t5.18 Parent Lease Obligations. Parent represents that its current
aggregate obligations under the Real Estate Lease do not exceed $1,500,000.
Parent shall use reasonable efforts from and after the date hereof (a) to
terminate, assign or sublease the Real Estate Lease, such that it shall no
longer have any obligation under the Lease (or such liabilities shall be
materially reduced), and (b) to satisfy all of its liabilities (including any
liabilities

 \t\t

  \t\t

  \t\t\t-51-  \t\t

  

created by any "Black Scholes" fundamental transaction provisions contained in
any outstanding warrants of Parent or any of its Subsidiaries) other than
Permitted Liabilities. \t\t

 \t\t

 \t\t\t5.19 Funding Condition. The Company shall use reasonable efforts
from and after the date hereof to arrange for and thereafter consummate the
Timber Funding and satisfy the funding condition in Section 7.4, and Parent
shall use reasonable efforts to provide information to potential financing
providers and otherwise to assist the Company in such efforts to secure
financing so as to satisfy such funding conditions. \t\t

 \t\t

 \t\t\tSection 6 CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH
PARTY \t\t

 \t\t

 \t\t\tThe obligations of each Party to effect the Merger and otherwise
consummate the Contemplated Transactions to be consummated at the Closing are
subject to the satisfaction or, to the extent permitted by applicable Law, the
written waiver by each of the Parties, at or prior to the Closing, of each of
the following conditions: \t\t

 \t\t

 \t\t\t6.1 Effectiveness of Registration Statement. The Registration
Statement shall have become effective in accordance with the provisions of the
Securities Act, and shall not be subject to any stop order or proceeding (or
threatened proceeding by the SEC) seeking a stop order with respect to the
Registration Statement that has not been withdrawn. \t\t

 \t\t

 \t\t\t6.2 No Restraints. No temporary restraining order, preliminary
or permanent injunction or other order preventing the consummation of the
Contemplated Transactions shall have been issued by any court of competent
jurisdiction or other Governmental Body of competent jurisdiction and remain
in effect and there shall not be any Law which has the effect of making the
consummation of the Contemplated Transactions illegal. \t\t

 \t\t

 \t\t\t6.3 Stockholder/Member Approval. (a) Parent shall have obtained
the Required Parent Stockholder Vote and (b) the Company shall have obtained
the Required Company Member Vote. \t\t

 \t\t

 \t\t\t6.4 Listing. The shares of Parent Common Stock to be issued in
the Merger, and all other shares of Parent Common Stock issuable in connection
with the transactions contemplated herein, as described in Exhibit C, shall
have been approved for listing (subject to official notice of issuance) on the
NYSE American Market as of the Closing. \t\t

 \t\t

 \t\t\tSection 7 ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF
PARENT AND MERGER SUB \t\t

 \t\t

 \t\t\tThe obligations of Parent and Merger Sub to effect the Merger and
otherwise consummate the transactions to be consummated at the Closing are
subject to the satisfaction or the written waiver by Parent, at or prior to
the Closing, of each of the following conditions: \t\t

 \t\t

 \t\t\t7.1 Accuracy of Representations. The Company Fundamental
Representations shall have been true and correct in all respects as of the
date of this Agreement and shall be true and correct on and as of the Closing
Date with the same force and effect as if made on and as of such date (except
to the extent such representations and warranties are specifically made as of
a particular date, in which case such representations and warranties shall be
true and correct as of such date). The Company Capitalization Representations
shall have been true and correct in all respects as of the date of this
Agreement and shall be true and correct on and as of the Closing Date with the
same force and effect as if made on and as of such date, except, in each case,
(x) for such inaccuracies which are de minimis, individually or in the
aggregate or (y) for those representations and warranties which address
matters only as of a particular date (which representations and warranties
shall have been true and correct, subject to the qualifications as set forth
in the preceding clause (x), as of such particular date). The representations

 \t\t

  \t\t

  \t\t\t-52-  \t\t

  

and warranties of the Company contained in this Agreement (other than the
Company Fundamental Representations and the Company Capitalization
Representations) shall have been true and correct as of the date of this
Agreement and shall be true and correct on and as of the Closing Date with the
same force and effect as if made on the Closing Date except (a) in each case,
or in the aggregate, where the failure to be true and correct would not
reasonably be expected to have a Company Material Adverse Effect (without
giving effect to any references therein to any Company Material Adverse Effect
or other materiality qualifications), or (b) for those representations and
warranties which address matters only as of a particular date (which
representations shall have been true and correct, subject to the
qualifications as set forth in the preceding clause (a), as of such particular
date) (it being understood that, for purposes of determining the accuracy of
such representations and warranties, any update of or modification to the
Company Disclosure Schedule made or purported to have been made after the date
of this Agreement shall be disregarded). \t\t

 \t\t

 \t\t\t7.2 Performance of Covenants. The Company shall have performed
or complied with in all material respects all agreements and covenants
required to be performed or complied with by it under this Agreement at or
prior to the Effective Time. \t\t

 \t\t

 \t\t\t7.3 Documents. Parent shall have received a certificate
executed by the Chief Executive Officer or Chief Accounting Officer of the
Company certifying (i) that the conditions set forth in Sections 7.1, 7.2, and
7.6 have been duly satisfied and (ii) that the information set forth in the
Timber Allocation Certificate delivered by the Company in accordance with
Section 5.14 and Exhibit C remains true and accurate in all respects as of the
Closing Date. \t\t

 \t\t

 \t\t\t7.4 Funding Condition. The Company shall have consummated the
Timber Funding and provided Parent with an amendment, if required, to Exhibit
C to reflect the treatment of investors in the Timber Funding as a result of
the Merger. \t\t

 \t\t

 \t\t\t7.5 Tax Certificate. Each holder of Company Equity shall
furnish to Parent a properly executed IRS Form W-9 and a nonforeign affidavit,
in form and substance acceptable to Parent, for the purpose of certifying such
holder's "non-foreign" status in accordance with Treasury Regulations Section
1.1445-2(b)(2) and Section 6.01 of IRS Notice 2018-29. \t\t

 \t\t

 \t\t\t7.6 No Company Material Adverse Effect. Since the date of this
Agreement, there shall not have occurred any Company Material Adverse
Effect. \t\t

 \t\t

 \t\t\tSection 8 ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE
COMPANY \t\t

 \t\t

 \t\t\tThe obligations of the Company to effect the Merger and otherwise
consummate the transactions to be consummated at the Closing are subject to
the satisfaction or the written waiver by the Company, at or prior to the
Closing, of each of the following conditions: \t\t

 \t\t

 \t\t\t8.1 Accuracy of Representations. The Parent Fundamental
Representations shall have been true and correct in all respects as of the
date of this Agreement and shall be true and correct on and as of the Closing
Date with the same force and effect as if made on and as of such date (except
to the extent such representations and warranties are specifically made as of
a particular date, in which case such representations and warranties shall be
true and correct as of such date). The Parent Capitalization Representations
shall have been true and correct in all respects as of the date of this
Agreement and shall be true and correct on and as of the Closing Date with the
same force and effect as if made on and as of such date, except, in each case,
(x) for such inaccuracies which are de minimis, individually or in the
aggregate or (y) for those representations and warranties which address
matters only as of a particular date (which representations and warranties
shall have been true and correct, subject to the qualifications as set forth
in the preceding clause (x), as of such particular date). The representations
and

 \t\t

  \t\t

  \t\t\t-53-  \t\t

  

warranties of Parent and Merger Sub contained in this Agreement (other than
the Parent Fundamental Representations and the Parent Capitalization
Representations) shall have been true and correct as of the date of this
Agreement and shall be true and correct on and as of the Closing Date with the
same force and effect as if made on the Closing Date except (a) in each case,
or in the aggregate, where the failure to be true and correct would not
reasonably be expected to have a Parent Material Adverse Effect (without
giving effect to any references therein to any Parent Material Adverse Effect
or other materiality qualifications), or (b) for those representations and
warranties which address matters only as of a particular date (which
representations shall have been true and correct, subject to the
qualifications as set forth in the preceding clause (a), as of such particular
date) (it being understood that, for purposes of determining the accuracy of
such representations and warranties, any update of or modification to the
Parent Disclosure Schedule made or purported to have been made after the date
of this Agreement shall be disregarded). \t\t

 \t\t

 \t\t\t8.2 Performance of Covenants. Parent and Merger Sub shall have
performed or complied with in all material respects all of their agreements
and covenants required to be performed or complied with by each of them under
this Agreement and all agreements related to the Bridge Note and the Bridge
Warrant at or prior to the Effective Time and given all notices and received
all consents contemplated in the Parent Disclosure Schedules. \t\t

 \t\t

 \t\t\t8.3 Documents. The Company shall have received the following
documents, each of which shall be in full force and effect: \t\t

 \t\t

 \t\t\t(a) a certificate executed by the Chief Executive Officer or
Chief Accounting Officer of Parent confirming that the conditions set forth in
Sections 8.1, 8.2, and 8.4 have been duly satisfied; and \t\t

 \t\t

 \t\t\t(b) a written resignation, in a form reasonably satisfactory to
the Company, dated as of the Closing Date and effective as of the Closing,
executed by each of the officers and directors of Parent who are not to
continue as officers or directors of Parent after the Closing pursuant to
Section 5.11 hereof; \t\t

 \t\t

 \t\t\t(c) a certificate executed by the Chief Executive Officer or
Chief Accounting Officer of Parent confirming that Parent and Merger Sub have
no liabilities (including any liabilities created by any "Black Scholes"
fundamental transaction provisions contained in any outstanding warrants of
Patent or any of its Subsidiaries or any severance obligations or other
employee liabilities not included within the Budget) other than a Permitted
Liability (and other proof of satisfaction of such liabilities reasonably
requested by the Company); and \t\t

 \t\t

 \t\t\t(d) pay off letters and releases, in a form reasonably
satisfactory to the Company, from any party receiving proceeds of the Bridge
Note, including but not limited to the bankers, financial advisors, counsel,
accountants, and other processionals providing services to Parent in this
Transaction and any executives receiving severance or other payments in
connection with a "change of control". \t\t

 \t\t

 \t\t\t8.4 No Parent Material Adverse Effect. Since the date of this
Agreement, there shall not have occurred any Parent Material Adverse
Effect. \t\t

 \t\t

 \t\t\tSection 9 TERMINATION \t\t

 \t\t

 \t\t\t9.1 Termination. This Agreement may be terminated prior to the
Effective Time (whether before or after adoption of this Agreement by the
Company's members and whether before or after approval of the Required Parent
Stockholder Matters by Parent's stockholders, unless otherwise specified
below): \t\t

 \t\t

 \t\t\t(a) by mutual written consent of Parent and the Company; \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-54-  \t\t

  

 \t\t

 \t\t

 \t\t\t(b) by either Parent or the Company if the Contemplated
Transactions shall not have been consummated by June 15, 2020 (subject to
extension to July 15, 2020 if the SEC reviews the Registration Statement and
to possible extension as provided in this Section 9.1(b), the "End Date");
provided, however, that the right to terminate this Agreement under this
Section 9.1(b) shall not be available to the Company, on the one hand, or to
Parent, on the other hand, if such Party's action or failure to act has been a
principal cause of the failure of the Contemplated Transactions to occur on or
before the End Date and such action or failure to act constitutes a breach of
this Agreement, provided, further, however, that, in the event that a
request for additional information has been made by any Governmental Body, or
in the event that the SEC has not declared effective under the Securities Act
the Registration Statement by the date which is sixty (60) days prior to the
End Date, then either the Company or Parent shall be entitled to extend the
End Date for an additional sixty (60) days by written notice to the other the
Party; \t\t

 \t\t

 \t\t\t(c) by either Parent or the Company if a court of competent
jurisdiction or other Governmental Body shall have issued a final and
nonappealable order, decree or ruling, or shall have taken any other action,
having the effect of permanently restraining, enjoining or otherwise
prohibiting the Contemplated Transactions; \t\t

 \t\t

 \t\t\t(d) by Parent if the Required Company Member Vote shall not
have been obtained on the date that the Required Parent Stockholder Vote is
obtained; provided, however, that once the Required Company Member Vote has
been obtained, Parent may not terminate this Agreement pursuant to this
Section 9.1(d); \t\t

 \t\t

 \t\t\t(e) by either Parent or the Company if (i) the Parent
Stockholders' Meeting (including, if Parent seeks to terminate, any
adjournments and postponements thereof as described in Section 5.3(a)) shall
have been held and completed and Parent's stockholders shall have taken a
final vote on the Parent Stockholder Matters and (ii) the Required Parent
Stockholder Matters shall not have been approved at the Parent Stockholders'
Meeting (or at any adjournment or postponement thereof) by the Required Parent
Stockholder Vote. \t\t

 \t\t

 \t\t\t(f) by the Company (at any time prior to the approval of the
Required Parent Stockholder Matters by the Required Parent Stockholder Vote)
if a Parent Triggering Event shall have occurred; \t\t

 \t\t

 \t\t\t(g) by Parent (at any time prior to the Required Company Member
Vote being obtained) if a Company Triggering Event shall have occurred; \t\t

 \t\t

 \t\t\t(h) by the Company, upon a breach of any representation,
warranty, covenant or agreement set forth in this Agreement by Parent or
Merger Sub or if any representation or warranty of Parent or Merger Sub shall
have become inaccurate, in either case, such that the conditions set forth in
Section 8.1 or Section 8.2 would not be satisfied as of the time of such
breach or as of the time such representation or warranty shall have become
inaccurate; provided that the Company is not then in material breach of any
representation, warranty, covenant or agreement under this Agreement;
provided, further, that if such inaccuracy in Parent's or Merger Sub's
representations and warranties or breach by Parent or Merger Sub is curable by
the End Date by Parent or Merger Sub, then this Agreement shall not terminate
pursuant to this Section 9.1(h) as a result of such particular breach or
inaccuracy until the expiration of a 30-day period commencing upon delivery of
written notice from the Company to Parent or Merger Sub of such breach or
inaccuracy and its intention to terminate pursuant to this Section 9.1(h) (it
being understood that this Agreement shall not terminate pursuant to this
Section 9.1(h) as a result of such particular breach or inaccuracy if such
breach by Parent or Merger Sub is cured prior to such termination becoming
effective); \t\t

 \t\t

 \t\t\t(i) by Parent, upon a breach of any representation, warranty,
covenant or agreement set forth in this Agreement by the Company or if any
representation or warranty of the Company shall have become inaccurate, in
either case, such that the conditions set forth in Section 7.1 or Section 7.2
would not be satisfied as of the time of such breach or as of the time such
representation or warranty shall have become inaccurate; provided

 \t\t

  \t\t

  \t\t\t-55-  \t\t

  

that Parent is not then in material breach of any representation, warranty,
covenant or agreement under this Agreement; provided, further, that if such
inaccuracy in the Company's representations and warranties or breach by the
Company is curable by the End Date by the Company then this Agreement shall
not terminate pursuant to this Section 9.1(i) as a result of such particular
breach or inaccuracy until the expiration of a 30-day period commencing upon
delivery of written notice from Parent to the Company of such breach or
inaccuracy and its intention to terminate pursuant to this Section 9.1(i) (it
being understood that this Agreement shall not terminate pursuant to this
Section 9.1(i) as a result of such particular breach or inaccuracy if such
breach by the Company is cured prior to such termination becoming effective);
or \t\t

 \t\t

 \t\t\t(j) by Parent, at any time, if (i) Parent has received a
Superior Offer, (ii) Parent has complied with its obligations under Section
5.3(c) in order to accept such Superior Offer, (iii) Parent concurrently
terminates this Agreement and enters into a Permitted Alternative Agreement
with respect to such Superior Offer and (iv) within two Business Days of such
termination, Parent pays to the Company the Company Termination Fee and repays
and discharge all of its obligations under the Bridge Note. \t\t

 \t\t

 \t\t\t(k) by the Company, at any time, if (i) the Company has
received a Superior Offer, (ii) the Company has complied with its obligations
under Section 5.3(c) in order to accept such Superior Offer, (iii) the Company
concurrently terminates this Agreement and enters into a Permitted Alternative
Agreement with respect to such Superior Offer and (iv) within two Business
Days of such termination, the Company pays to Parent the Parent Termination
Fee less any amounts due it under the Bridge Note. \t\t

 \t\t

 \t\t\t9.2 Effect of Termination. In the event of the termination of
this Agreement as provided in Section 9.1, this Agreement shall be of no
further force or effect; provided, however, that (a) this Section 9.2,
Section 5.8, Section 9.3, Section 10 and the definitions of the defined
terms in such Sections shall survive the termination of this Agreement and
shall remain in full force and effect, and (b) the termination of this
Agreement and the provisions of Section 9.3 shall not relieve any Party of any
liability for fraud or for any willful or intentional breach of any
representation, warranty, covenant, obligation or other provision contained in
this Agreement. \t\t

 \t\t

 \t\t\t9.3 Expenses; Termination Fees. \t\t

 \t\t

 \t\t\t(a) Except as set forth in this Section 9.3, Section 5.6(d),
and Section 5.9, all fees and expenses incurred in connection with this
Agreement and the Contemplated Transactions shall be paid by the Party
incurring such expenses, whether or not the Merger is consummated; provided,
however, that Parent shall pay all fees and expenses incurred in relation to
the printing and filing with the SEC of the Registration Statement (including
any financial statements and exhibits) and any amendments or supplements
thereto and paid to a financial printer or the SEC. It is understood and
agreed that all fees and expenses incurred or to be incurred by the Parent in
connection with the Contemplated Transactions and preparing, negotiating and
entering into this Agreement and the performance of its obligations under this
Agreement are taken into account in the Budget. \t\t

 \t\t

 \t\t\t(b) If (i) this Agreement is terminated by the Company pursuant
to Section 9.1(f), (ii) an Acquisition Proposal with respect to Parent shall
have been publicly announced or disclosed or otherwise communicated to Parent
or the Parent Board after the date of this Agreement but prior to the
termination of this Agreement and (iii) within twelve months after the date of
such termination, Parent consummates a Subsequent Transaction in respect of
the Acquisition Proposal referred to in clause (ii), then Parent shall, within
ten (10) Business Days of such entry into a definitive agreement or
consummation of such Subsequent Transaction, (A) pay to the Company the
Company Termination Fee and (B) repay and discharge all of Parent's
obligations under the Bridge Note. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-56-  \t\t

  

 \t\t

 \t\t

 \t\t\t(c) If this Agreement is terminated by the Company or Parent
pursuant to Section 9.1(e), Parent shall (A) pay to the Company the Company
Termination Fee and (B) repay and discharge all of Parent's obligations under
the Bridge Note. \t\t

 \t\t

 \t\t\t(d) If this Agreement is terminated by Parent pursuant to
Section 9.1(j), Parent shall, within ten (10) Business Days of such
termination, (A) pay to the Company the Company Termination Fee and (B) repay
and discharge all of Parent's obligations under the Bridge Note. \t\t

 \t\t

 \t\t\t(e) If (i) this Agreement is terminated by Parent pursuant to
Section 9.1(g), (ii) an Acquisition Proposal with respect to the Company shall
have been publicly announced or disclosed or otherwise communicated to the
Company or the Company Managers after the date of this Agreement but prior to
the termination of this Agreement and (iii) within twelve months after the
date of such termination, the Company consummates a Subsequent Transaction in
respect of the Acquisition Proposal referred to in clause (ii), then the
Company shall pay to Parent the Parent Termination Fee less any amounts due it
under the Bridge Note within ten Business Days of such entry into a definitive
agreement or consummation of such Subsequent Transaction. \t\t

 \t\t

 \t\t\t(f) If this Agreement is terminated by the Company pursuant to
Section 9.1(k), the Company shall pay to Parent, within ten Business Days of
such termination, the Parent Termination Fee less any amounts due it under the
Bridge Note. \t\t

 \t\t

 \t\t\t(g) If this Agreement is terminated by the Parent pursuant to
Section 9.1(b) solely because the Company has not satisfied the Funding
Condition in Section 7.4 hereof by the End Date (other than by reason of
Parent's failure to assist the Company as provided in Section 5.19), then the
Company shall pay to Parent an amount equal to the Parent Termination Fee less
any amounts due it under the Bridge Note within ten Business Days of its
receiving such a notice of termination from Parent. \t\t

 \t\t

 \t\t\t(h) Any Company Termination Fee or Bridge Note repayment due
under this Section 9.3 shall be paid by wire transfer of same day funds. If a
Party fails to pay when due any amount payable by it under this Section 9.3,
then such Party shall (i) reimburse the other Party for reasonable costs and
expenses (including reasonable fees and disbursements of counsel) incurred by
it in connection with the collection of such overdue amount and the
enforcement by such Party of its rights under this Section 9.3, and (ii) such
Party shall pay to the other Party interest on such overdue amount (for the
period commencing as of the date such overdue amount was originally required
to be paid and ending on the date such overdue amount is actually paid to the
Company in full) at a rate per annum equal to the "prime rate" (as published
in The Wall Street Journal or any successor thereto) in effect on the date
such overdue amount was originally required to be paid. \t\t

 \t\t

 \t\t\t(i) The Parties agree that, subject to Section 9.2, payment of
the Company Termination Fee shall, in the circumstances in which it is owed in
accordance with the terms of this Agreement, constitute the sole and exclusive
remedy of the Company following the termination of this Agreement, it being
understood that in no event shall Parent be required to pay the amounts
payable pursuant to this Section 9.3 on more than one occasion and following
payment of the Company Termination Fee (x) Parent shall have no further
liability to the Company in connection with or arising out of this Agreement
or the termination thereof, any breach of this Agreement by Parent giving rise
to such termination, or the failure of the Contemplated Transactions to be
consummated, (y) neither the Company nor any of its Affiliates shall be
entitled to bring or maintain any other claim, action or proceeding against
Parent or Merger Sub or seek to obtain any recovery, judgment or damages of
any kind against such Parties (or any partner, member, stockholder, director,
officer, employee, Subsidiary, Affiliate, agent or other Representative of
such Parties) in connection with or arising out of this Agreement or the
termination thereof, any breach by any such Parties giving rise to such
termination or the failure of the Contemplated Transactions to be consummated
and (z) the Company and its Affiliates shall be precluded from any other
remedy against Parent, Merger Sub and their respective Affiliates, at law or
in equity or otherwise, in

 \t\t

  \t\t

  \t\t\t-57-  \t\t

  

connection with or arising out of this Agreement or the termination thereof,
any breach by such Party giving rise to such termination or the failure of the
Contemplated Transactions to be consummated. \t\t

 \t\t

 \t\t\t(j) The Parties agree that, subject to Section 9.2, payment of
the Parent Termination Fee shall, in the circumstances in which it is owed in
accordance with the terms of this Agreement, constitute the sole and exclusive
remedy of Parent following the termination of this Agreement, it being
understood that in no event shall the Company be required to pay the amounts
payable pursuant to this Section 9.3 on more than one occasion and following
payment of the Parent Termination Fee (x) the Company shall have no further
liability to Parent in connection with or arising out of this Agreement or the
termination thereof, any breach of this Agreement by the Company giving rise
to such termination, or the failure of the Contemplated Transactions to be
consummated, (y) neither Parent nor any of its Affiliates shall be entitled to
bring or maintain any other claim, action or proceeding against the Company or
seek to obtain any recovery, judgment or damages of any kind against such
Parties (or any partner, member, stockholder, director, officer, employee,
Subsidiary, Affiliate, agent or other Representative of such Parties) in
connection with or arising out of this Agreement or the termination thereof,
any breach by any such Parties giving rise to such termination or the failure
of the Contemplated Transactions to be consummated and (z) Parent and its
Affiliates shall be precluded from any other remedy against the Company and
its Affiliates, at law or in equity or otherwise, in connection with or
arising out of this Agreement or the termination thereof, any breach by such
Party giving rise to such termination or the failure of the Contemplated
Transactions to be consummated. \t\t

 \t\t

 \t\t\t(k) Each of the Parties acknowledges that (i) the agreements
contained in this Section 9.3 are an integral part of the Contemplated
Transactions, (ii) without these agreements, the Parties would not enter into
this Agreement and (iii) any amount payable pursuant to this Section 9.3 is
not a penalty, but rather is liquidated damages in a reasonable amount that
will compensate the Company in the circumstances in which such amount is
payable. \t\t

 \t\t

 \t\t\tSection 10 MISCELLANEOUS PROVISIONS \t\t

 \t\t

 \t\t\t10.1 Non-Survival of Representations and Warranties. The
representations and warranties of the Company, Parent and Merger Sub contained
in this Agreement or any certificate or instrument delivered pursuant to this
Agreement shall terminate at the Effective Time, and only the covenants that
by their terms survive the Effective Time and this Section 10 shall survive
the Effective Time. \t\t

 \t\t

 \t\t\t10.2 Amendment. This Agreement may be amended with the approval
the Parent Board, the Merger Sub Board and the Company Managers at any time
(whether before or after the adoption and approval of this Agreement by the
Company's members or before or after obtaining the Required Parent Stockholder
Vote); provided, however, that after any such approval of this Agreement by a
Party's stockholders, no amendment shall be made which by Law requires further
approval of such stockholders without the further approval of such
stockholders. This Agreement may not be amended except by an instrument in
writing signed on behalf of each of the Company, Merger Sub and Parent. \t\t

 \t\t

 \t\t\t10.3 Waiver. \t\t

 \t\t

 \t\t\t(a) No failure on the part of any Party to exercise any power,
right, privilege or remedy under this Agreement, and no delay on the part of
any Party in exercising any power, right, privilege or remedy under this
Agreement, shall operate as a waiver of such power, right, privilege or
remedy; and no single or partial exercise of any such power, right, privilege
or remedy shall preclude any other or further exercise thereof or of any other
power, right, privilege or remedy. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-58-  \t\t

  

 \t\t

 \t\t

 \t\t\t(b) No Party shall be deemed to have waived any claim arising
out of this Agreement, or any power, right, privilege or remedy under this
Agreement, unless the waiver of such claim, power, right, privilege or remedy
is expressly set forth in a written instrument duly executed and delivered on
behalf of such Party and any such waiver shall not be applicable or have any
effect except in the specific instance in which it is given. \t\t

 \t\t

 \t\t\t10.4 Entire Agreement; Counterparts; Exchanges by Electronic
Transmission. This Agreement and the other agreements referred to in this
Agreement constitute the entire agreement and supersede all prior agreements
and understandings, both written and oral, among or between any of the Parties
with respect to the subject matter hereof and thereof; provided, however, that
the Confidentiality Agreement shall not be superseded and shall remain in full
force and effect in accordance with its terms. This Agreement may be executed
in several counterparts, each of which shall be deemed an original and all of
which shall constitute one and the same instrument. The exchange of a fully
executed Agreement (in counterparts or otherwise) by all Parties by electronic
transmission in .PDF format shall be sufficient to bind the Parties to the
terms and conditions of this Agreement. \t\t

 \t\t

 \t\t\t10.5 Applicable Law; Jurisdiction. This Agreement shall be
governed by, and construed in accordance with, the Laws of the State of
Delaware, regardless of the Laws that might otherwise govern under applicable
principles of conflicts of laws. In any action or proceeding between any of
the Parties arising out of or relating to this Agreement or any of the
Contemplated Transactions, each of the Parties: (a) irrevocably and
unconditionally consents and submits to the exclusive jurisdiction and venue
of the Court of Chancery of the State of Delaware or, to the extent such court
does not have subject matter jurisdiction, the United States District Court
for the District of Delaware or, to the extent that neither of the foregoing
courts has jurisdiction, the Superior Court of the State of Delaware; (b)
agrees that all claims in respect of such action or proceeding shall be heard
and determined exclusively in accordance with clause (a) of this Section 10.5;
(c) waives any objection to laying venue in any such action or proceeding in
such courts; (d) waives any objection that such courts are an inconvenient
forum or do not have jurisdiction over any Party; (e) agrees that service of
process upon such Party in any such action or proceeding shall be effective if
notice is given in accordance with Section 10.8 of this Agreement; and (f)
irrevocably and unconditionally waives the right to trial by jury. \t\t

 \t\t

 \t\t\t10.6 Attorneys' Fees. In any action at law or suit in equity to
enforce this Agreement or the rights of any of the Parties, the prevailing
Party in such action or suit (as determined by a court of competent
jurisdiction) shall be entitled to recover its reasonable out-of-pocket
attorneys' fees and all other reasonable costs and expenses incurred in such
action or suit. \t\t

 \t\t

 \t\t\t10.7 Assignability. This Agreement shall be binding upon, and
shall be enforceable by and inure solely to the benefit of, the Parties and
their respective successors and permitted assigns; provided, however, that
neither this Agreement nor any of a Party's rights or obligations hereunder
may be assigned or delegated by such Party without the prior written consent
of the other Party, and any attempted assignment or delegation of this
Agreement or any of such rights or obligations by such Party without the other
Party's prior written consent shall be void and of no effect. \t\t

 \t\t

 \t\t\t10.8 Notices. All notices and other communications hereunder
shall be in writing and shall be deemed to have been duly delivered and
received hereunder (a) one Business Day after being sent for next Business Day
delivery, fees prepaid, via a reputable international overnight courier
service, (b) upon delivery in the case of delivery by hand, or (c) on the date
delivered in the place of delivery if sent by email or facsimile (with a
written or electronic confirmation of delivery) prior to 5:00 p.m. San
Francisco time, otherwise on the next succeeding Business Day, in each case to
the intended recipient as set forth below: \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t

  \t\t

  \t\t\t-59-  \t\t

  

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tif to Parent or Merger Sub:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tBioPharmX Corporation:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t115 Nicholson Lane,

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSan Jose, CA 95134

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tFacsimile: (305) 349-4833

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tAtt: Chief Executive Officer

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\twith a copy to (which shall not constitute notice):

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tAkerman LLP

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t350 East Las Olas Blvd.

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSuite 1600

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tFort Lauderdale, FL 33131

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tFacsimile: (305) 349-4833

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tAtt: Philip B. Schwartz, Esq.

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tif to the Company:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tTimber Pharmaceuticals, LLC

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t50 Tice Blvd, Suite A26

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tWoodcliff Lake, NJ 07677

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tE-mail: jkoconis@timberpharma.com

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tAtt: John Koconis, Chief Executive Officer

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\twith a copy to (which shall not constitute notice):

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t1251 Avenue of the Americas

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tNew York, New York 10020

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tFacsimile: +1 973-597-2477

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tE-mail: sskolnick@lowenstein.com

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tAtt: Steven M. Skolnick, Esq.

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t10.9 Cooperation. Each Party agrees to cooperate fully with the
other Party and to execute and deliver such further documents, certificates,
agreements and instruments and to take such other actions as may be reasonably
requested by the other Party to evidence or reflect the Contemplated
Transactions and to carry out the intent and purposes of this Agreement. \t\t

 \t\t

 \t\t\t10.10 Severability. Any term or provision of this Agreement that is
invalid or unenforceable in any situation in any jurisdiction shall not affect
the validity or enforceability of the remaining terms and provisions of this
Agreement or the validity or enforceability of the offending term or provision
in any other situation or in any other jurisdiction. If a final judgment of a
court of competent jurisdiction declares that any term or provision of this
Agreement is invalid or unenforceable, the Parties agree that the court making
such determination shall have the power to limit such term or provision, to
delete specific words or phrases or to replace such term or provision with a
term or provision that is valid and enforceable and that comes closest to
expressing the intention of the invalid or unenforceable term or provision,
and this Agreement shall be valid and enforceable as so modified. In the event
such court does not exercise the power granted to it in the prior sentence,
the Parties agree to replace such invalid or unenforceable term or provision
with a valid and enforceable term or provision that will achieve,

 \t\t

  \t\t

  \t\t\t-60-  \t\t

  

to the extent possible, the economic, business and other purposes of such
invalid or unenforceable term or provision. \t\t

 \t\t

 \t\t\t10.11 Other Remedies; Specific Performance. Except as otherwise
provided herein, any and all remedies herein expressly conferred upon a Party
will be deemed cumulative with and not exclusive of any other remedy conferred
hereby, or by law or equity upon such Party, and the exercise by a Party of
any one remedy will not preclude the exercise of any other remedy. The Parties
agree that irreparable damage for which monetary damages, even if available,
would not be an adequate remedy, would occur in the event that any Party does
not perform the provisions of this Agreement (including failing to take such
actions as are required of it hereunder to consummate this Agreement) in
accordance with its specified terms or otherwise breaches such provisions.
Accordingly, the Parties acknowledge and agree that the Parties shall be
entitled to an injunction, specific performance and other equitable relief to
prevent breaches of this Agreement and to enforce specifically the terms and
provisions hereof, in addition to any other remedy to which they are entitled
at law or in equity. Each of the Parties agrees that it will not oppose the
granting of an injunction, specific performance or other equitable relief on
the basis that any other Party has an adequate remedy at law or that any award
of specific performance is not an appropriate remedy for any reason at law or
in equity. Any Party seeking an injunction or injunctions to prevent breaches
of this Agreement shall not be required to provide any bond or other security
in connection with any such order or injunction. \t\t

 \t\t

 \t\t\t10.12 No Third Party Beneficiaries. Nothing in this Agreement,
express or implied, is intended to or shall confer upon any Person (other than
the Parties and the DandO Indemnified Parties to the extent of their respective
rights pursuant to Section 5.6) any right, benefit or remedy of any nature
whatsoever under or by reason of this Agreement. \t\t

 \t\t

 \t\t\t10.13 Construction. \t\t

 \t\t

 \t\t\t(a) References to "cash," "dollars" or "$" are to U.S.
dollars. \t\t

 \t\t

 \t\t\t(b) For purposes of this Agreement, whenever the context
requires: the singular number shall include the plural, and vice versa; the
masculine gender shall include the feminine and neuter genders; the feminine
gender shall include the masculine and neuter genders; and the neuter gender
shall include masculine and feminine genders. \t\t

 \t\t

 \t\t\t(c) The Parties have participated jointly in the negotiating
and drafting of this Agreement and agree that any rule of construction to the
effect that ambiguities are to be resolved against the drafting Party shall
not be applied in the construction or interpretation of this Agreement, and no
presumption or burden of proof shall arise favoring or disfavoring any Party
by virtue of the authorship of any provision of this Agreement. \t\t

 \t\t

 \t\t\t(d) As used in this Agreement, the words "include" and
"including," and variations thereof, shall not be deemed to be terms of
limitation, but rather shall be deemed to be followed by the words "without
limitation." \t\t

 \t\t

 \t\t\t(e) The use of the word "or" shall not be exclusive. \t\t

 \t\t

 \t\t\t(f) Except as otherwise indicated, all references in this
Agreement to "Sections," "Exhibits" and "Schedules" are intended to refer to
Sections of this Agreement and Exhibits and Schedules to this Agreement,
respectively. \t\t

 \t\t

 \t\t\t(g) Any reference to legislation or to any provision of any
legislation shall include any modification, amendment, re-enactment thereof,
any legislative provision substituted therefore and all rules, regulations,
and statutory instruments issued or related to such legislations. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-61-  \t\t

  

 \t\t

 \t\t

 \t\t\t(h) The bold-faced headings and table of contents contained in
this Agreement are for convenience of reference only, shall not be deemed to
be a part of this Agreement and shall not be referred to in connection with
the construction or interpretation of this Agreement. \t\t

 \t\t

 \t\t\t(i) The Parties agree that each of the Company Disclosure
Schedule and the Parent Disclosure Schedule shall be arranged in sections and
subsections corresponding to the numbered and lettered sections and
subsections contained in this Agreement. The disclosures in any section or
subsection of the Company Disclosure Schedule or the Parent Disclosure
Schedule shall qualify other sections and subsections in this Agreement to the
extent it is readily apparent on its face from a reading of the disclosure
that such disclosure is applicable to such other sections and
subsections. \t\t

 \t\t

 \t\t\t(j) Each of "delivered" or "made available" means, with
respect to any documentation, that prior to 11:59 p.m. (San Francisco time) on
the date that is two calendar days prior to the date of this Agreement (i) a
copy of such material has been posted to and made available by a Party to the
other Party and its Representatives in the electronic data room maintained by
such disclosing Party or (ii) such material is disclosed in the Parent SEC
Documents publicly made available on the SEC's Electronic Data Gathering
Analysis and Retrieval system. \t\t

 \t\t

 \t\t\t(k) Whenever the last day for the exercise of any privilege or
the discharge of any duty hereunder shall fall upon a Saturday, Sunday, or any
date on which banks in San Francisco, California are authorized or obligated
by Law to be closed, the Party having such privilege or duty may exercise such
privilege or discharge such duty on the next succeeding day which is a regular
Business Day. \t\t

 \t\t

 \t\t\t(Remainder of page intentionally left blank) \t\t

 \t\t

 \t\t\t \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-62-  \t\t

  

 \t\t

 \t\t

 \t\t\tIN WITNESS WHEREOF, the Parties have caused this Agreement to be
executed as of the date first above written. \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tBIOPHARMX CORPORATION

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tBy:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t/s/ David S. Tierney

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tName:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tDavid S. Tierney, M.D.

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTitle:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tPresident and Chief Executive Officer

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tBITI MERGER SUB, INC.

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tBy:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t /s/ Steven M. Bosacki

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tName:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tSteven M. Bosacki

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTitle:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tSecretary

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTIMBER PHARMACEUTICALS, LLC

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tBy:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t/s/ John Koconis

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tName:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tJohn Koconis

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tTitle:

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tChief Executive Officer

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-63-  \t\t

  

 \t\t

 \t\t

 \t\t\tEXHIBIT A \t\t

 \t\t

 \t\t\tCERTAIN DEFINITIONS \t\t

 \t\t

 \t\t\t(a) For purposes of this Agreement (including this Exhibit A): \t\t

 \t\t

 \t\t\t"Acquisition Inquiry" means, with respect to a Party, an inquiry,
indication of interest or request for information (other than an inquiry,
indication of interest or request for information made or submitted by the
Company, on the one hand, or Parent, on the other hand, to the other Party)
that would reasonably be expected to lead to an Acquisition Proposal. \t\t

 \t\t

 \t\t\t"Acquisition Proposal" means, with respect to a Party, any offer or
proposal, whether written or oral (other than an offer or proposal made or
submitted by or on behalf of the Company or any of its Affiliates, on the one
hand, or by or on behalf of Parent or any of its Affiliates, on the other
hand, to the other Party) contemplating or otherwise relating to any
Acquisition Transaction with such Party. \t\t

 \t\t

 \t\t\t"Acquisition Transaction" means any transaction or series of related
transactions involving: \t\t

 \t\t

 \t\t\t(a) any merger, consolidation, amalgamation, share exchange, business
combination, issuance of securities, acquisition of securities,
reorganization, recapitalization, tender offer, exchange offer or other
similar transaction: (i) in which a Party is a constituent entity; (ii) in
which a Person or "group" (as defined in the Exchange Act and the rules
promulgated thereunder) of Persons directly or indirectly acquires beneficial
or record ownership of securities representing more than 20% of the
outstanding securities of any class of voting securities of a Party or any of
its Subsidiaries; or (iii) in which a Party or any of its Subsidiaries issues
securities representing more than 20% of the outstanding securities of any
class of voting securities of such Party or any of its Subsidiaries; or \t\t

 \t\t

 \t\t\t(b) any sale, lease, exchange, transfer, license, acquisition or
disposition of any business or businesses or assets that constitute or account
for 20% or more of the consolidated book value or the fair market value of the
assets of a Party and its Subsidiaries, taken as a whole; provided, however,
that a transaction described in Section 4.4 of the Parent Disclosure Schedules
shall not constitute an Acquisition Transaction.. \t\t

 \t\t

 \t\t\t"Affiliate" of a Person means any other Person that directly or
indirectly, through one or more intermediaries, controls, is controlled by, or
is under common control with, such Person. The term "control" (including the
terms "controlled by" and "under common control with") means the possession,
directly or indirectly, of the power to direct or cause the direction of the
management and policies of a Person, whether through the ownership of voting
securities, by contract or otherwise. \t\t

 \t\t

 \t\t\t"Agreement" means the Agreement and Plan of Merger and Reorganization
to which this Exhibit A is attached, as it may be amended from time to
time. \t\t

 \t\t

 \t\t\t"Anticipated Closing Date" means the anticipated Closing Date (as
mutually agreed in good faith by Parent and the Company). \t\t

 \t\t

 \t\t\t"Bridge Note" means the senior secured notes issued this date by
Parent in the aggregate amount of $2,500,000, issued with a 10% original issue
discount, whereby certain investors (the "Bridge Investors") will advance
$2,250,000 to Parent in three tranches, which Bridge Note matures on the
maturity date set forth in the Credit Agreement relating to such Bridge
Note. \t\t

 \t\t

 \t\t\t"Bridge Warrant" means the common stock purchase warrant issued on the
date hereof to the Bridge Investors to purchase a number of shares of Parent
Common Stock equal to the Bridge Warrant Share Number. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-64-  \t\t

  

 \t\t

 \t\t

 \t\t\t"Bridge Warrant Share Number" means, initially, 2,255,336 shares of
Parent Common Stock as of the date hereof, which number of shares is subject
to adjustment as provided in the Bridge Warrant. \t\t

 \t\t

 \t\t\t "Budget" means the Parent's operating budget for the period from the
date hereof through the Closing as set forth in Section 4.1(a) of the Parent
Disclosure Schedule. \t\t

 \t\t

 \t\t\t"Business Day" means any day other than a Saturday, Sunday or other
day on which banks in New York, New York are authorized or obligated by Law to
be closed. \t\t

 \t\t

 \t\t\t"Cash and Cash Equivalents" means all (a) cash and cash equivalents
(excluding restricted cash), and (b) marketable securities, in each case,
determined in accordance with GAAP, consistently applied. \t\t

 \t\t

 \t\t\t"Code" means the Internal Revenue Code of 1986, as amended. \t\t

 \t\t

 \t\t\t"Company Affiliate" means any Person that is (or at any relevant time
was) under common control with the Company within the meaning of Sections
414(b), (c), (m) and (o) of the Code, and the regulations issued
thereunder. \t\t

 \t\t

 \t\t\t"Company Associate" means any current or former employee, independent
contractor, officer or manager of the Company. \t\t

 \t\t

 \t\t\t"Company Capitalization Representations" means the representations and
warranties of the Company set forth in Sections 2.6(a) and 2.6(c). \t\t

 \t\t

 \t\t\t"Company Common Equity" means the common Units of the Company. \t\t

 \t\t

 \t\t\t "Company Contract" means any Contract: (a) to which the Company is a
Party; (b) by which the Company or any Company IP Rights or any other asset of
the Company is or may become bound or under which the Company has, or may
become subject to, any obligation; or (c) under which the Company has or may
acquire any right or interest. \t\t

 \t\t

 \t\t\t"Company Equity" means all preferred and common membership interests
or Units of the Company. \t\t

 \t\t

 \t\t\t"Company ERISA Affiliate" means any corporation or trade or business
(whether or not incorporated) which is treated with the Company as a single
employer within the meaning of Section 414 of the Code. \t\t

 \t\t

 \t\t\t"Company Fundamental Representations" means the representations and
warranties of the Company set forth in Sections 2.1 (Due Organization;
Subsidiaries), 2.3 (Authority; Binding Nature of Agreement), 2.4 (Vote
Required), and 2.20 (No Financial Advisors). \t\t

 \t\t

 \t\t\t"Company IP Rights" means all Intellectual Property owned by, licensed
to, or controlled by the Company that is necessary for or used in the business
of the Company as presently conducted. \t\t

 \t\t

 \t\t\t"Company IP Rights Agreement" means any Contract governing, related to
or pertaining to any Company IP Rights. \t\t

 \t\t

 \t\t\t"Company Managers" means the managers of the Company. \t\t

 \t\t

 \t\t\t"Company Material Adverse Effect" means any Effect that, considered
together with all other Effects that have occurred prior to the date of
determination of the occurrence of a Company Material Adverse Effect, has or
would reasonably be expected to have a material adverse effect on the
business, condition (financial or

 \t\t

  \t\t

  \t\t\t-65-  \t\t

  

otherwise), assets, liabilities or results of operations of the Company;
provided, however, that Effects arising or resulting from the following shall
not be taken into account in determining whether there has been a Company
Material Adverse Effect: (a) general business or economic conditions affecting
the industry in which the Company operates, (b) acts of war, armed hostilities
or terrorism, (c) changes in financial, banking or securities markets or (d)
the taking of any action required to be taken by this Agreement; except in
each case with respect to clauses (a) through (c), to the extent
disproportionately affecting the Company, relative to other similarly situated
companies in the industries in which the Company operates. \t\t

 \t\t

 \t\t\t"Company Preferred Equity" means the preferred Units of the
Company. \t\t

 \t\t

 \t\t\t "Company Registered IP" means all Company IP Rights that are owned
by or exclusively licensed to the Company that are registered, filed or issued
under the authority of, with or by any Governmental Body, including all
Patents, registered Copyrights, and registered Trademarks (including domain
names) and all applications for any of the foregoing. \t\t

 \t\t

 \t\t\t "Company Termination Fee" means the greater of (a) $1,250,000 or (b)
the amount due to the Company under the Bridge Note \t\t

 \t\t

 \t\t\t"Company Triggering Event" shall be deemed to have occurred if: (a)
the Company shall have made a Company Managers Adverse Recommendation Change;
(b) the Company Managers or any committee thereof shall have publicly
approved, endorsed or recommended any Acquisition Proposal; or (c) the Company
shall have entered into any letter of intent or similar document or any
Contract relating to any Acquisition Proposal (other than a confidentiality
agreement permitted pursuant to Section 4.5). \t\t

 \t\t

 \t\t\t "Company VARs" means the value appreciation rights issued by the
Company. \t\t

 \t\t

 \t\t\t"Confidentiality Agreement" means the Confidentiality Agreement, dated
as of June 19, 2019, by and between the Company and Parent. \t\t

 \t\t

 \t\t\t"Consent" means any approval, consent, ratification, permission,
waiver or authorization (including any Governmental Authorization). \t\t

 \t\t

 \t\t\t"Contemplated Transactions" means the Merger and the other
transactions contemplated by this Agreement. \t\t

 \t\t

 \t\t\t"Contract" means, with respect to any Person, any agreement, contract,
subcontract, lease (whether for real or personal property), mortgage, license,
sublicense or other legally binding commitment or undertaking of any nature to
which such Person is a party or by which such Person or any of its assets are
bound or affected under applicable Law. \t\t

 \t\t

 \t\t\t "DGCL" means the General Corporation Law of the State of
Delaware. \t\t

 \t\t

 \t\t\t"DLLCA" means the Limited Liability Company Act of the State of
Delaware. \t\t

 \t\t

 \t\t\t"Effect" means any effect, change, event, circumstance, or
development. \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t"Encumbrance" means any lien, pledge, hypothecation, charge, mortgage,
security interest, lease, license, option, easement, reservation, servitude,
adverse title, claim, infringement, interference, option, right of first
refusal, preemptive right, community property interest or restriction or
encumbrance of any nature (including any restriction on the voting of any
security, any restriction on the transfer of any security or other asset, any
restriction

 \t\t

  \t\t

  \t\t\t-66-  \t\t

  

on the receipt of any income derived from any asset, any restriction on the
use of any asset and any restriction on the possession, exercise or transfer
of any other attribute of ownership of any asset). \t\t

 \t\t

 \t\t\t"Enforceability Exceptions" means the (a) Laws of general application
relating to bankruptcy, insolvency and the relief of debtors; and (b) rules of
law governing specific performance, injunctive relief and other equitable
remedies. \t\t

 \t\t

 \t\t\t"Entity" means any corporation (including any non-profit corporation),
partnership (including any general partnership, limited partnership or limited
liability partnership), joint venture, estate, trust, company (including any
company limited by shares, limited liability company or joint stock company),
firm, society or other enterprise, association, organization or entity, and
each of its successors. \t\t

 \t\t

 \t\t\t"Environmental Law" means any federal, state, local or foreign Law
relating to pollution or protection of human health or the environment
(including ambient air, surface water, ground water, land surface or
subsurface strata), including any Law or regulation relating to emissions,
discharges, releases or threatened releases of Hazardous Materials, or
otherwise relating to the manufacture, processing, distribution, use,
treatment, storage, disposal, transport or handling of Hazardous
Materials. \t\t

 \t\t

 \t\t\t"ERISA" means the Employee Retirement Income Security Act of 1974, as
amended. \t\t

 \t\t

 \t\t\t"Exchange Act" means the Securities Exchange Act of 1934. \t\t

 \t\t

 \t\t\t"Exchange Agreement" means that certain Exchange Agreement, dated as
of January 28, 2020, by and between Parent and the investors signatory thereto
(the "Warrant Investors"), pursuant to which Parent has agreed, in reliance on
Section 3(a)(9) of the Securities Act, to exchange with the Warrant Investors
all of the warrants set forth on the Warrant Investors' respective signature
pages thereto for the number of shares of Parent Common Stock set forth on the
Warrant Investors' respective signature pages thereto, which equals 850,000
shares in the aggregate. \t\t

 \t\t

 \t\t\t"GAAP" means generally accepted accounting principles and practices in
effect from time to time within the United States applied consistently
throughout the period involved. \t\t

 \t\t

 \t\t\t"Governmental Authorization" means any: (a) permit, license,
certificate, franchise, permission, variance, exception, order, clearance,
registration, qualification or authorization issued, granted, given or
otherwise made available by or under the authority of any Governmental Body or
pursuant to any Law; or (b) right under any Contract with any Governmental
Body. \t\t

 \t\t

 \t\t\t"Governmental Body" means any: (a) nation, state, commonwealth,
province, territory, county, municipality, district or other jurisdiction of
any nature; (b) federal, state, local, municipal, foreign or other government;
(c) governmental or quasi-governmental authority of any nature (including any
governmental division, department, agency, commission, bureau,
instrumentality, official, ministry, fund, foundation, center, organization,
unit, body or Entity and any court or other tribunal, and for the avoidance of
doubt, any Taxing authority); or (d) self-regulatory organization (including
the NYSE American Market). \t\t

 \t\t

 \t\t\t"Hazardous Materials" means any pollutant, chemical, substance and any
toxic, infectious, carcinogenic, reactive, corrosive, ignitable or flammable
chemical, or chemical compound, or hazardous substance, material or waste,
whether solid, liquid or gas, that is subject to regulation, control or
remediation under any Environmental Law, including without limitation, crude
oil or any fraction thereof, and petroleum products or by-products. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-67-  \t\t

  

 \t\t

 \t\t

 \t\t\t"Intellectual Property" means any and all intellectual and industrial
property rights and other similar proprietary rights, in any jurisdiction
throughout the world, whether registered or unregistered, including all rights
pertaining to or deriving from: (a) patents and patent applications,
(including any and all provisionals, continuations, continuations-in-part,
continued prosecution, divisionals and patents of addition; requests for, and
grants of, continued examination, extensions, supplemental protection
certificates, re-examinations, post-grant confirmations or amendments,
counterparts claiming priority from, or reissues of, any of the foregoing; and
any patents or patent applications that claim priority to or from any of the
foregoing) and all rights to claim priority arising from or related to any of
the foregoing (collectively, "Patents"); (b) inventions, invention
disclosures, discoveries and improvements, whether or not patentable; (c)
copyrights and works of authorship, whether or not copyrightable
("Copyrights"); (d) computer software and firmware, including data files,
source code, object code and software-related specifications and
documentation; (e) trademarks, trade names, service marks, certification
marks, service names, brands, trade dress and logos, applications therefore,
and the goodwill associated therewith (collectively, "Trademarks"); (f) trade
secrets (including those trade secrets defined in the Uniform Trade Secrets
Act and under corresponding foreign statutory Law and common law), non-public
information, and confidential information, know-how, business and technical
information, and rights to limit the use or disclosure thereof by any Person
(collectively "Trade Secrets"); (g) mask works; (h) domain names; (i)
proprietary databases and data compilations and all documentation relating to
the foregoing; and, including in each case any and all (1) rights under which
an employee, inventor, author or other person is obligated to assign ownership
any of the foregoing; (2) registrations of, applications to register, and
renewals of, any of the foregoing with or by any Governmental Body in any
jurisdiction throughout the world, (3) rights of action arising from the
foregoing, including all claims for damages by reason of present, past and
future infringement, misappropriation, violation misuse or breach of contract
in respect of the foregoing, and present, past and future rights to sue and
collect damages or seek injunctive relief for any such infringement,
misappropriation, violation, misuse or breach; and (4) income, royalties and
any other payments now and hereafter due and/or payable in respect of the
foregoing. \t\t

 \t\t

 \t\t\t"IRS" means the United States Internal Revenue Service. \t\t

 \t\t

 \t\t\t"Key Employee" means, with respect to the Company or Parent, an
executive officer of such Party or any employee of such Party that reports
directly to the board of directors, or the managers of such Party or to the
Chief Executive Officer or Chief Operating Officer of such Party. \t\t

 \t\t

 \t\t\t"Knowledge" means, with respect to an individual, that such individual
is actually aware of the relevant fact or such individual would reasonably be
expected to know such fact in the ordinary course of the performance of such
individual's employment responsibilities. Any Person that is an Entity shall
have Knowledge if any officer or director of such Person as of the date such
knowledge is imputed has Knowledge of such fact or other matter. The
Knowledge Group for each of Parent and the Company shall be the four
individuals listed in Section K of their respective Disclosure
Schedules. \t\t

 \t\t

 \t\t\t"Law" means any federal, state, national, foreign, material local or
municipal or other law, statute, constitution, principle of common law,
resolution, ordinance, code, edict, decree, rule, regulation, ruling or
requirement issued, enacted, adopted, promulgated, implemented or otherwise
put into effect by or under the authority of any Governmental Body (including
under the authority of the NYSE American Market or the Financial Industry
Regulatory Authority). \t\t

 \t\t

 \t\t\t"Legal Proceeding" means any action, suit, litigation, arbitration,
proceeding (including any civil, criminal, administrative, investigative or
appellate proceeding), hearing, inquiry, audit, examination or investigation
commenced, brought, conducted or heard by or before, or otherwise involving,
any court or other Governmental Body or any arbitrator or arbitration
panel. \t\t

 \t\t

 \t\t\t"Merger Sub Board" means the board of directors of Merger Sub. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-68-  \t\t

  

 \t\t

 \t\t

 \t\t\t"Ordinary Course of Business" means, in the case of each of the
Company and Parent, such actions taken in the ordinary course of its normal
operations and consistent with its past practices. \t\t

 \t\t

 \t\t\t"Organizational Documents" means, with respect to any Person (other
than an individual), (a) the certificate or articles of association or
incorporation or organization or limited partnership or limited liability
company, and any joint venture, limited liability company, operating or
partnership agreement and other similar documents adopted or filed in
connection with the creation, formation or organization of such Person and (b)
all bylaws, regulations and similar documents or agreements relating to the
organization or governance of such Person, in each case, as amended or
supplemented. \t\t

 \t\t

 \t\t\t"Parent Affiliate" means any Person that is (or at any relevant time
was) under common control with Parent within the meaning of Sections 414(b),
(c), (m) and (o) of the Code, and the regulations issued thereunder. \t\t

 \t\t

 \t\t\t"Parent Associate" means any current or former employee, independent
contractor, officer or manager of Parent. \t\t

 \t\t

 \t\t\t"Parent Balance Sheet" means the unaudited balance sheet of Parent as
of October 31, 2019 (the "Parent Balance Sheet Date"), included in Parent's
Report on Form 10-Q for the quarterly period ended October 31, 2019, as filed
with the SEC. \t\t

 \t\t

 \t\t\t"Parent Board" means the board of directors of Parent. \t\t

 \t\t

 \t\t\t"Parent Capitalization Representations" means the representations and
warranties of Parent set forth in Sections 3.6(a) and 3.6(c). \t\t

 \t\t

 \t\t\t"Parent Closing Price" means the volume weighted average closing
trading price of a share of Parent Common Stock on the NYSE American Market
for the five consecutive trading days ending five trading days immediately
prior to the date upon which the Merger becomes effective. \t\t

 \t\t

 \t\t\t"Parent Common Stock" means the common stock, $0.001 par value per
share, of Parent. \t\t

 \t\t

 \t\t\t"Parent Contract" means any Contract: (a) to which Parent is a party;
(b) by which Parent or any Parent IP Rights or any other asset of Parent is or
may become bound or under which Parent has, or may become subject to, any
obligation; or (c) under which Parent has or may acquire any right or
interest. \t\t

 \t\t

 \t\t\t"Parent ERISA Affiliate" means any corporation or trade or business
(whether or not incorporated) which is treated with Parent or any of its
Subsidiaries as a single employer within the meaning of Section 414 of the
Code. \t\t

 \t\t

 \t\t\t"Parent Fully Diluted Number" means the fully diluted number of shares
of Parent Common Stock, including all shares issued and outstanding, all
shares issued or issuable pursuant to the Exchange Agreement, an amount of
shares that would be issued (whether or not actually issued) pursuant to the
exchange, prior to the Effective Time, of all of the warrants outstanding as
of the date hereof (other than those held by the Warrant Investors) in each of
the classes of warrants from which warrants held by the Warrant Investors will
be exchanged pursuant to the Exchange Agreement, assuming the same ratio of
shares per warrant as is used in the Exchange Agreement for the warrants of
the Warrant Investors from the applicable class, and all shares reserved for
issuance with respect to any other outstanding stock options, warrants,
convertible notes or other convertible debt or equity securities, but not (a)
awards under the Parent Stock Plan or warrants issued in connection with any
financing that in either case are either (i) "out of the money" (i.e., having
an exercise price that is greater than the Parent Closing

 \t\t

  \t\t

  \t\t\t-69-  \t\t

  

Price on the Anticipated Closing Date) or (ii) will be cancelled without
liability to Parent at or prior to the Closing Date or (b) the Bridge
Warrant. \t\t

 \t\t

 \t\t\t"Parent Fundamental Representations" means the representations and
warranties of Parent and Merger Sub set forth in Sections 3.1(a) (Due
Organization; Subsidiaries), 3.3 (Authority; Binding Nature of Agreement), 3.4
(Vote Required) and 3.18 (No Financial Advisors). \t\t

 \t\t

 \t\t\t"Parent IP Rights" means all Intellectual Property owned by, licensed
to, or controlled by Parent that is necessary for or used in the business of
Parent as presently conducted. \t\t

 \t\t

 \t\t\t"Parent Material Adverse Effect" means any Effect that, considered
together with all other Effects that have occurred prior to the date of
determination of the occurrence of a Parent Material Adverse Effect, has or
would reasonably be expected to have a material adverse effect on the
business, condition (financial or otherwise), assets, liabilities or results
of operations of Parent; provided, however, that Effects arising or resulting
from the following shall not be taken into account in determining whether
there has been a Parent Material Adverse Effect: (a) general business or
economic conditions affecting the industry in which Parent operates, (b) acts
of war, armed hostilities or terrorism, (c) changes in financial, banking or
securities markets, or (d) the taking of any action required to be taken by
this Agreement. \t\t

 \t\t

 \t\t\t"Parent Net Cash" means the amount, whether positive or negative, of
Parent's Cash and Cash Equivalents after the Closing (taking into account,
for the avoidance of doubt, the state of affairs necessary for Parent to cause
to be delivered the certificate referenced in Section 8.3(c)), determined in a
manner consistent with the manner in which such items were determined in the
Budget; provided, however, that (a) no amounts incurred by Parent in excess
of projected amounts included in the Budget line items for Printer and
Broadridge/Mediant shall reduce Parent Net Cash and (b) no amounts included
under Public Company Expenses at the end of the Parent Budget (i.e., NYSE
Annual Listing Fees, FY 1.31.2020 Audit, reverse stock split implementation
and FINRA Fee) shall be included in determining Parent Net Cash, but (c) all
other obligations and liabilities existing or incurred by Parent through
consummation of the Merger and Closing shall be included in reducing Cash and
Cash Equivalents and determining Parent Net Cash.  \t\t

 \t\t

 \t\t\t"Parent Net Cash Schedule" means a written schedule prepared and
certified by the Chief Accounting Officer of Parent, on behalf of Parent and
not in his or her personal capacity, setting forth, in reasonable detail,
Parent's good faith estimate of Parent Net Cash as of the Anticipated Closing
Date. \t\t

 \t\t

 \t\t\t"Parent Options" means options or other rights to purchase shares of
Parent Common Stock issued by Parent. \t\t

 \t\t

 \t\t\t"Parent Preferred Stock" means the preferred stock, $0.001 par value
per share, of Parent. \t\t

 \t\t

 \t\t\t"Parent Registered IP" means all Parent IP Rights that are owned by or
exclusively licensed to Parent that are registered, filed or issued under the
authority of, with or by any Governmental Body, including all Patents,
registered Copyrights, and registered Trademarks (including domain names) and
all applications for any of the foregoing. \t\t

 \t\t

 \t\t\t"Parent Termination Fee" means the greater of (a) $1,250,000 or (b)
the amount due to the Company under the Bridge Note. \t\t

 \t\t

 \t\t\t"Parent Triggering Event" shall be deemed to have occurred if: (a)
Parent shall have failed to include in the Proxy Statement the Parent Board
Recommendation or shall have made a Parent Board Adverse Recommendation
Change; (b) the Parent Board or any committee thereof shall have publicly
approved, endorsed

 \t\t

  \t\t

  \t\t\t-70-  \t\t

  

or recommended any Acquisition Proposal; or (c) Parent shall have entered into
any letter of intent or similar document or any Contract relating to any
Acquisition Proposal (other than a confidentiality agreement permitted
pursuant to Section 4.4). \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t"Party" or "Parties" means the Company, Merger Sub and Parent. \t\t

 \t\t

 \t\t\t"Permitted Alternative Agreement" means a definitive agreement that
contemplates or otherwise relates to an Acquisition Transaction that
constitutes a Superior Offer. \t\t

 \t\t

 \t\t\t"Permitted Encumbrance" means: (a) any liens for current Taxes not yet
due and payable or for Taxes that are being contested in good faith and for
which adequate reserves have been made on the Company Unaudited Balance Sheet
or the Parent Balance Sheet, as applicable; (b) minor liens that have arisen
in the Ordinary Course of Business and that do not (in any case or in the
aggregate) materially detract from the value of the assets or properties
subject thereto or materially impair the operations of the Company or any of
its Subsidiaries or Parent, as applicable; (c) statutory liens to secure
obligations to landlords, lessors or renters under leases or rental
agreements; (d) deposits or pledges made in connection with, or to secure
payment of, workers' compensation, unemployment insurance or similar programs
mandated by Law; (e) non-exclusive licenses of Intellectual Property granted
by the Company or any of its Subsidiaries or Parent, as applicable, in the
Ordinary Course of Business and that do not (in any case or in the aggregate)
materially detract from the value of the Intellectual Property subject
thereto; and (f) statutory liens in favor of carriers, warehousemen, mechanics
and materialmen, to secure claims for labor, materials or supplies. \t\t

 \t\t

 \t\t\t"Permitted Liabilities" shall mean (a) the Real Estate Lease, (b) the
Bridge Note and (c) any liabilities associated with any litigation challenging
the Contemplated Transactions. \t\t

 \t\t

 \t\t\t"Person" means any individual, Entity or Governmental Body. \t\t

 \t\t

 \t\t\t"Proxy Statement" means the proxy statement to be sent to Parent's
stockholders in connection with the Parent Stockholders' Meeting. \t\t

 \t\t

 \t\t\t"Real Estate Lease" means Parent's lease for 115 Nicholson Lane, San
Jose California 95134. \t\t

 \t\t

 \t\t\t"Registration Statement" means the registration statement on Form S-4
(or any other applicable form under the Securities Act to register Parent
Common Stock) to be filed with the SEC by Parent registering the public
offering and sale of Parent Common Stock to all holders of the Units of the
Company in the Merger, including all shares of Parent Common Stock to be
issued in exchange for all other Units of the Company in the Merger, as said
registration statement may be amended prior to the time it is declared
effective by the SEC. \t\t

 \t\t

 \t\t\t"Representatives" means directors, managers, officers, employees,
agents, attorneys, accountants, investment bankers, advisors and
representatives. \t\t

 \t\t

 \t\t\t"Sarbanes-Oxley Act" means the Sarbanes-Oxley Act of 2002. \t\t

 \t\t

 \t\t\t"SEC" means the United States Securities and Exchange
Commission. \t\t

 \t\t

 \t\t\t"Securities Act" means the Securities Act of 1933, as amended. \t\t

 \t\t

 \t\t\t"Subsequent Transaction" means any Acquisition Transaction (with all
references to 20% in the definition of Acquisition Transaction being treated
as references to 50% for these purposes).  \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-71-  \t\t

  

 \t\t

 \t\t

 \t\t\tAn entity shall be deemed to be a "Subsidiary" of a Person if such
Person directly or indirectly owns or purports to own, beneficially or of
record, (a) an amount of voting securities or other interests in such entity
that is sufficient to enable such Person to elect at least a majority of the
members of such entity's board of directors or other governing body, or (b) at
least 50% of the outstanding equity, voting, beneficial or financial interests
in such Entity. \t\t

 \t\t

 \t\t\t"Superior Offer" means an unsolicited bona fide written Acquisition
Proposal (with all references to 20% in the definition of Acquisition
Transaction being treated as references to greater than 50% for these
purposes) that: (a) was not obtained or made as a direct or indirect result of
a breach of (or in violation of) this Agreement; and (b) is on terms and
conditions that the Parent Board or the Company Managers, as applicable,
determines in good faith, based on such matters that it deems relevant
(including the likelihood of consummation thereof), as well as any written
offer by the other Party to this Agreement to amend the terms of this
Agreement, and following consultation with its outside legal counsel and
outside financial advisors, if any, are more favorable, from a financial point
of view, to Parent's stockholders or the Company's members, as applicable,
than the terms of the Contemplated Transactions. \t\t

 \t\t

 \t\t\t"Takeover Statute" means any "fair price," "moratorium," "control
share acquisition" or other similar anti-takeover Law. \t\t

 \t\t

 \t\t\t"Tax" means any federal, state, local, foreign or other tax, including
any income, capital gain, gross receipts, capital stock, profits, transfer,
estimated, registration, stamp, premium, escheat, unclaimed property, customs
duty, ad valorem, occupancy, occupation, alternative, add-on, windfall
profits, value added, severance, property, business, production, sales, use,
license, excise, franchise, employment, payroll, social security, disability,
unemployment, workers' compensation, national health insurance, withholding or
other taxes, duties, fees, assessments or governmental charges, surtaxes or
deficiencies thereof of any kind whatsoever, however denominated, and
including any fine, penalty, addition to tax or interest imposed by a
Governmental Body with respect thereto. \t\t

 \t\t

 \t\t\t"Tax Return" means any return (including any information return),
report, statement, declaration, estimate, schedule, notice, notification,
form, election, certificate or other document, and any amendment or supplement
to any of the foregoing, filed with or submitted to, or required to be filed
with or submitted to, any Governmental Body in connection with the
determination, assessment, collection or payment of any Tax or in connection
with the administration, implementation or enforcement of or compliance with
any Law relating to any Tax. \t\t

 \t\t

 \t\t\t"Timber Allocation Number" means (a) a number of shares of Parent
Common Stock such that the Timber Allocation Number (or TAN) divided by the
sum of the Timber Allocation Number plus the Parent Fully Diluted Number (or
PFDN) would equal the Timber Percentage (or TP), as further shown by the
formula that follows, less (b) 200,000 shares of Parent Common Stock (which
number shall be appropriately adjusted for any stock dividend, subdivision,
reclassification, recapitalization, split, combination or exchange of shares
or other like change between the date of this Agreement and the Effective
Time): \t\t

 \t\t

 \t\t\t![Picture 1](ex-2d1g001.jpg) \t\t

 \t\t

 \t\t\t"Timber Funding" means an equity financing to be consummated at or
immediately prior to the Closing whereby the Company receives gross proceeds
of not less than twenty million dollars ($20,000,000). The Timber membership
interests to be issued in the Timber Funding are part of the Timber
Percentage. \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-72-  \t\t

  

 \t\t

 \t\t

 \t\t\t"Timber Percentage" means 88.5%; provided however, that (a) if the
Real Estate Lease has not been terminated, subleased or fully discharged prior
to Closing, in a manner such that neither Parent not the Surviving Entity will
have any liability therefor at or after Closing then the Timber Percentage
shall be increased by one and one-half percentage points (1.5%), so that the
Timber Percentage would become 90% absent any adjustments pursuant to clauses
(b) and (c) below; (b) if the Parent Net Cash as of the Anticipated Closing
Date is higher than the amount projected for such date in the Budget, the
Timber Percentage will be decreased by one-tenth of one percentage point
(0.1%) for each full interval of $100,000 by which the Parent Net Cash exceeds
the applicable amount set forth in the Budget; and (c) if the Parent Net Cash
as of the Anticipated Closing Date is lower than as set forth in the Budget
for such date, the Timber Percentage will be increased by one-tenth of one
percentage point (0.1%) for each full interval of $100,000 by which the Parent
Net Cash is less than the applicable amount set forth in the Budget. Further,
if the Real Estate Lease is subleased so that not all of the liability
therewith is fully discharged, then the Timber Percentage shall be increased
by one-tenth of one percentage point (0.1%) for each full interval of $100,000
of remaining liability under the Real Estate Lease, up to a maximum of 1.5%,
as contemplated by clause (a) above. \t\t

 \t\t

 \t\t\t"Treasury Regulations" means the United States Treasury regulations
promulgated under the Code. \t\t

 \t\t

 \t\t\t"Units" means membership interests in the Company. \t\t

 \t\t

 \t\t\t(b) Each of the following terms is defined in the Section set forth
opposite such term: \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tTerm

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tSection

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tAllocation Certificate

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.14

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tAnti-Bribery Laws

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.22

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tBenefit Plan

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.17(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCapitalization Date

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.6(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCertificate of Merger

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.3

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCertifications

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.7(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tClosing

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.3

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tClosing Date

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.3

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tPreamble

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Audited Financial Statements

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.15

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Disclosure Schedule

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tSection 2

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Dispute Notice

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.17(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Financials

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.7(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Interim Financial Statements

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.15

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Managers Adverse Recommendation Change

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.2(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Managers Recommendation

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.2(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Material Contract

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.13(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Member Written Consent

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tRecitals

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Notice Period

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.2(c)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Permits

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.14(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Plans

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.6(c)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Products

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.14(d)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Real Estate Leases

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.11

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Regulatory Permits

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.14(d)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Stock Certificate

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.6

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Termination Fee

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t9.3(b)

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t \t\t

 \t\t

 \t\t

  \t\t

  \t\t\t-73-  \t\t

  

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCompany Unaudited Balance Sheet

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.7(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tContinuing Employees

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.5

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tCosts

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.6(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tDandO Indemnified Parties

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.6(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tDissenting Shares

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.8(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tDrug Regulatory Agency

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.14(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tEffective Time

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.3

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tEnd Date

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t9.1(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tExchange Agent

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.7(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tExchange Fund

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.7(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tFDA

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.14(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tFDCA

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.14(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tForeign Plans

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.17(m)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tHIPAA

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.14(g)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tIntended Tax Treatment

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.10(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tInvestor Agreements

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.21(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tLiability

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.9

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tMember Notice

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.2(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tMerger

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tRecitals

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tMerger Consideration

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.5(a)(i)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tMerger Sub

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tPreamble

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tName Change Proposal

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tNYSE Listing Application

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.9

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tPreamble

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Benefit Plan

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.17(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Board Adverse Recommendation Change

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Board Recommendation

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Designees

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.14

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Disclosure Schedule

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Financial Advisor

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.23

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent IP Agreements

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.10

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Material Contract

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.13(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Net Cash Response Date

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.17(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Notice Period

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3(c)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Permits

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.14(b)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Products

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.14(d)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Real Estate Leases

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.11

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Regulatory Permits

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.14(d)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent SEC Documents

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.7(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Stock Plan

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.6(c)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Stockholder Matters

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Stockholder Support Agreement

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\tRecitals

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Stockholders' Meeting

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tParent Termination Fee

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t9.3(e)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tPost-Closing Plans

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.5

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tPre-Closing Period

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t4.1(a)

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tRequired Company Member Vote

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t2.4

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tRequired Parent Stockholder Matters

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.4

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tRequired Parent Stockholder Vote

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t3.4

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t \t\t

 \t\t

 \t\t\t

 \t\t

  \t\t

  \t\t\t-74-  \t\t

  

 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tReverse Stock Split Proposal

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3

 \t\t\t\t \t\t\t 
---|--- 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tShare Issuance Proposal

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t5.3

 \t\t\t\t \t\t\t 
 \t\t\t \t\t\t\t \t\t\t\t\t

 \t\t\t\t\t\tSurviving Entity

 \t\t\t\t \t\t\t\t|  \t\t\t\t\t

 \t\t\t\t\t\t1.1

 \t\t\t\t \t\t\t 
 \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

 \t\t\t  \t\t

 \t\t

  \t\t

  \t\t\t-75-  \t\t

  

 \t    '

